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SUMMARY
This dissertation describes how the isolation and characterisation of ovine liver cytochrome
b5 was accomplished by referring to the following goals achieved in this study:
y The optimisation of the isolation and purification procedure for ovine liver
microsomal cytochrome b5 in order to obtain sufficient material for aggregation and
immunological studies.
y The removal of the membrane binding domain of cytochrome b5 by means of tryptic
digestion to establish the role of the carboxyl terminal in ovine cytochrome b5
aggregation.
y The raising of antibodies against both the trypsin truncated and intact forms of
cytochrome b5 to study the aggregation of the protein.
y The investigation into the influence of purified cytochrome b5 on steroidogenesis in
ovine adrenal microsomes.
OPSOMMING
Die isolering en karakterisering van skaaplewersitochroom b5, soos beskryf in hierdie
proefskrif, is uitgevoer deur die volgende doelwitte suksesvol af te handel:
y Die optimalisering van die prosedure vir die suksesvolle isolering en suiwering van
skaaplewersitochroom b5 ten einde genoegsame hoeveelhede van die suiwer proteïen
te hê vir die bestudering van die aggregasie van die proteïen sowel as ‘n
immunologiese studie.
y Die verwydering van die membraanbindingsdomein van sitochroom b5 om die invloed
van die karboksielterminaal op die aggregering van die proteïen te bestudeer.
y Die gebruik van sowel die tripties gesnyde as die intakte vorms van sitochroom b5 om
‘n immuunrespons in hase op te wek vir die verkryging van sitochroom b5 spesifieke
anti-liggame.
y Die gebruik van die gesuiwerde proteïene om die invloed van sitochroom b5 op
adrenale steroïdogenese te bestudeer.
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CHAPTER 1
INTRODUCTION
Cytochrome b5 was first observed in 1940 in liver homogenates as a cytochrome with a broad
α-peak in the region of 560nm (1). This new cytochrome was initially designated cytochrome
b1, but was later renamed by Strittmatter and Ball (2) to cytochrome m (microsomes) as the
pigment was detected in relative high concentrations in liver microsomes (2). In 1950, a
unique cytochrome was also detected in cecropia silkworm larvae (3). This pigment was later
designated cytochrome b5 by Pappenheimer and Williams (4), who concluded from the
position of the absorption bands that this cytochrome was the same as the cytochrome
observed by Keilin et al. in liver homogenates. Several years later, in 1956, the soluble form
of cytochrome b5 was isolated and partially characterised by Velick and Strittmatter (5).
 Cytochrome b5, an electron carrier for several oxygenases, is a small heme containing
protein that is found in both a soluble form, necessary for its function in the erythrocytes, and
a membrane bound form found in the endoplasmic reticulum and mitochondria (6).
Endoplasmic reticula of all cells in the body contain cytochrome b5, but the highest levels are
found in liver cells where cytochrome b5 participates in various biochemical reactions, such
as lipid biosynthesis, hepatic cholesterologenesis and N-glycolylneuraminic acid biosynthesis
(6). The hemoprotein is reduced by cytochrome b5 reductase with electrons derived from
NADH or from NADPH via cytochrome P450 reductase (7). It has been shown that the
presence of cytochrome b5 in the testis and adrenal gland also plays an important role in
steroidogenesis (8, 9). In the adrenal gland the protein can either inhibit or enhance certain
reactions through direct electron transfer or through an allosteric interaction with cytochrome
P450. Abnormalities in the levels of cytochrome b5 in any of the above mentioned cells can
lead to serious disorders, ranging from methemoglobinemia to Cushing’s syndrome (10, 11).
 Recombinant technology offers an attractive option to produce of cytochrome b5 for the
investigation of the physiological influences of the protein on cellular processes. Doebler et
al. (12) investigated the self association of cytochrome b5 in phosphatidylcholine vesicles.
Purified recombinant mutant cytochrome b5 was used in this study and he showed that self
association of cytochrome b5 in a phospholipid double membrane does not occur. During his
studies into the influence of cytochrome b5 on the lyase activity of cytochrome P450c17,
Miller et al. (13, 14) also used a recombinant protein. Initial studies of sheep liver
cytochrome b5 in our laboratory contradicted the work published by Doebler et al. (12). This
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observation of self-assembly prompted us to isolate and characterise native cytochrome b5
from sheep liver to further elucidate the self association of cytochrome b5 and to determine
the physiological significance, if any, of this association. The influence of purified full length
and trypsin truncated cytochrome b5 on ovine adrenal steroidogenesis was also investigated. 
Sequences for cytochrome b5 have been determined for a number of species that have been
studied, as shown in Chapter 2. These studies highlighted the wide range of activities that this
ubiquitous hemoprotein has exhibited in different mammalian species. In our laboratory,
ovine cytochrome b5, and its influence on ovine steroidogenesis, has been under investigation
for a number of years. Initial investigation of the structural properties of ovine liver
cytochrome b5 in our laboratory indicated that protein occurs mainly as an aggregate with a
relative molecular mass of ~60,000 Da. In an effort to dissociate the aggregate, various
methods where utilised of which a lowering of the pH from 8.1 to 5.2 was the most effective.
Immunoblots, using an antibody prepared against a monomeric isolate of cytochrome b5,
showed that the antibody recognised only the aggregated form of the hemoprotein. The same
antiserum, when applied in immunohistochemical studies, showed that cytochrome b5 was
concentrated in the cytoplasm of the cells of the zona fasciculata of the sheep adrenal cortex
(15).
Further experiments focused on the solubilization of the aggregated cytochrome b5 to obtain
the monomeric form of microsomal cytochrome b5. The membrane anchoring domain was
subsequently removed by means of controlled tryptic digestion. A product was obtained that
was smaller in size, but still retained its spectrophotometric properties. From this study
evidence was obtained that the hydrophobic membrane anchoring domain was involved in
the observed aggregation (16). This study utilised methods of Strittmatter et al. (17) and
Omura and Takesue (18) for the preparation of cytochrome b5 and the tryptic truncated form
of the protein from ovine liver. The yields from these methods were low and the results were
not reproducible. It was therefore not possible to make any definitive deduction about the
aggregation state of ovine microsomal cytochrome b5. A number of questions therefore
remain unanswered, of which the most intriguing was the aggregation state of ovine
cytochrome b5 in vivo and the influence of this aggregation on the physiological role of
cytochrome b5 in adrenal steroidogenesis.
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The current study was initiated with the following aims in mind:
1. to gain a thorough knowledge of the structure and functions of cytochrome b5 from
available literature;
2. to optimise the isolation and purification procedure for ovine liver microsomal
cytochrome b5 in order to obtain sufficient material for aggregation and
immunological studies;
3. to remove the membrane binding domain of cytochrome b5 by means of tryptic
digestion to establish the role of the carboxy terminal in ovine cytochrome b5
aggregation;
4. to raise antibodies against both the trypsin truncated and intact forms of cytochrome b5
to study the aggregation of the protein; and
5. to investigate the influence of purified cytochrome b5 on steroidogenesis in ovine
adrenal microsomes.
In Chapter 2 a review of the current knowledge of the structure, function and properties of
cytochrome b5 is given as background for the study.
 An alternative method for the isolation of ovine liver cytochrome b5 and the preparation of
trypsin truncated cytochrome b5 was developed in this study. This method used to isolate the
catalytic domain of cytochrome b5, produced a significant higher yield of active truncated
protein than isolation procedures used previously. These methods and the results obtained,
are discussed in Chapter 3.
An investigation into the aggregation states of ovine cytochrome b5 is described in Chapter 4.
The molecular mass of the purified ovine liver cytochrome b5 was 15,260 Da as determined
by electrospray mass spectrometry (ESMS). No other proteins with a higher or a lower
molecular mass were observed indicating a pure preparation. SDS-Polyacrylamide gel
electrophoresis (SDS PAGE), however, indicated multimeric forms of the protein, even after
stringent detergent and mercaptoethanol pre-treatment. Trypsin treatment of cytochrome b5
resulted in a truncated enzyme with a molecular mass of ±10,000 Da. The aggregation of
cytochrome b5 was abolished by the tryptic removal of the membrane binding region. 
High performance gel permeation chromatography (HPGPC) of the purified full length
cytochrome b5 showed two distinct molecular species, a monomer and a tetramer. The
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equilibrium between the monomeric and tetrameric form of the enzyme could be manipulated
by changes in the ionic strength of the elution buffer. In Western blot analyses antibodies
against the truncated protein recognised only the low molecular mass truncated form of the
protein and not the full length cytochrome b5, or any of the higher molecular mass
complexes. This result showed the involvement of the membrane binding domain of the
protein, not only in aggregation, but also in the quaternary structure which determined
epitope presentation for antibody production. Immunoblot analyses and
immunocytochemistry of adrenal tissue, using antibodies against the full length cytochrome
b5, indicated that the tetrameric form of the protein was in all probability the dominant specie
in vivo.
Serum containing antibodies raised against both the truncated and intact forms of ovine
cytochrome b5 was used in the above mentioned investigations. The antibody serum against
the intact form of the protein recognised the aggregated as well as the monomeric form of the
protein. A method was developed to separate antibodies recognising the tetrameric form of
the protein from antibodies recognising the monomeric form. Western blot analyses of
purified trypsin truncated and native cytochrome b5 as well as ovine adrenal, liver and
testicular microsomes showed that the tetrameric form of the protein prevailed in vivo. The
investigation into the aggregation of cytochrome b5 is presented in Chapter 5.
Cytochrome b5 has been shown to influence the 17,20-lyase activity of cytochrome P450c17
in vitro, apparently not through normal electron transfer. An allosteric mechanism for this
action of cytochrome b5 has been proposed by Auchus et al. (13). Chapter 6 deals with the
results obtained from our study into the effect of purified cytochrome b5 on ovine adrenal
steroidogenesis thus addressing our final aim. The results indicate that cytochrome b5 plays a
role in the regulation of the 17,20-lyase activity of cytochrome P450c17 in ovine adrenal
steroidogenesis.
In the final chapter conclusions are drawn from the results obtained in this study, and the
relevance and implications of these results are discussed.
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CHAPTER 2
CYTOCHROME b5: STRUCTURE, PROPERTIES AND
FUNCTIONS
1.1 INTRODUCTION
Cytochrome b5 is a small electron transfer hemoprotein and, in conjunction with cytochrome
b5 reductase, is capable of transferring or accepting a single electron originating from NADH
(1). It exists as both a soluble cytosolic protein and an amphipathic membrane-bound protein.
The main function of the soluble form is to maintain the oxygen carrying capacity of
hemoglobin in vivo by keeping it in a reduced state (2). A second form of cytochrome b5 was
isolated from the mitochondrial outer membrane by proteolytic digestion (3), but the
amphipathic properties of cytochrome b5 was only recognised when it was later purified in an
intact form in the presence of detergents (4, 5). 
Although the membrane-bound form exists at low levels in the endoplasmic reticulum of all
cells, the highest concentration is observed in the liver, where it provides reducing
equivalents in various biochemical reactions (6). Cytochrome b5 provides electrons for the
desaturases responsible for lipid biosynthesis. Cytochrome b5, together with cytochrome b5
reductase, was shown to be essential for the elongation reaction of N-glycolyleuraminic acid
by CMP-N-glycolyleuraminic acid hydroxylase (7). Reducing equivalents for the oxidation
of lanosterol, a cholesterol precursor, are provided by cytochrome b5 (8). 
Due to its pivotal role in physiological and biochemical processes, cytochrome b5 was the
subject of numerous studies from as early as the 1940’s. These investigations were hampered
by the amphipathic character of the protein as well as the low solubility of the full length
membrane bound form. Investigations have been facilitated by the availability of the
recombinant protein. The bovine form was the first cytochrome b5 gene to be isolated and
characterised. Crystallisation of cytochrome b5, together with amino acid residue alignments,
permitted the identification and characterisation of the heme- and membrane-binding
domains of the full length protein. The unique spectral properties as well as the stability of
cytochrome b5 makes it an ideal model for membrane bound protein.
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1.2 THE STRUCTURE OF CYTOCHROME b5
2.2.1 Genes encoding cytochrome b5
The soluble erythrocyte cytochrome b5 is very similar in amino acid sequence to the
hydrophilic part of the liver cytochrome b5. It has thus been suggested that the erythrocyte
form is deduced from the liver form by proteolytic action during erythroid maturation. This
hypothesis was experimentally supported by treating liver cytochrome b5 with lysosomal
proteases to yield two hydrophilic segments, one of which was indistinguishable from the
erythrocyte form (9). 
It was found that the sequences of the erythrocyte form were identical to the liver form,
except for the C-terminal residue when the amino acid sequences of the erythrocyte
cytochrome b5 of human, rabbit and porcine origin were compared to the liver cytochrome b5
of the same species. The residue at the end of the C-terminal of the erythrocyte form was
found to be proline in human and rabbit cytochrome b5 while for porcine it was a serine
residue. A threonine residue was found at the C-terminal end in the three species’
corresponding liver forms. This led to the suggestion that the two molecules are encoded by
different mRNA species (10). Giordano et al. (11) suggested that the two forms of
cytochrome b5 are derived from two almost identical genes or from a common precursor
mRNA through alternative splicing mechanisms.
It was found that the chicken DNA sequence was the same as that from liver cells when the
cDNA clone encoding for erythrocyte cytochrome b5 was isolated. The erythrocyte clone also
encoded a protein that was exactly the same as the liver form, complete with a hydrophobic
tail-region. These results led to the deduction that both forms are transcribed from a single
gene, with the erythrocyte form resulting from proteolytic processing. The difference in the
C-terminal residue between the two forms suggest the possible existence of a
post-translational modification (12).
mRNA encoding for soluble rabbit cytochrome b5 was demonstrated to be homologous to the
mRNA of the liver form, but due to the inclusion of an internal exon, was 24 bp longer.
Although the mRNA for the soluble form is longer, it encodes a smaller protein. This is due
to the presence of a termination codon in the additional exon. It was therefore suggested that
the mRNAs for the soluble and membrane-bound forms are derived from a common
precursor mRNA through alternative splicing mechanisms (11).
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The bovine form was the first cytochrome b5 gene to be isolated and characterised (figure
2.1). It showed that the gene is divided into six exons, including the non-functional exon 4,
and span about 28 kb. Consistent with other housekeeping genes, a TATA box is absent in
the 5´ flanking region while it contains two CAAT boxes and several G:C-rich SpI motifs.
The general size and organisation of the gene is comparable with that of the human and rabbit
genes. No sequence coding for soluble cytochrome b5 could be found in reticulocyte mRNA
but evidence for a transcribed pseudogene exists. It was thus concluded for bovine
cytochrome b5 that the soluble form is derived from the membrane-bound form by a
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Figure 2.1 Restriction map of the bovine cytochrome b5 gene. The hatched regions
represent 5’ and 3’ nontranslated sequences while the broken line represents
the region of the gene that has been sequenced. E: EcoRI H: HindIII B: BglII
(11).
The human gene for cytochrome b5 was mapped to chromosome 18. One of its pseudogenes
was mapped to the X-chromosome. This was done by means of restriction enzyme digestion
of PCR-amplified DNA (14).
2.2.2 Primary structure
In most mammals, liver cytochrome b5 is membrane bound comprising of 134 amino acids,
whereas soluble erythrocyte cytochrome b5 comprises of 98 amino acids (15). The two forms
are however indistinguishable in catalytic and spectral properties (16).
Initial isolations of cytochrome b5 from rabbit liver microsomes were achieved by pancreatic
lipase solubilization of the microsomes (17). In an adapted method, in the presence of trypsin
inhibitor, what was believed to be two different forms of cytochrome b5 was isolated from
calf liver. These two forms differed in that one contained a carboxyl-terminal glutamylserine
peptide sequence which was absent in the other. Tryptic digestion of either one of the two
proteins yielded the same core heme peptide by cleaving two peptides off each protein from
both the carboxyl-terminal and the amino-terminal ends (18).
A cytochrome b5 that was larger than the trypsin- or lipase-extracted enzyme was obtained
from rabbit liver microsomes when detergents instead of lipase were used to solubilise
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proteins. The detergent solubilized cytochrome b5 contained an additional 40 amino acids,
which formed an extremely hydrophobic appendage. The presence of this hydrophobic
appendage caused cytochrome b5 to aggregate when placed in an aqueous environment in the
absence of detergent (5).
Cytochrome b5 isolated from human and porcine erythrocytes consist of 97 amino acid
residues. The tryptic digested form, without its hydrophobic membrane binding domain,
contain about 90 residues, while intact porcine cytochrome b5 contain 133 residues (16). A
comparison between rabbit and calf liver microsomal cytochrome b5 showed that the rabbit
cytochrome was 4 residues longer at the NH2 terminal and differed with respect to 10 other
residues (19).
It was noted by Ozols (20) that the sequence of the cytosolic heme-binding domain, residues
1-96, was highly conserved. The different forms of cytochrome b5 all show a high degree of
sequence identity. In a review by Schenkman et al. (21), 15 different forms of cytochrome b5
from different phyla were compared. For all 15 forms, 12 of the ~134 amino acid residues
showed complete identity in alignment (19 if the bacterial alignment is not included). The
different mammalian species showed over 80% identity. The carboxy-terminal domains on
the other hand showed a somewhat lower identity (figure 2.2).
2.2.3 Secondary and tertiary structure
Cytochrome b5 is a small cylindrical acidic membrane protein consisting of 6 helices and 5
β-strands. The protein is folded into two domains, the larger of which is the cytosolic
heme-containing, amino-terminal, hydrophilic region. The smaller region is the hydrophobic,
membrane-binding, carboxyl portion of 14-18 residues. This domain is connected to the
globular domain by a proline-containing hinge region of ~7 amino acid residues and followed
by 7 polar amino acid residues (21, 22). Proteases can clip the protein before or after the
hinge region.
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Figure 2.2 Alignment of cytochrome b5 from different phyla. Accession numbers are
provided for the various forms of cytochrome b5. Forms include bacteria
(bacti), tobacco plant, housefly (MusDom), rat mitochondria outer membrane
(Rat_OMb5) and erythrocyte soluble protein (RBCsolpi). Asterisks above
alignments indicate fully conserved residues; plus signs above alignment
indicate acidic residues implicated in charge-pairing interactions with redox
partners. Black indicates identical residues for a position, gray indicates a
conservative substitution (such as an aspartate for glutamate or lysine for
arginine) (19).
2.2.3.1 Heme binding domain. The hydrophilic domain of cytochrome b5 contains a
non-covalently bound heme group. The heme is located in a hydrophobic pocket. Two highly
conserved histidine sidechains, His44 and His68 (figure 2.2), co-ordinate the heme-iron. The
heme is inserted in a cleft, between 4 α-helices, on the catalytic region with a heme edge
exposed to the environment (figure 2.3) (21, 23).
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Figure 2.3 Computer model (RasMol) of the structure of cytochrome b5 showing the 4
α-helices (pink) surrounding the heme.
A hydrophobic patch of 350 82 is found on the surface of cytochrome b5. This is an exception
to the rule that hydrophobic residues are primarily grouped in the interior of a protein
molecule (24). The hydrophobic patch, surrounded by negatively charged residues, consists
of amino acid residues, Phe40, Pro45, Leu75 and Phe79 as depicted in figure 2.2. Except for
residue Phe79 which is conservatively substituted for tyrosine, this patch is totally conserved
among different species. 
Phe/Tyr79 is partially exposed to the surface of cytochrome b5 and its buried surface contacts
the heme crevice (23). It has been claimed that this hydrophobic patch could be the second
electron transfer site of cytochrome b5 with its amphipathic redox partners although it has
been proven that Tyr79 is not necessary for the binding and electron transfer function. Nor is
it a determinant of the reduction potential or spectroscopic properties of cytochrome b5.
Rather, it seems to shield the heme from solvent and thus enhances the association of the
heme with the polypeptide chain of cytochrome b5 (25).
The Phe40 residue, which is closer to the heme than the Phe/Tyr79, plays an important role in
the stability of the protein. If the hydrophobic phenylalanine residue is replaced with a
slightly more hydrophilic hydroxyphenyl or imidazole, it disturbs the hydrophobicity of the
heme pocket, having a marked effect on the redox potential (26).
Several acidic residues around the exposed heme edge as well as one of the heme propionate
residues, protrude into a common plane in the solvent. These anionic residues are Glu49,
Glu53 and Asp65 (figure 2.2), of which residues Glu49 and Asp65 are highly conserved in
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all species examined, except in bacteria. These residues have been implicated in
charge-pairing interactions between cytochrome b5 and other electron transfer proteins,
indicating electrostatic forces stabilising the formation of redox complexes with cytochrome
b5 (21). 
2.2.3.2 Membrane-binding domain. Although not as highly conserved as the heme-binding
domain, considerable identity exists in the tail region, especially in the mammalian proteins
(27). The carboxyl termini of all cytochrome b5 proteins investigated so far exhibit a
hydrophobic stretch of ~23 residues with 10 residues at the carboxy terminal which are
thought to play an important role in membrane binding. It was in fact shown that these 10
residues are necessary for the targeting of cytochrome b5 to the endoplasmic reticulum (28).
High levels of free energy are required to remove charged and polar amino acid residues from
an aqueous environment and to bury the residues in a hydrophobic lipid bilayer. Charged and
polar residues will bind to the charged head groups of phospholipids in the endoplasmic
reticulum. In order to remove a polypeptide from an aqueous environment and insert it into a
hydrophobic lipid bilayer, the amino and carbonyl groups of the protein must be maximally
hydrogen bonded to one another to favour the negative change in free energy required for
insertion. A protein in the hydrophobic core of a membrane would be stable as either an
α-helix or as a β-barrel, as these are the simplest and energetically the most stable structures,
with all backbone amino and carbonyl groups hydrogen bonded to one another. In contrast, in
a two-stranded anti-parallel β structure, only one-half of the carbonyl and amino groups are
hydrogen bonded to one another. The structure with the highest number of hydrogen bonds
and highest thermodynamic stability, is the α-helix. This led Singer (29) to conclude that the
membrane-binding regions of proteins may largely be in an α-helical conformation.
Two different conformations for the membrane-binding domain of cytochrome b5 have been
proposed. One, a conventional transmembrane α-helix (30, 31) and the other a model where
both the amino and carboxyl termini are on the cytosolic side of the membrane due to a
hairpin loop in the α-helical hydrophobic segment (figure 2.4) (32, 33). This loop could
occur at Pro116 (figure 2.2) of the hydrophobic segment. More recent work, however, tends
to support the transmembrane model (34).
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Figure 2.4 Proposed model of cytochrome b5 residence in the membrane. A: The
trans-membrane model B: The hairpin loop model (35).
It was noted by Hanlon et al. (27) that the conformation could be the product of experimental
procedures followed when incorporating cytochrome b5 into lipid vesicles. When cytochrome
b5 was co-solubilized or sonicated with the lipid, it appears to adopt the transmembrane
conformation. When the cytochrome b5 was bound to the surface of a membrane initially,
even after heat treatment, it seems to span only half the membrane, like a hairpin.
Proteins inserted in the membrane of the endoplasmic reticulum or translocated into its lumen
either remain in the endoplasmic reticulum or are transported to another destination through
the secretory pathways (figure 2.5). 
2.2.4 Membrane targeting and binding
A protein must contain a specific signal for it to remain in the endoplasmic reticulum. Such
signals have been identified for both membrane-bound and lumenal proteins in the
endoplasmic reticulum. Rather than functioning on the retention of the proteins, these signals
appear to retrieve proteins that escaped the endoplasmic reticulum (36, 37). Many lumenal
proteins contain a KDEL or KDEL-like sequence on their C-teminals, which is recognised by
a recycling receptor. The endoplasmic reticulum membrane-bound proteins, type I and II,
will typically carry a double lysine or double arginine containing motif at the end of their
cytoplasmic domain (38, 39, 40). No signal has, however, been identified for the
tail-anchored proteins to date.
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Figure 2.5 Endoplasmic reticulum and the Golgi complex. Proteins that enter the
endoplasmic reticulum undergo the first steps of glycosylation at this point.
These proteins are carried to the cis face of the Golgi complex by vesicles that
bud off the endoplasmic reticulum. The vesicles that bud off the trans face of
the Golgi complex form lysosomes, peroxisomes, glycosomes or migrate to
the plasma membrane (reproduced from 42).
Three potential pathways for the targeting and incorporation of these proteins into the
endoplasmic reticulum membrane were revealed by the analyses of in vitro systems: 
(i) the signal-recognition-particle/signal-recognition-particle receptor-dependent pathway
(figure 2.6); (ii) the signal-recognition-particle/signal-recognition-particle receptor-
independent but receptor-mediated pathway, and (iii) the receptor independent and
hydrophobic insertion pathway (35, 41). 
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Figure 2.6 Sequence of events during the synthesis of proteins and their subsequent
targeting of the endoplasmic reticulum membrane. 1: Ribosomal binding to
the mRNA and initiation of translation; 2: The signal sequence is translated at
the 5’ end of the mRNA; 3: Recognition of signal sequence by signal
recognition particle (SRP) and the temporarily halting of further translation; 4:
The SRP recognize and bind to the SRP receptor (docking protein). The signal
sequence is inserted into the endoplasmic reticulum; 5: The SRP is released; 6:
Protein synthesis is resumed and the polypeptide chain is pulled through the
membrane; 7: Signal sequence is cleaved by signal peptidase. Proteins
destined to remain in the endoplasmic reticulum have peptidase resistant
signal sequences; 8: The protein enters the endoplasmic reticulum lumen and
the ribosome recycled (reproduced from 42).
Early studies into the incorporation of the membrane-bound form of cytochrome b5 in the
endoplasmic reticulum membrane concluded that the process is spontaneous and
promiscuous, i.e. pathway (iii) (receptor independent and hydrophobic insertion pathway)
(31, 33). This, according to more recent authors, will lead to intracellular chaos in vivo, as a
specific membrane receptor is needed for in vivo binding of cytochrome b5 to the
endoplasmic reticulum membrane and the subsequent functioning with its membrane
associated electron transfer partners (43).
Ten amino acid residues were identified on the C-terminal of cytochrome b5 as necessary for
targeting the endoplasmic reticulum (28). With these residues removed, targeting and binding
of cytochrome b5 to the endoplasmic reticulum membrane was abolished. When these ten
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residues were coupled to foreign proteins, it was found that these proteins targeted the
endoplasmic reticulum membrane (27). The proposed pathway for targeting and
incorporation of cytochrome b5 to the endoplasmic reticulum membrane is thus the
‘signal-recognition-particle/signal-recognition-particle receptor-independent, but
receptor-mediated’ pathway.
A second type of membrane bound cytochrome b5 exists. Mitochondrial cytochrome b5,
which is analogous to the endoplasmic reticulum form, is associated with the mitochondrial
outer membrane. Cytochrome b5 possibly has another mechanism for targeting either the
mitochondrial outer membrane or the endoplasmic reticulum membrane since one gene
presumably encodes a membrane-bound form. Recent results obtained with mammalian
cytochrome b5 indicated that the net charge at the extreme of the C-terminal plays a role in
targeting the protein to the membrane (44). The seven C-terminal residues of mammalian
endoplasmic reticulum cytochrome b5 were substituted with one or two arginine residues.
This resulted in targeting of the mitochondrial outer membrane by the endoplasmic isoform.
The insertion of a single threonine C-terminal residue also resulted in promiscuous
localisation. A protein possessing a net positive charge will favour the mitochondrial outer
membrane, while one with a net negative charge will favour the endoplasmic reticulum.
Analyses of cytochrome b5 sequences in the data bank revealed that only the mammalian
endoplasmic reticulum isoform showed a characteristic negative charge in the extreme
C-terminal portion (44). It is thus possible that in many organisms, cytochrome b5 is a
mitochondrial outer membrane protein, and not an endoplasmic reticulum protein. It was
therefore concluded by Borgese et al. (44) that the endoplasmic reticulum and the
mitochondrial outer membrane compete for the same polypeptide, while targeting occurs
directly from the cytosol.
The question of the mechanism of residence was addressed by tagging two versions of
cytochrome b5 with potential N- and O-glycosylation (N-glyc and O-glyc) sites at the
C-terminal extremity (45). The approach allowed discrimination between retention and
retrieval. The assay, based on carbohydrate acquisition by O-glyc cytochrome b5, showed
evidence that cytochrome b5 gained access to enzymes which are localised in the Golgi
complex and capable of catalysing the first steps of O-glycosylation. Although it is known
that Golgi enzymes slowly recycle through the endoplasmic reticulum, those which are
modified are not generally found in the endoplasmic reticulum. It is accepted that these
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enzymes are inactive in the endoplasmic reticulum. Glycosylation could be inhibited by the
addition of okadaic acid, a phosphatase inhibitor, which blocks transport out of the
endoplasmic reticulum. If the Golgi enzymes were active in the endoplasmic reticulum, the
addition of the inhibitor would not have been able to inhibit glycosylation due to the
entrapment of the circulating enzymes. The N-linked oligosaccharide provided no evidence
of retrieval from a downstream compartment. These results led to the suggestion that
cytochrome b5 recycles slowly between the endoplasmic reticulum and the cis-Golgi
complex. Furthermore, it was suggested that the sorting of tail-anchored proteins involve
both dynamic retrieval as well as retention (45).
1.3 PROPERTIES OF CYTOCHROME b5 
2.3.1 Relative molecular mass
Since the amino acid composition is highly conserved through all species, the relative
molecular mass for cytochrome b5 does not differ much among species. Initial studies
suggested that the relative molecular mass of pig liver and calf liver cytochrome b5 was
12,800 Da and 12,700 Da respectively (46, 47). These relative molecular masses were
determined by means of ultracentrifugation. A relative molecular mass of 16,000 Da was
obtained when cytochrome b5 was isolated from calf livers using detergents at a low
temperature to preserve the isolated proteins (48).
Reported relative molecular masses for different species were 16,900 Da for rabbit liver
microsomal cytochrome b5, values between 15,000 Da and 17,000 Da for pig liver
cytochrome b5 and 14,400 Da to 16,000 Da for calf liver cytochrome b5 (1, 48, 49). It was
only when mass spectrometric analyses were employed that the relative molecular mass
could be determined more accurately. The hydrophobic membrane binding domain of
cytochrome b5 was removed by means of tryptic digestion to enhance cytochrome b5
solubility in an aqueous medium prior to analyses. Although the trypsin solubilized form of
cytochrome b5 was used, valuable information about the structure could be gathered due to
the high accuracy of liquid secondary ion mass spectrometry (LSIMS) and tandem mass
spectrometry (MS/MS) analyses (values determined within a 2 Da accuracy). Relative
molecular masses for the solubilized forms of bovine and rabbit cytochrome b5 were
determined at 9,462.2 ±2 Da and 9,502.3 ±2 Darespectively. A second, larger form of
10,144.5 ±2 Da was observed for the rabbit cytochrome b5 which was attributed to a blocked
amino-terminal residue (6).
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2.3.2 Stability of cytochrome b5
Cytochrome b5 is stable at room temperature for days and indefinitely at -20°C (48). At a
neutral pH, the heme dissociates partly from the protein at temperatures between 50-70°C. At
temperatures higher than 70°C the heme dissociates completely. The dissociation reaction is
reversible after a short heating period (50). Work done on intact bovine microsomal
cytochrome b5 showed that, as opposed to the single transition during thermal unfolding of
the truncated hydrophilic protein, the intact protein exhibits two transitions. The midpoint
temperature for the hydrophilic variant is around 73°C while the midpoint temperatures for
the two transitions of the intact protein are around 43.4°C and 71°C (51). By the addition of a
non-ionic detergent to intact cytochrome b5 only one transition point was observed as
opposed to the reported two.
At a neutral to slightly alkaline pH and ionic strength of 0.02 to 0.4, cytochrome b5 forms
aggregates. Ito and Sato (4) reported octameric aggregation complexes in aqueous solution
which involve non-polar segments of the molecule. The heme peptide remains in the
monomeric state under these conditions while the non-polar segment alone forms high
molecular weight aggregates (48). At sufficiently high pH values, rearrangement of the heme
ligands takes place which gives a product with increased high-spin characteristics which can
be observed spectrophotometrically. This transition is reversible (46).
2.3.3 Spectral properties
There are three principal absorption bands in the absorption spectrum of many
ferrohemoproteins, called the cytochrome absorption bands. The bands, the α-band, β-band
and the γ-band (the Soret band), result from the absorption of radiation by the heme groups
(52). Oxidised cytochrome b5 exhibits an absorption maximum at 413nm in the Soret area.
Reduced cytochrome b5 shows absorption maxima at 556nm for the α-band, 526nm for the
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Figure 2.7 The absorption spectra of oxidised and reduced microsomal cytochrome b5
(15).
A wide range of reducing agents can be used to obtain the same spectrum in the visible
region. In a microsomal system, NADH is used as reducing agent in the presence of
cytochrome b5 reductase to distinguish cytochrome b5 from the other cytochromes present in
the solution (17, 49, 53). In a purified cytochrome b5 sample, in the absence of reductase, it
can be reduced with sodium dithionite. From the absorption values for the oxidised and
reduced forms, the concentration of cytochrome b5 in the solution can be determined by using
the Beer-Lambert law. The Beer-Lambert states that the absorbance of a beam of collimated
monochromatic radiation in a homogenous isotropic medium is proportional to the absorption
path length and to the concentration of the absorbing species. The law may be expressed by
the following relations:
∆A=εlc
Where ‘∆A’ represents the change in absorbance, ‘ε’ the molar (decadic) absorption
coefficient, ‘l’ the absorbance pathlength (in centimetre) and ‘c’ the concentration of the
substance (in molar) (52).
A microsomal suspension contains NADH cytochrome b5 reductase and cytochromes other
than just cytochrome b5, such as cytochrome P450. The suspension is therefore reduced with
NADH as only cytochrome b5 can utilise electrons originating from this electron donor. This
results in a rapid reduction of cytochrome b5 characterised by an increase in absorbance at
556nm and 426nm and a decrease of absorbance at 409nm. The cytochrome b5 content of the
25
suspension may be calculated from difference in absorbance between 556nm and 575nm
(∆A556-575) and by applying the millimolar absorbance coefficient of 21. Alternatively for
∆A426-409 the millimolar absorbance coefficient of 185 can be used (53).
In solutions where the cytochrome b5 is pure enough to record a spectrum of the oxidised
form, the cytochrome b5 concentration can be calculated by applying the molar absorbance
coefficient of 117,000 to the absorbance at 423nm of the oxidised form. Another method
would be to apply the molar absorbance coefficient of 100,000 to the difference in
absorbance between the oxidised and reduced forms at 424nm (53).
The paramagnetic susceptibility at 20° shows that cytochrome b5 has essentially low-spin
characteristics in both the reduced and oxidised states. The electron spin resonance
absorption of cytochrome b5 in frozen aqueous solution, at a neutral pH, shows the
characteristic features of an essentially low-spin compound with some high-spin
contributions. An increase in the pH (≥11.3) disrupts the heme with a concomitant gradual
change in the light absorption properties until a poor defined spectrum with a broad γ-band at
385nm and an increase in absorption at 610nm remains. As mentioned previously, this is due
to the formation of a product with increased high-spin character (46).
2.3.4 Reduction potential of cytochrome b5
The standard potential (Eo’) for cytochrome b5 has been determined at +0.02V at pH 7 from
equilibrium experiments (54). According to biochemical convention, the more positive the
value for Eo’, the more oxidising the compound. To put this value in perspective, it can be
compared to the standard potential of NAD+/NADH + H+, which is -0.32V.
When the reduction potential of cytochrome b5 was measured with potentiometric electrodes,
lower values were obtained than the more positive values (40-100mV) measured with surface
modified electrodes. Surface modified electrodes function on the basis of electrostatic
interaction of the modified surface with the protein. Such electrodes were used by Rivera et
al. (55) to determine the factors modulating the reduction potential of cytochrome b5.
Observed positive shifts in the voltametric measurements were thought to originate from the
complex formation between the modified surface of the electrode and cytochrome b5. This is
due to the fact that such a complex will neutralise the charge on the heme propionate on the
exposed heme edge and by excluding water from the complex interface, lower the dielectric
constant of the exposed heme microenvironment, both factors which result in the
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destabilisation of the positive charge on the ferric heme with respect to the neutral ferrous
heme. These results indicate that similar shifts in reduction potential may occur when
cytochrome b5 form a complex with its redox partners, prior to electron transfer. They
concluded that the reduction potential of cytochrome b5 is modulated by the heme edge
containing the exposed heme propionate, a heme methyl and a heme vinyl, all of which form
part of the surface of cytochrome b5 (55).
Interprotein complex formation immediately precedes electron transfer. The binding of
cytochrome b5 with its redox partners involves the cluster of negative charges around the
heme on the surface of the heme-binding domain. An anionic ring is formed around the heme
by carboxyl groups, including a heme propionate, which induce a dipole moment. This dipole
moment orientates the cytochrome b5 for effective interaction with the complementary,
positively charged dipole of its redox partner. Three of the seven anionic residues on the
cytochrome b5 surface are used for binding to specific basic residues on the redox partners
(56).
One of the first 1H-NMR studies of cytochrome b5 indicated that the solution structure of this
hemoprotein differs from the crystal structure. The solution structure consists of a mixture of
isomeric forms which differ from each other in the orientation of the heme-moeity by a 180°
rotation about the axis through the α and γ meso-carbon atoms (57). The two equilibrium
forms were designated A and B by Dangi et al. (58). They determined by NMR studies that
the most significant differences between the two forms were the presence of a hydrogen bond
between the 7-propionate and the Ser64 amide in the A form, but not in the B form as well as
a displacement of the heme group by 0.9 Å out of the binding pocket of the B form relative to
the A form. 
Factors which could contribute to the difference in reduction potentials in the bovine protein
include the differences in orientation of the axial imidazoles and differences in hydrogen
bond strength to the imidazoles (59). It would appear as though the major effector of the
reduction potential is the absence of the hydrogen bond to the S64 amide in the B form. The
absence of the hydrogen bond frees up the propionate to charge stabilise the iron in the
oxidised state and thus lowering the reduction potential.
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Although most of the work was done using trypsin-solubilised cytochrome b5, due to its
thermal stability and high solubility, evidence exists for the independent folding of the
hydrophilic and hydrophobic moieties in the intact molecule (60). It is thus unlikely that the
hydrophobic tail-region will affect the heme exchange in the catalytic domain.
1.4 FUNCTIONS OF CYTOCHROME b5
2.4.1. Lipid biosynthesis
2.4.1.1. Fatty acid desaturation. Cytochrome b5 participates in the aerobic unsaturated fatty
acid biosynthesis pathway in mammals. Electrons, which it received from
NADH-cytochrome b5, are donated to desaturases, a microsomal, cyanide-sensitive,
non-heme, iron-containing protein. These electrons are used to generate an electron-deficient







2 cytochrome b5 Fe2+ 2 cytochrome b5 Fe3+
2H+ + cytochrome b5 
reductase FAD
2H+ + cytochrome b5 
reductase FADH2
NADH + H+ NAD+A B
Figure 2.8 The fatty acid desaturase system. A: The flow of electrons from NADH to the
desaturase enzyme. B: A model depicting the location of the proteins involved
in the redox reactions in the membrane. (Redrawn 61)
As unsaturated fatty acids serve a structural role in cellular membrane fluidity, it is evident
that enzymes that catalyse fatty acid desaturation play an important role in the control of
membrane fluidity (62). Besides a structural role, unsaturated fatty acids are also the
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precursors for polyunsaturated fatty acids, which in turn are the precursors for
prostaglandins, thromboxanes and leukotrienes themselves.
Mammals possess at least three different microsomal fatty acid desaturases, namely ∆5, ∆6
and ∆9 desaturases. The ∆5 desaturase is the least well characterised of the three. Cytochrome
b5 participation in this desaturase reaction can only be assumed due its requirement for
NADH and oxygen. The ∆5 desaturase introduces a double bond between C5 and C6 of C20
fatty acids, producing eicosotrienoic acid and arachidonic acid.
Okayasu et al. (63) confirmed the involvement of cytochrome b5 in the ∆6 desaturase
reaction. The ∆6 desaturase introduces a double bond between C6 and C7 of the C18 fatty
acids, oleic acid, linoleic acid and linolenic acid. It has been suggested that ∆5 and ∆6
desaturase activities are present in the renal cortical microsomes, where they partially fulfil
the kidney’s need for arachidonic acid (64). During arachidonic acid synthesis in rat liver
microsomes, the ∆6 desaturation reaction is the rate-limiting step.
The ∆12 desaturation reaction catalyses for the formation of the essential fatty acids, linoleic
and linolenic acid. In plants, where ∆12 desaturation takes place, cytochrome b5 has been
strongly implicated in the desaturation reaction. Antibodies to cytochrome b5 were shown to
inhibit the desaturation reaction by 93% in safflower microsomes (65).
2.4.1.2. Plasmalogen biosynthesis. Plasmalogens are a type of phospholipid in which the sn-1
position of the glycerol backbone bears a vinyl ether-linked fatty alcohol (an O-(1-alkenyl)
group). Plasmalogens make up almost 20% of the phospholipid mass in humans and are
found primarily within the ethanolamine phospholipid class. The final step in the
biosynthesis of plasmenylethanolamine, the plasmalogen form of ethanolamine










































Figure 2.9 Synthesis of plasmalogens through the desaturation of
1-alkyl-2-acylglycerophosphoethanolamine to the vinyl ether. Electrons for
the reaction are derived from NADH via cytochrome b5. (Redrawn 66)
Plasmanylethanolamine ∆′-desaturase, a cytochrome b5-dependent desaturase, is responsible
for introducing the double bond α, β into the ether linkage (67). These phosphoglycerides are
especially abundant in the membranes of muscle and nerve cells.
2.4.2. Hepatic cholesterologenesis
The desaturase that presumably oxidises the C-30 methyl group of lanosterol (a cholesterol
precursor) to steroid-4α-oic acid, is 4-methyl sterol oxidase. Treating liver microsomes with
trypsin destroyed cytochrome b5 with an observed loss in 4-methyl sterol oxidase activity.
Adding purified cytochrome b5 to these microsomes restored the 4-methyl sterol oxidase
activity. These results indicate that reducing equivalents for this reaction are provided by
cytochrome b5 (8). 
Another cytochrome b5 dependent desaturase is lathosterol ∆5-desaturase. This enzyme
introduces a double bond into lathosterol (∆7-cholesterol, a cholesterol precursor) between
C5 and C6 to produce 7-dehydrocholesterol (68).
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2.4.3. Biosynthesis of N-glycolylneuraminic acid
N-glycolylneuraminic acid is the most common sialic acid in animals. It represents more than
95% of the total sialic acid in brain gangliosides. It was shown that, for the elongation
reaction of N-glycolylneuraminic acid by CMP-N-glycolylneuraminic acid hydroxylase
(figure 2.10), cytochrome b5 and cytochrome b5 reductase were essential (7).
Figure 2.10 Involvement of cytochrome b5 in the hydroxylation of N-acetylneuramine acid
(NeuAc) by CMP-NeuAc hydroxylase to yield N-glycolylneuramine acid
(NeuGc). (Redrawn 69)
2.4.4. Reduction of methemoglobin
In an adult human, about 3% of the circulating hemoglobin is oxidised to the non-functional
ferric methemoglobin. It is generally accepted that red blood cells possess enzymatic
reducing mechanisms to reduce the methemoglobin back to the ferrous state. Reducing
equivalents are recruited from NADH via NADH-cytochrome b5 reductase and cytochrome
b5 (70, 71). 
NADH dehydrogenase, cytochrome b5 reductase or methemoglobin reductase as it was also
known, was originally shown to be a component of the system. A deficiency of this enzyme
or structural abnormalities resulted in congenital methemoglobinemia. In cytochrome b5
reductase reconstituted systems the methemoglobin reduction was slow in comparison with
the rate of reduction in intact cells. The involvement of an additional component was
therefore suggested. The reduction of methemoglobin by cytochrome b5 reductase was
stimulated markedly in vitro by cytochrome b5 isolated from human erythrocyte cytosol. The
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flow of electrons from NADH to methemoglobin can thus be described by the model depicted
in figure 2.11.
Methemoglobin Fe3+ Hemoglobin Fe2+
 Cytochrome b5 Fe2+ Cytochrome b5 Fe3+
NADH cytochrome b5 
reductase (ox)
NADH cytochrome b5 
reductase (red)
NADH + H+ NAD+
Figure 2.11 Redox reactions involved in the reduction of methemoglobin. NADH
cytochrome b5 reductase alone cannot support the reduction of methemoglobin
cytochrome b5 was shown to be an obligatory component in the effective
reduction reaction. (Adapted from 71)
Qiao et al. (72) suggested that, contrary to the general paradigm, the acceptor and the donor
protein do not have to bind in a specific complex before electron transfer can take place. The
reaction between cytochrome b5 and methemoglobin may simply involve bimolecular
collision, as commonly found in small molecule electron transfer reactions. By aligning the
dipoles prior to collision, electron transfer may be steered to take place effectively.
2.4.5. Reduction of cytochrome P450
The cytochromes P450 are mixed function oxidases which catalyse the oxidation of a wide
range of compounds. Since the involvement of cytochrome b5 in cytochrome P450-dependent
reactions was suggested in 1971 (73), it has been a controversial issue. This stemmed from
findings that certain cytochromes P450 were not stimulated by cytochrome b5 while other
researchers came to the conclusion that cytochrome b5 was obligatory to a certain degree for
the hydroxylation of certain substrates (21). As the cytochrome P450 monooxygenase
reaction requires two electrons, it was suggested that while the first electron is provided by
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cytochrome P450 reductase from NADPH, the second electron could be provided by
cytochrome b5 from NADH. To explain the mechanism of the cytochrome b5-imposed
positive modifier action of the cytochrome P450 monooxygenase reaction, four suggestions
have been made which will be discussed in more detail in Chapter 6 together with the
influence of cytochrome b5 on steroidogenesis (21, 74).
1.5 CONCLUSION 
There are very few proteins that have such a profound effect on such a wide range of
reactions in the living system as cytochrome b5. Although one soluble form and two
membrane bound forms have been isolated and characterised to date, they all seem to
originate from the same gene. The function of the soluble form to keep the hemoglobin in the
reduced state is common through out all species. The hydrophilic region of the membrane
bound forms show great homology with the soluble form of cytochrome b5 as far as protein
sequence is concerned. Functions of the mitochondrial outer membrane associated form also
seem to be quite constant through all species. As far as the membrane-bound cytochrome b5
form associated with the endoplasmic reticulum is concerned, many differences have been
shown and reported. The most profound of these differences is found in its role in
steroidogenesis. These differences, together with the fact that inconclusive results were
obtained from isolated from tissue cytochrome b5, stimulated our interest to investigate these
functions of cytochrome b5. With a specific interest in the role cytochrome b5 plays in the
adrenal steroidogenesis, it was necessary to first isolate and characterise cytochrome b5 from
an appropriate source. As the ovine liver form of this hemoprotein was previously
investigated by one other group (75), sheep liver was chosen as a source of cytochrome b5 for
this study.
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THE ISOLATION, PURIFICATION AND SOLUBILISATION
OF CYTOCHROME b5 FROM OVINE LIVER MICROSOMES
1.1 INTRODUCTION
 As discussed in Chapter 2, cytochrome b5 is an electron transfer heme protein that can accept
and transfer single electrons in a number of biosynthetic pathways. It exists as a soluble
cytosolic protein as well as an amphipathic membrane bound protein. In erythrocytes, the
soluble form of cytochrome b5 maintains methemoglobin in a reduced state while the
membrane-bound form participates in various reactions that include lipid biosynthesis,
cholesterol biosynthesis and steroidogenesis (3, 4, 5).
The availability of recombinant cytochrome b5 has contributed greatly to the current
knowledge of the protein. Although many studies into the physiological role and
characterisation of cytochrome b5 employed heterologous protein expression systems as a
source of cytochrome b5 (6, 7), the membrane binding domain of recombinant cytochrome b5
is routinely modified to facilitate expression and subsequent purification. Yubisui et al. (7),
for instance, could not express the membrane bound form of the protein, although the soluble
form was successfully expressed and characterised. When Ito and Sato (8) initially isolated
cytochrome b5 from rabbit liver microsomes by means of detergent solubilization, they
observed an aggregate which appeared to be an octamer. Western blot analyses, published by
Lombard et al. (9), identified a high molecular mass protein when cytochrome b5 was isolated
from sheep liver. A relative molecular mass for ovine cytochrome b5 of 16,200 ±500 Da as
determined by SDS PAGE was reported by Arinç et al. (1). During earlier studies in our
laboratory, SDS PAGE analyses of a purified preparation showed an apparent aggregated
form as well as a monomeric form of cytochrome b5 with protein bands corresponding to
molecular masses of 60,000 Da and 16,000 Da respectively. Electrospray mass spectrometry
(ESMS) subsequently yielded an accurate molecular mass of 15,865 Da for ovine cytochrome
b5 (2). The molecular mass of 60,000 Da was approximately four times higher than the
molecular mass of monomeric ovine cytochrome b5. To date, no recombinant cytochrome b5
has shown a tetrameric or octameric aggregate when analysed, though the native form of
membrane bound cytochrome b5 seems to exist as an aggregate. This raises the question
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whether experimental data obtained with recombinant cytochrome b5 would accurately reflect
the physiological role of the protein in vivo. 
An alternative method of isolation and purification was employed during our current study to
determine whether the observed aggregation may result from the isolation procedure. The
method was adapted from previously published methods and had a number of advantages
when compared to established methods of cytochrome b5 isolation. The hydrophobic
membrane binding domain was removed by means of tryptic digestion under stringent
conditions to elucidate the cause of cytochrome b5 aggregation. The existing method for the
removal of the hydrophobic domain of cytochrome b5 has two inherent shortcomings – the
yield of truncated cytochrome b5 is low and the results are not reproducible when different
types of trypsin are used.
Here we report an efficient, novel method for the successful isolation and purification of the
intact form of cytochrome b5 from sheep livers and the subsequent tryptic removal of the
hydrophobic domain of the hemoprotein. The method consistently yielded high levels of
truncated cytochrome b5.
1.2 MATERIALS AND METHODS
Materials
Unless otherwise specified, all chemicals used were of reagent grade and purchased from
scientific supply houses. Pierce BCA kit was acquired from Pierce chemical company,
Rockford Ill, USA. TPCK trypsin-sepharose, trypsin and sodium deoxycholate were acquired
from Sigma, St Louis MO, USA. Whatman DE52 DEAE-cellulose resin and Triton x-100
were supplied by Merck, Darmstadt, Germany. Polyethylene glycol was purchased from
Fluka, Sigma-Aldrich, St Louis MO, USA.
Preparation and detergent solubilisation of ovine adrenal microsomes.
Liver microsomes were prepared and fractionated using PEG as described by Yang and
Cederbaum (10). Calcium chloride (CaCl2) precipitated microsomes were prepared using a
method adapted from Strittmatter et al. (11) The liver of a freshly slaughtered sheep was
removed and kept on ice to minimise protein denaturing and protease activity. All subsequent
steps were carried out at 4°C. After removal of connective tissue and fat, the liver was
dissected into strips and homogenised in three parts 10 mM Tris-acetate buffer pH 8.1,
containing 0.25 M sucrose and 0.1 mM EDTA, in a Waring blender at medium speed for 30
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seconds. The homogenate was centrifuged at 13,000 g for 15 minutes after which the
resulting supernatant was filtered through four layers of cheesecloth to remove excess
solidified fat. The filtrate was diluted three times with cold distilled water, and 0.8 M CaCl2
solution (1 ml/100 ml diluted filtrate) was added. After centrifugation of the suspension at
8,000 g for 5 minutes, the resultant microsomal pellet was resuspended in three parts 0.1 M
Tris-acetate buffer, pH 8.1, containing 1 mM EDTA ) in a Waring blender and dialysed
overnight against 10 volumes 0.1 M Tris-acetate buffer, pH 8.1, containing 10 mM EDTA.
Glycerol was added to the dialysate to a final concentration of 20% v/v and the resulting
mixture was stirred for 1 hour. NADH (50 mg per litre) was added to the microsomal
suspension before it was added to rapidly stirring acetone, at -7°C to -10°C. This mixture was
stirred for 15 minutes and subsequently allowed to settle. The supernatant was siphoned off
and the remaining acetone suspension centrifuged at 13,000 g for 10 minutes. The resulting
pellet was resuspended in 0.1 M Tris-acetate buffer, pH 8.1, containing 1 mM EDTA, using a
Waring blender. The centrifugation step was repeated and the washed pellet was resuspended
in the same Tris buffer.
The microsomal preparations were solubilised as described by Strittmatter et al. (11). Triton
X-100 was added to the microsomal suspension (2% final concentration) after which the
suspension was stirred overnight and subsequently centrifuged at 15,000 g for 30 minutes.
The supernatants were stored at -20°C until further use.
Purification of cytochrome b5 
The isolation and purification of ovine liver cytochrome b5 was carried out as described by
Swart et al. (12) using microsomes prepared by the CaCl2 and PEG precipitation methods.
Removal of Triton X-100 
The purified cytochrome b5 obtained in the previous step was dialysed against ten volumes
equilibration buffer (10mM Tris-acetate, pH 8.1, containing 0.1mM EDTA and 0.05%
deoxycorticosterone) and applied to a DEAE-cellulose column (2 X 5cm). The column was
extensively washed with equilibration buffer and the concentrated cytochrome b5
subsequently eluted from the column with equilibration buffer containing 0.25M NaSCN.
The purified cytochrome b5 was dialysed against 10mM Tris-acetate buffer, pH 8.1,
containing 10% glycerol and stored in aliquots at –80°C.
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Tryptic digestion of intact purified cytochrome b5 
Purified cytochrome b5, 0.5ml, was dialysed against ten volumes equilibration buffer and
applied to a DEAE-cellulose column (1 X 5cm). The column was washed with 20ml
equilibration buffer after which equilibration buffer containing 5000 BAEE
(α-benzoyl-L-arginine ethyl ester) units of trypsin per millilitre buffer was circulated through
the column at a flow rate of 27.5cm/hr for 3 hours. The procedure was repeated and the
circulation time was extended to 24 hours. The column was washed with 50 ml equilibration
buffer. The truncated cytochrome b5 was eluted with equilibration buffer containing 0.25M
NaSCN and subsequently dialysed against equilibration buffer.
High performance gel permeation chromatography (HPGPC)
HPGPC was performed on a Waters Hydrogel column connected to a Waters HPLC-system
equipped with a Waters 991 photo diode array detector. A flow rate of 0.7ml/min was
maintained for the mobile phase (10 mM Tris acetate pH 7.4 ) under conditions as described
by Calabro et al. (13).
Electrospray Masspectrometry (ESMS) of purified cytochrome b5 
Cytochrome b5 samples were analysed by ESMS under conditions as described by Swart et
al. (12).
Quadropole-Time of Flight Mass Spectrometry (Q-ToF MS) of purified cytochrome b5
Protein samples were prepared for analysis under denaturing and native conditions according
to the following protocols. Stock protein solutions, 0.2 mg/ml, were prepared in
acetonitrile/aqueous 1% formic acid (50/50) for denaturing conditions and in 25 mM
ammonium bicarbonate for native conditions.
Positive ion electrospray MS data for the denatured protein samples were acquired using
Q-ToF Micro and Q-ToF Ultima Global mass spectrometers fitted with nanoflow
electrospray sources. For each analyte ~6 µL of denatured protein solution was loaded into a
borosilicate needle (Type F). The borosilicate needle was positioned in the nanoflow probe
housing and the sample was infused into the mass spectrometer at a flow rate of ~10 nL
min-1. Positive ion electrospray MS data for the native protein samples were acquired using
Q-ToF Micro and Q-ToF Ultima Global mass spectrometers fitted with standard electrospray
sources. For each analyte, the protein was infused at 5 µL min-1 into the standard electrospray
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source using the built-in syringe driver on the mass spectrometer. Both mass spectrometers
were calibrated with a multipoint
Post acquisition processing using either the Max Ent or Transform software provided
molecular mass information for the two samples. Max Ent 1 calculates the average mass of
the species, while the Transform algorithm retains the isotopic distribution of the multiple
charged ion species.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) analyses
SDS PAGE was carried out according to the method of Laemmli (14). Analyses of the
protein samples, 5 µg, were done on a 15% resolving gel. Molecular weight markers
(Rainbow® markers) were purchased from Pharmacia.
Non-denaturing polyacrylamide gel electrophoresis analyses
Non-denaturing polyacrylamide gel electrophoresis was carried out as described by
Crambach et al. (15).
Cytochrome b5 assay methods
The cytochrome b5 content of microsomal preparations and purified fractions were
determined spectrophotometricaly as previously described (16) using a Beckman DU 650
spectrophotometer. A spectrum for oxidised cytochrome b5 in 10 mM Tris-acetate buffer, pH
8.1 was recorded between 350 nm and 800 nm. The sample was reduced by the addition of
NADH when reductase was present in the solution and with sodium dithionite in the absence
of reductase and the reduced spectrum recorded as above. The content of cytochrome b5 for
the purified protein sample was calculated from the difference between the reduced and
oxidised spectra at 424 nm (extinction coefficient, 100,000 M-1cm-1) (17). Microsomal
cytochrome b5 content was calculated from the reduced wavelength spectrum by applying a
millimolar extinction coefficient of 185 to the absorbance change at 426 nm minus 409 nm
(∆A426-409). 
Protein concentration assay
The protein concentrations of all samples were determined using the bicinchoninic acid
(BCA) method (18) according to the manufacturers’ instructions.
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1.3 RESULTS AND DISCUSSION
Results
Microsomes prepared from sheep liver tissue by PEG precipitation yielded the highest
protein levels of and a three fold increase in the yield was obtained compared to the yield
obtained with CaCl2 precipitation (table 3.1).
















Microsomes were solubilised with Triton X-100 for the isolation and purification of
cytochrome b5. The resulting solubilised microsomal solution was centrifuged to obtain a
clear red supernatant which was subjected to ion-exchange chromatography. A gradient
system was developed for the chromatographic separation by combining the most
advantageous aspects of the two methods described by Strittmatter et al. (11) and Yang and
Cederbaum (10). It was found that after a second round of anion exchange chromatography,
no further purification took place with either ion exchange or size exclusion chromatography
(tables 2 and 3). 
The purity of both batches of cytochrome b5, isolated by the two different methods, was
assessed by means of SDS PAGE analyses (figure 3.1). Protein bands corresponding to two
distinct molecular mass species, a higher molecular mass specie of approximately 60,000 Da
and one with a lower molecular mass of approximately 16,000 Da were observed,
representative of the tetrameric and monomeric forms of ovine liver cytochrome b5
respectively.
Table1:Summary of purification procedures in cytochrome b5 isolation from CaCl2


























Table2:Summary of purification procedures in cytochrome b5 isolation from PEG









































Figure 3.1 SDS PAGE analyses of purified cytochrome b5 using a 15% resolving gel. Lane
I: Molecular weight markers; lane II: Cytochrome b5 prepared from the CaCl2
precipitated microsomes; lane III: Cytochrome b5 prepared from the PEG
precipitated microsomes; and lane IV: Tryptic solubilised cytochrome b5.
The hydrophobic membrane binding domain was removed by means of restricted tryptic
digestion to prepare truncated cytochrome b5. A method was developed that produced
solubilised cytochrome b5 with consistently high yields, irrespective of the source and type of
trypsin used. Truncated ovine cytochrome b5 was prepared using two types of trypsin – a
twice crystallised bovine pancreatic trypsin with a high specific activity, and a low specific
activity form of trypsin, which contained a high percentage of lactose. Both these enzyme
preparations yielded the same amount of active truncated cytochrome b5. 
The effect of time on the exposure of cytochrome b5 to trypsin shows that the solubilisation of
approximately 0.5 ml (290 µg) purified intact cytochrome b5 at 4 °C was complete after
approximately 180 minutes. A second experiment was carried out, extending trypsin exposure
to 24 hours under the same conditions. The prolonged exposure to trypsin did not alter the
yield of truncated cytochrome b5 markedly (table 4).
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Table3:Analysis of the effect of trypsin and time on the purification of soluble cytochrome b5

























When analysed by SDS PAGE (figure 3.1, lane IV), the truncated cytochrome b5 exhibited an
apparent molecular mass of 10,000 Da while the intact form of the protein exhibited an
apparent molecular mass of 16,000 Da. 
Samples of the native and truncated cytochrome b5 were subsequently analysed by ESMS
(figure 3.2). Intact cytochrome b5 exhibited a molecular mass of 15,263 Da when analysed on
a quadropole ESMS (figure 3.2A). The truncated sample showed two species with different
molecular masses of 9,816 Da and 10,182 Da (figure 3.2B). Both these species were present
in the same ratio in the samples digested for 3 and 24 hours. A fragmentation study of each of
the protein species was subsequently carried out on the quadropole ESMS. The study
indicated that the two truncated species were derived from the same protein. The 10,182 Da
specie correlated with the mass obtained for the truncated form of ovine cytochrome b5
prepared according to the modified method of Omura and Takesue (19) previously used in
our laboratory (20). Cytochrome b5 truncated by TPCK trypsin immobilised on Sepharose
beads yielded a protein with a molecular mass of 10,182 Da which was in accordance with
results obtained by Roos (20).
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Figure 3.2 Resolved ESMS spectra of monomeric cytochrome b5. A: The molecular mass of
intact cytochrome b5 without its heme group. B: Truncated cytochrome b5
showing two molecular mass species. 
The proteins were subsequently analysed on a Quadropole-Time of Flight Mass Spectrometer
(Q-ToF MS) to determine the accurate masses of the different forms of cytochrome b5
(figures 3.3 and 3.4). The molecular mass of apo cytochrome b5 (without the heme group) and
holo cytochrome b5 (with the heme group) was 15,249 Da and 15,865 Da, respectively (figure
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3.3). A sample of the trypsin truncated protein was analysed by Q-ToF MS. The analyses
showed four fragments (figure 3.4A). In addition to the 9,812 Da and 10,184 Da fragments
previously detected by ESMS, which differed by 370 Da from each other, two new fragments
were detected at 10,028 Da and 10,399 Da, also differing by 370 Da. Non-denaturing
conditions on the Q-ToF MS revealed molecular masses of only two larger species of the
trypsin truncated holo cytochrome b5 (figure 3.4B).
















Figure 3.3 Resolved QToF MS spectrum of intact ovine liver cytochrome b5. The molecular
mass for apo cytochrome b5 was determined at 15,249 Da and the molecular
mass for holo cytochrome b5 at 15,865. An unidentified specie with a molecular
mass of 16,221 was also observed. 

































Figure 3.4 Q-ToF ESMS spectra of tryptic digested cytochrome b5. A: Four different
species of apo cytochrome b5. The 10,399 and 10,028 species are most likely the
products of incomplete digestion. B: Two larger species of cytochrome b5
indicating the intact heme groups. Signals at 10822, 10844, 10866, 11027, 11049
and 11071 represent sodium adducts of the two species.
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The results from non-denaturing PAGE indicated a single band for the intact cytochrome b5
(figure 3.5). Protein that did not penetrate the gel is visible in the wells at the top of the gel.
At higher protein concentrations, a faint band further down the gel became visible. The
trypsin truncated form of cytochrome b5 exhibited two distinct bands. This correlates with the
ESMS results where two different species of truncated cytochrome b5 were observed. With
SDS PAGE analyses, no distinction could be made between these two species.
Absorption spectra were recorded for both the oxidised and reduced forms of the intact and
truncated hemoproteins to determine whether the truncated cytochrome b5 had retained its
activity as an electron transport protein (figure 3.6). Samples were reduced with sodium
dithionite. The spectra of the intact and truncated proteins were identical in the Soret region
indicating that the heme binding region was unaffected by the trypsin treatment.
I II III IV V VI
Figure 3.5 Non-denaturing gel electrophoresis of cytochrome b5. I: Truncated cytochrome
b5; II: Intact cytochrome b5 prepared from CaCl2 precipitated microsomes; III:
Intact cytochrome b5 prepared from PEG precipitated microsomes; IV: Sheep
adrenal microsomes; V: Sheep liver microsomes and VI: Sheep testicular
microsomes.
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Figure 3.6 Absorption spectra of the oxidised (---) and reduced (— ) forms of intact (A) and
truncated (B) cytochrome b5. The oxidised form exhibits an absorbance
maximum at 413 nm. The reduced form exhibits absorbance maxima at 556, 526
and 423 nm.
The aggregation of intact and truncated cytochrome b5 in an aqueous environment was
subsequently investigated. HPGPC analyses of intact cytochrome b5 under conditions of low
ionic strength (10 mM Tris, 0.1 mM EDTA, pH 8.15) yielded two peaks (figure 3.7A). Both
fractions exhibited a typical cytochrome b5 spectrum.
HPGPC of truncated cytochrome b5 yielded a single peak with a retention time indicative of a










































































Figure 3.7 High performance gel permeation chromatograms (—) and absorbance spectra
(—) of cytochrome b5 in a low ionic strength buffer (10 mM Tris, 0.1 mM
EDTA, pH 8.15). A: Two forms of cytochrome b5 were observed at 280 nm, each
with the typical cytochrome b5 absorption spectrum; B: The truncated
cytochrome b5 sample exhibited a single peak.
Discussion
Cytochromes play a central role in mammalian metabolism and homeostasis. These
hemoproteins are involved in mitochondrial electron transport and the subsequent oxidative
phosphorylation of ADP, in the metabolism of xenobiotics and drug detoxification as the
so-called Phase I enzymes, as well as in the biosynthesis of steroid hormones. Amongst the
different cytochromes found in the mammalian body, cytochrome b5 is the most ubiquitous
hemoprotein extending the influence of the cytochromes to oxygen transport and lipid and
cholesterol biosynthesis. Our laboratory is specifically interested in the role of cytochrome b5
in ovine steroidogenesis. Most studies investigating the influence of cytochrome b5 on
mammalian steroidogenesis, utilised recombinant proteins which are modified to facilitate
expression. To study the physicochemical properties of native ovine cytochrome b5 requires a
sufficient quantity of the hemoprotein. 
Since published methods for cytochrome b5 isolation from fresh mammalian tissue yielded
unsatisfactory results in our hands, we modified and optimised the isolation of this protein
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from sheep liver. Previously, microsomes prepared for cytochrome b5 isolation employed
ultracentrifugation for the precipitation of the final microsomal pellet. However,
ultracentrifugation is not a practical option due to volume limitations and lengthy
centrifugation times which are required. Strittmatter et al. (11) used CaCl2 precipitation in the
preparation of microsomes for subsequent isolation and purification of steer liver cytochrome
b5. Yang and Cederbaum (10) compared PEG precipitation of liver microsomes to
ultracentrifugation in the isolation and purification of rat liver cytochrome b5. They showed
that PEG precipitated microsomes compared favourably with the microsomes prepared by
conventional centrifugation. We compared PEG and CaCl2 precipitation methods in the
preparation of liver microsomes and subsequent purification of ovine cytochrome b5.
Our study showed that the PEG precipitation method has a number of advantages over the
CaCl2 precipitation method. No dialyses of the PEG precipitated microsomal preparation is
needed before detergent solubilisation, saving at least 24 hours in the preparation of
cytochrome b5. PEG precipitated microsomes yielded a higher protein content as well as a
higher levels of cytochrome b5 than the CaCl2 precipitation preparation yielded (table 1). 
The yields of cytochrome b5, obtained from the PEG and CaCl2 methods were comparable
(tables 2 and 3). SDS PAGE analyses of the purified cytochrome b5 from the PEG and CaCl2
precipitated microsomes indicated no difference in distribution of the monomeric and
tetrameric forms. We therefore conclude that the isolation and purification method does not
play an important role in the observed aggregation of the protein. ESMS was employed to
verify that the 60,000 Da specie observed by SDS PAGE was indeed a tetramer of the
monomeric cytochrome b5. Due to the nature of the operating conditions in the ESMS, heme
groups are often removed from cytochrome molecules during analyses. Although a peak at
m/z 615, which corresponded to the heme moiety, was observed, it could not be assumed that
the molecular mass of 15,263 Da, obtained by ESMS, was the accurate mass of apo ovine
liver cytochrome b5. ESMS analyses indicated only the monomeric form of the hemoprotein
and no signal was obtained at any other m/z value up 80,000. Samples were analysed by
Q-ToF MS at a low cone voltage for an accurate determination of the molecular mass. These
analyses yielded mass spectra of holo and apo cytochrome b5. The accurate mass of both
forms of sheep liver cytochrome b5 could thus be obtained, confirming that only the
monomeric form of the protein was present. All mass spectroscopic studies were carried out
on cytochrome b5 preparations obtained from both PEG and CaCl2 precipitated microsomes.
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No differences were observed. Finally the activity of both preparations was assayed using
dithionite reduced vs. oxidised difference spectra. These assays confirmed that both
precipitation methods yielded intact cytochrome b5.
It was established that cytochrome b5 exhibits both the monomeric and aggregated forms
during SDS PAGE. After being denatured and coated with SDS, samples in a SDS PAGE
analyses are separated according to their mass/charge ratio, allowing for the determination of
an apparent molecular mass for the different protein fractions. Samples were analysed on a
non-denaturing PAGE system to obtain a qualitative indication of the presence of monomeric
cytochrome b5 under non-denaturing electrophoretic conditions. The same principles are not
valid for the non-denaturing electrophoretic system where proteins are separated mainly on
the basis of their charge at a given pH in the gel during electrophoresis (15). Non-denaturing
PAGE analyses showed that the trypsin truncated protein has a higher net negative charge
than the intact protein. It is evident that the removal of the membrane binding carboxy
terminal exposed a higher number of negatively charged residues on the surface of the
protein. In contrast, the full length cytochrome b5 showed low electrophoretic mobility under
non denaturing conditions. This could be ascribed to the presence of the hydrophobic
membrane binding domain as well as a shielding of charges due to aggregation. Non
denaturing gel electrophoresis could possibly provide the means to selectively purify a single
specie of the trypsin truncated cytochrome b5.
Truncated cytochrome b5 was obtained by removal of the hydrophobic membrane binding
domain by restricted tryptic digestion. In our initial studies we used the method described by
Omura and Takesue (19) for the preparation of truncated ovine cytochrome b5. Problems
were, however, encountered with the commercially available trypsin. In our hands removal of
the hydrophobic region of cytochrome b5 was only moderately successful when trypsin type
III or double crystallised trypsin was used. The yields were relatively low when compared to
the total amount of cytochrome b5 present in the microsomes. The average yield of solubilised
cytochrome b5, using the method described in this study for the preparation of truncated
cytochrome b5, was approximately 14 fold higher than yields obtained using the method
reported by Omura and Takesue (19) and Roos (20) (table 4).
ESMS analyses of the trypsin treated cytochrome b5 showed two species with different
molecular masses. Both these species were present in the same ratio in both samples which
had been digested for 3 hour and 24 hours thus ruling out incomplete digestion. 
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During the digestion, as described by Omura and Takesue (19), as well as digestion by means
of immobilised TPCK trypsin, the cytochrome b5 catalytic domain is exposed to trypsin.
Immobilisation of the cytochrome b5 on the DEAE resin protects the protein’s catalytic
domain. The smaller truncated specie found during immobilised digestion of cytochrome b5,
was not observed in any of the two previously published methods used. During an
investigation of rabbit cytochrome b5, Gibson et al. (21) showed that trypsin treatment of
intact rabbit cytochrome b5 yielded two distinct forms of the truncated hemoprotein with
molecular masses of 9,502 Da and 10,144 Da. Previous studies indicated that the removal of
the amino terminal of rabbit cytochrome b5 by tryptic digestion, may be blocked by
N-acetylation of certain amino acids (22, 23). This finding was later confirmed by Gibson et
al. (24) when he concluded that the conversion of the third residue, glutamine, to glutamic
acid was most likely due to deamination during protein isolation. In our study, using the
immobilisation method for the preparation of truncated ovine cytochrome b5, two species
with molecular masses of 9,812 Da and 10,184 Da were indicated by ESMS. Further
investigation into the structure of ovine cytochrome b5 is, however, needed to determine
whether N-acetylation also occurs for sheep liver cytochrome b5. 
It is well documented that there is a well conserved serine-lysine in the hinge region at
position 90 to 91 of cytochrome b5. The molecular mass of this di-peptide is ~215 Da and
have trypsin recognition sites on both sides of the dipeptide. It is thus highly likely that the
two new species observed at 10,028 Da and 10,399 Da by Q-ToF MS analyses both have an
intact serine-lysine moiety at their carboxyl termini, brought about by incomplete trypsin
digestion of the protein sample. The ~370 Da difference between the species of the respective
two pairs cannot be explained by any of the known sequences on the carboxyl terminal side
of other species, as there are no fragments between two trypsin sites which have molecular
masses of ~370 Da on either side of the serine-lysine pair (figure 3.8). This difference in size




















Figure 3.8 Schematic representation of the four observed species of cytochrome b5. A: Two
species previously observed by ESMS with a ~370 Da difference in mass. B:
Two new species observed, also with a ~370 Da difference, but ~215 Da larger
than the species depicted in A.
With a significant portion of the cytochrome b5 molecule removed by tryptic digestion, it had
to be determined to what extent the smaller molecule would still be able to function as
cytochrome b5. Difference spectra which were recorded for the oxidised and reduced forms of
intact and truncated cytochrome b5 were identical in the Soret region, suggesting that the
protein domain removed by trypsin treatment might not play a direct role in the electron
transfer function of ovine cytochrome b5.
Conclusion
It is important to achieve maximum yields when isolating proteins from small quantities of a
limited source. The method reported here for the isolation and purification of cytochrome b5
and the subsequent treatment with trypsin proved to be effective in more than one respect.
The method is less time consuming than previously published methods and higher yields of
intact and truncated cytochrome b5 were obtained from the same amount of raw material.
Preparing microsomes by means of ultracentrifugation would be suitable for this type of
isolation, but expensive equipment is required and the procedure is extremely time
consuming. Furthermore, the type of trypsin used had no influence on the yield or the
integrity of truncated cytochrome b5.
This study showed that the use of PEG precipitation for the preparation of ovine liver
microsomes has considerable advantages over ultracentrifugation in the isolation of
cytochrome b5. A more robust, practical and reproducible method for the isolation from liver
microsomes of cytochrome b5 was achieved by PEG precipitation and modification of
subsequent chromatographic steps. It is now possible to isolate cytochrome b5 from small
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samples of raw material, such as adrenal glands, in markedly shorter times with concomitant
higher yields. The method is also suitable for large scale preparation in the isolation of
cytochrome b5. In addition, a novel method for the preparation of trypsin truncated
cytochrome b5 was developed. This method resulted in considerably higher yields of
truncated b5 (14 fold) and was not dependent to the type of trypsin employed. The
development of these methods will contribute markedly to the study of cytochrome b5.
Of all the techniques used in this study to characterise the purified intact cytochrome b5, it is
only ESMS analyses that failed to show an aggregate form of the protein. Results obtained
from the above mentioned experimental work raised the question whether cytochrome b5
occurs as a monomer or an aggregate in vivo. The experiments to further investigate this
question is described in Chapter 4.
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CHAPTER 4
AN INVESTIGATION OF THE AGGREGATION OF SHEEP
ADRENAL CYTOCHROME b5 IN VIVO
1.1 INTRODUCTION
As mentioned earlier, during the isolation and purification of ovine liver cytochrome b5 in our
laboratory, SDS PAGE analyses of the purified protein yielded two distinct bands
corresponding to molecular masses of ~60,000 Da and ~16,000 Da. Even under the most
stringent denaturing conditions (high mercaptoethanol levels and prolonged heat
denaturation) the SDS-banding pattern of purified cytochrome b5 did not change (1).
Electrospray massspectrometry (ESMS) of the isolated cytochrome b5 did, however, show
that the protein was pure and that only one molecular specie, with a molecular mass of
15,263 Da, was present. 
The ESMS data clearly indicated that native ovine cytochrome b5 formed aggregates and that
a very stable complex of tetrameric cytochrome b5 with an apparent molecular mass of
~60,000 Da was the predominant form. The 60,000 Da complex was also identified by SDS
PAGE analyses when monomeric cytochrome b5 (Mr 15,263 Da) was isolated from SDS
PAGE gels and stored at 4 ºC for 2 weeks. 
In the presence of high levels of detergent (deoxycholate), the monomeric specie prevailed.
Other factors which are known to influence aggregation of cytochrome b5 are the ionic
strength of the solution and the protein concentration. From the results presented in the
previous chapter it is clear that ovine cytochrome b5 favours the aggregated (60,000 Da) form
at physiological salt concentrations in an aqueous solution. The stable tetrameric complex of
native ovine cytochrome b5, even in the presence of the detergents used to solubilise the
enzyme from the microsomal membranes, inevitably raises the question whether the native
form of the protein in vivo is monomeric or tetrameric. 
Cytochrome b5 is an electron transfer hemoprotein that catalyses a wide range of reactions in
mammalian tissue. The protein exists in two forms, an amphipathic membrane-bound form
and a water-soluble cytosolic form. The membrane-bound form is found in the endoplasmic
reticulum and mitochondria of all cells and consists of a hydrophobic membrane-anchoring
domain and a hydrophilic catalytic domain (2). During adrenal and gonadal steroidogenesis
cytochrome b5 influences the action of the cytochromes P450-dependent steroid
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17α-hydroxylase and 21-hydroxylase (CYP17 and CYP21). These enzymes play a central
role in glucocorticoid, mineralocorticoid, and androgen biosynthesis and a number of studies
have shown the importance of cytochrome b5 in C19-steroid production by CYP17 (3, 4).
We have previously shown, in preliminary studies, that cytochrome b5 influences the ratio of
deoxycorticosterone to deoxycortisol production in ovine adrenal microsomes (5). During our
previous investigations we encountered, what appeared to be, higher molecular mass
aggregates in our cytochrome b5 isolates. In this study the apparent aggregation of ovine
cytochrome b5 was investigated and the question arose whether the protein exists as a
monomer or an aggregate in vivo. Previous research has shown that the aggregation of
cytochrome b5 can be abolished by detergents (deoxycholate) and it was concluded that the
endoplasmic reticulum membrane will have the same influence on the enzyme in vivo (6). It
was, however, also demonstrated by Calabro et al. that low protein and salt concentrations
favoured smaller aggregates and that a pure monomeric form of cytochrome b5 could be
isolated by size-exclusion chromatography under these conditions (7). These results indicated
that the aggregation of cytochrome b5 in vivo was influenced by a number of factors.
To prevent cytochrome b5 aggregation in aqueous solution the hydrophobic
membrane-anchoring domain can be removed by means of tryptic digestion. In more recent
work it was suggested that cytochrome b5 influences CYP17 activity, not through direct
electron transfer, but by steric interactions. These findings implicate that cytochrome b5
would require its hydrophobic membrane binding domain to influence steroidogenesis (8). In
this study we investigated the aggregation state of ovine cytochrome b5 in solution, in adrenal
microsomes and in situ.
The results of this investigation was published in Endocrine Research, Vol. 28, No. 4, pp.
489-496, 2002 (Appendix A).
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1.2 MATERIALS AND METHODS
Isolation of full length and truncated cytochrome b5
Ovine liver microsomes were prepared as described by Yang and Cederbaum (9).
Cytochrome b5 was isolated from the ovine liver microsomes as described by Strittmatter et
al. (10). 
Tryptic digestion of intact cytochrome b5
Trypsin truncated cytochrome b5 was prepared as described in Chapter 3.
Electrospray mass spectrometry of purified cytochrome b5
ESMS analyses of cytochrome b5 samples were done under conditions described by Swart et
al. (11).
Raising of antibodies against full length and truncated cytochrome b5
Antibodies to full length and truncated cytochrome b5 were raised according to the method of
Bellstedt et al. (12). 
SDS PAGE and Western blot analyses 
SDS PAGE was carried out according to the method of Laemmli (13). Western blot analyses
were carried out with the West DuraTM western blotting kit from Pierce Chemical Co.,
Rockford, Ill, USA.
High Performance Gel Permeation Chromatography (HPGPC)
High performance gel permeation chromatography (HPGPC) was performed as described in
Chapter 3.
Assays for adrenal microsomal steroidogenic activity
Adrenal microsomal assays were carried out as described by Swart et al. (5).
1.3 RESULTS AND DISCUSSION
The purity of the full length and truncated cytochrome b5 was assessed for by means of SDS
PAGE. The full-length protein exhibited a major protein band corresponding to a molecular
mass of ~16,000 Da which represented the monomeric form of cytochrome b5. Several bands
corresponding to multimeric forms of the protein was, however, also observed. Electrospray
massspectrometry analyses of the cytochrome b5 solution loaded onto the gel indicated a
single protein (Mr 15,260) (figure 4.1). This result confirmed that SDS PAGE normally used
for the resolution of protein complexes did not fully dissociate the cytochrome b5 aggregates.
61
The truncated cytochrome b5 showed no aggregation, only a single band corresponding to a
molecular mass of ~10,000 Da.
Figure 3.9 (A) Electrospray mass spectrum of purified ovine cytochrome b5. Each peak
represents the same protein with a different charge to mass ratio. (B)
Deconvolution of the ESMS spectrum was carried out by MaxEnt program 1.
The molecular mass indicated for cytochrome b5 was 15,263. No other proteins
could be detected in the sample.
High performance gel permeation chromatography analyses of the purified protein under
conditions of low ionic strength (10mM Tris, 0.1mM EDTA, pH 8.15) yielded two peaks
(figure 4.2A). Both fractions exhibited a typical cytochrome b5 absorption spectrum. These
two fractions were collected and immediately rechromatographed under the same conditions.
Each sample produced a single peak (results not shown). When the same two fractions were
incubated for 24 hours before they were rechromatographed, the higher molecular mass
component dissociated into two fractions while the lower molecular mass fraction remained a
single peak. High performance gel permeation chromatography in phosphate buffered saline
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(PBS) yielded a single peak which correlated with the higher molecular mass fraction (figure
4.2B). High performance gel permeation chromatography of truncated cytochrome b5 yielded
a single peak at a lower molecular weight than any of the other samples chromatographed.
The retention time of this peak remained the same irrespective of the salt or protein
concentration (figure 4.2C). These results showed that, like rabbit liver cytochrome b5, the
aggregation of ovine cytochrome b5 was influenced by ionic strength. In addition the
aggregated form of the enzyme could be stabilized under appropriate conditions of ionic
strength and pH. 
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Figure 3.10 High performance gel permeation chromatogram of cytochrome b5 in a low ionic
strength buffer (10mM Tris, 0.1mM EDTA, pH 8.15) (A). Two forms of
cytochrome b5 with different retention times was observed. Both exhibited a
typical cytochrome b5 absorption spectrum. When rechromatographed after a
24-hour incubation period, the fraction correlating with the monomer still
exhibited a single peak while the fraction that correlated with the aggregate again
exhibited two peaks. When the buffer was changed to phosphate buffered saline,
only a single peak, with the same retention time as the aggregate, was observed
(B). Irrespective of the salt or protein concentration, the truncated cytochrome b5
always exhibited a single peak (C).
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The anti-serum against the intact purified cytochrome b5 recognised the monomeric, trimeric,
and tetrameric species (figure 4.3) of the enzyme. In the microsomal preparations of ovine
adrenal, liver and testes and bovine adrenal the tetrameric aggregate predominated. The same
anti-serum recognised cytochrome b5 in the zona fasciculate of the ovine adrenal cortex as
well as the adrenal medulla (results not shown). Antibodies raised against the truncated
protein did not show immunoprecipitation in any of the above-mentioned microsomal
preparations.
Figure 3.11 Western blot analyses of: lane 1; ovine liver microsomes, lane 2; bovine adrenal
microsomes, lane 3; ovine adrenal microsomes, lane 4; ovine testicular
microsomes, lane 5; purified cytochrome b5. Into wells 1–4, 50 mg of total
protein was loaded, while 10 mg of purified cytochrome b5 was loaded into well
5. Polyclonal rabbit anti-cytochrome b5 was used at a dilution of 1 : 2000.
The influence of cytochrome b5 on adrenal microsomal progesterone metabolism is shown in
figure 4.4. The truncated form of the protein did not have any influence on the conversion of
progesterone to deoxycortisol and deoxycorticosterone. Addition of full-length cytochrome
b5 increased the production of deoxycorticosterone with a concomitant reduction in
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Figure 3.12 Progesterone metabolism in ovine adrenal microsomes ([cytochrome P450]=0.09
mM). Progesterone, deoxycortisol (DOCL), and deoxycorticosterone (DOC) are
indicated after a 14-min incubation period. No cytochrome b5 was added to the
control which had a [Cytochrome P450] : [cytochrome b5]=2.26. The addition of
truncated cytochrome b5 had no effect on the progesterone metabolism. Addition
of full-length cytochrome b5 (1 µM) increased the production of DOC and
concomitantly reduced DOCL production.
At physiological ionic strength and pH ovine cytochrome b5 exists as a tetramer with a Mr of
~60,000 Da. Immunoblot analyses of ovine and bovine steroidogenic microsomes indicated
the tetrameric form as the predominant specie. Although the antibody could detect the
monomeric form of the purified protein no immunoprecipitation was detected at ~16,000 Da
in Western blot analyses of adrenal or liver microsomes. These results indicate that under
conditions of physiological pH and ionic strength the enzyme is in a tetrameric form in the
endoplasmic membrane. These findings are in contrast with previously published results of
Doebler et al. (14) which stated that neither cytochrome b5 nor its membrane-binding domain
will self associate in phosphatidylcholine vesicles. These experiments were, however, carried
out in an artificial system that contained no other proteins except cytochrome b5. In addition,
a purified recombinant mutant cytochrome b5 was used in these studies. Although the
aggregation state of intact cytochrome b5 in adrenal microsomes cannot be readily
determined, the addition of the aggregate to adrenal microsomes significantly influenced the
metabolism of progesterone while the truncated form of cytochrome b5 had no effect. The




It is possible that the smallest changes in the amino acid composition of cytochrome b5 could
have a significant effect on the structure and function of the protein as was discussed in
Chapter 2. A recombinant protein could thus differ only in a single amino acid from the
native protein, but this substitution could have a dramatic effect on the physiological function
and physical properties of the protein. We therefore investigated native cytochrome b5
isolated from ovine liver to obtain more accurate data about the physico-chemical
characteristics of this hemoprotein. The results obtained proved to yield a different
perspective on these characteristics of cytochrome b5.
Cytochrome b5 accepts reducing equivalents from NADH via cytochrome b5 reductase. Both
cytochrome b5 and its reductase are bound to the endoplasmic reticulum. It has also been
shown that cytochrome b5 can be reduced by NADPH, implicating cytochrome
P450-reductase as electron donor for cytochrome b5. The two-electron-requiring cytochrome
P450 monooxygenases can receive both electrons directly from NADPH-cytochrome P450
reductase, but the second rate-limiting electron may be supplied by cytochrome b5.
Cytochrome b5 reductase is not obligatory for the reduction of cytochrome P450, as
NADPH-cytochrome P450 reductase can receive electrons from NADPH (or NADH) and
reduce either cytochrome P450 or cytochrome b5 (figure 4.5). The difference in redox
potentials of reduced cytochrome b5 (~20 mV) and oxidised cytochrome P450 (~-300 mV)
dictates that electron transfer from cytochrome b5 will be thermodynamically unfavourable.
After receiving the first electron from cytochrome P450 reductase, the midpoint redox
potential of the oxyferrous cytochrome P450 is sufficiently close enough (~50 mV) to that of
reduced cytochrome b5 to receive an electron from cytochrome b5. Should the second electron
not be supplied fast enough, uncoupling could take place with a concurrent release of a
superoxide anion, resulting in hydrogen peroxide formation. The suggested mechanisms of
cytochrome b5 imposed action of the cytochrome P450 monooxygenase reaction is discussed
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Figure 3.13 Schematic representation of electron transport from NADH and NADPH to
cytochrome P450 in the endoplasmic reticulum.
Results given in Chapters 3 and 4 strongly suggest that cytochrome b5 exists and functions as
an aggregate in the microsomal membrane. The existence of an aggregated cytochrome b5
specie in the endoplasmic reticulum would provide an effective interaction of cytochrome b5
with either of the two reductases present and thus provide a buffer of reducing equivalents.
The effect of the slow transfer of an electron from NADH to cytochrome P450 would
therefore be reduced, thus minimising the chances of uncoupling taking place and producing
superoxide anions. In Chapter 6 we investigate the effect of the ratio of cytochrome b5 to
cytochrome P450 on adrenal steroidogenesis.
It is currently believed that it is unlikely for a membrane-bound protein to aggregate in a
phospholipid bilayer due to the hydrophobic environment. Although it is a credible argument,
our results show that the detergent levels required to solubilise the microsomal membrane
when extracting cytochrome b5 could not monomerise the multimer fully. The phospholipid
bilayer is a dynamic structure, allowing lateral movement of proteins embedded in the
membrane. Should two or more cytochrome b5 molecules come in close vicinity of each other
inside the phospholipid bilayer, it can be expected that the molecules will attract each other
with a hydrophobic force greater than that existing between cytochrome b5 and the
phospholipid membrane. HPGPC results indicate that the observed aggregation of purified
cytochrome b5 cannot be the product of the denaturing conditions of SDS PAGE.
Aggregation in microsomal samples is observed beyond doubt on SDS PAGE analyses.
Denaturing conditions during sample preparation, together with other membrane proteins or
phospholipids, may lead to the observed aggregation. This question is addressed in Chapter 5.
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Up to this point our studies focussed on the isolation and characterisation of cytochrome b5.
Cytochrome b5 was studied as a purified protein and in microsomes. The latter can be
interpreted as an in vivo model of the endoplasmic reticulum as all proteins present in the
endoplasmic reticulum are present in the microsomes. Our results clearly show the existence
of aggregated cytochrome b5 in the microsomes. 
The predominant form and mechanism of action of cytochrome b5 in the adrenal gland in
vivo, is still unknown. Adrenal physiology and histology are well documented and will be
discussed in detail in Chapter 6. Valuable information about the function of cytochrome b5
can be gleaned from knowledge pertaining to the localisation in the adrenal gland.
Immunological studies, carried out to determine the distribution and the native form of
cytochrome b5 in the adrenal gland, will be discussed in the following chapter.
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CHAPTER 5
AN IMMUNOLOGICAL STUDY OF OVINE LIVER
CYTOCHROME b5 AND ITS AGGREGATION STATES
1.1 INTRODUCTION
Although ovine cytochrome b5 is a monomeric protein, it is clear from the data presented in
Chapters 3 and 4 that the protein also exists as a stable multimeric complex under certain
conditions. In the presence of trypsin inhibitor two different forms of calf liver cytochrome b5
were isolated by pancreatic lipase solubilisation, although trypsin digestion of these two
forms yielded the same core protein (1). A larger cytochrome b5 molecule was obtained when
a detergent was used instead of lipase for the solubilisation of rabbit liver microsomes. This
cytochrome b5 molecule differed from the lipase solubilised protein by 40 amino acids, which
constituted an extremely hydrophobic region in the protein (2). In an aqueous environment
the cytochrome b5, obtained from detergent solubilised microsomes, formed aggregates (3).
Ito et al. (3) reported an octameric cytochrome b5 specie when the protein was isolated from
rabbit liver microsomes by means of detergent solubilisation. In a study using sheep liver
cytochrome b5, Lombard et al. (4) reported a tetrameric cytochrome b5 specie which could be
converted to the monomeric form by changing the ionic environment. Western blot analyses
showed, using an antiserum against intact cytochrome b5, positive immunostaining of a
tetrameric specie only in ovine and bovine adrenal microsomal preparations. In the same
study monomeric cytochrome b5 was only detected in purified protein preparations. These
results strongly suggested that, in vivo, sheep cytochrome b5 exists as a tetramer, or at least as
multimeric species (4).
In a previous study, carried out in our laboratory by Engelbrecht (5), anti-cytochrome b5
rabbit IgG was obtained after immunisation with full length, intact cytochrome b5 according
to the method of Bellstedt et al. (6). Immunoblot analyses of purified ovine cytochrome b5
and ovine adrenal microsomes indicated that anti-cytochrome b5 rabbit IgG serum recognised
only the cytochrome b5 complex with a molecular mass of ~60,000 Da (figure 5.1). In the
same study, no positive immunostaining occurred for the lower molecular mass (~16,000 Da)
form of the protein, even though the monomeric form, prepared by preparative SDS PAGE,
was used for immunisation. Similar results were obtained for ovine liver microsomes (results
not shown). It thus appeared that the antibody raised against cytochrome b5 during the
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previous study, recognised only the larger molecular mass cytochrome b5 complex and not






Figure 3.14 Immunoblot analyses of ovine cytochrome b5. (A) Cytochrome b5 purified from
ovine liver. (B) Ovine adrenal microsomes. Lane 1: Blot with day 0 serum
indicating non-specific binding. Lanes 2 and 3 represent dilutions of 1:500 and
1:1,000 of the antiserum respectively. (Reproduced from 5)
The above results showed that anti cytochrome b5 rabbit IgG serum recognised only a protein
with an approximate molecular mass of 60,000 Da (tetrameric form). A faint band was
detected at ~55,000 Da (not clearly visible in the image) indicative of non-specific binding.
The antibody recognised the tetrameric form in the microsomal preparation. No monomer
was detected. This finding posed two questions: (1) Did the antibody raised in the previous
study only recognise the tetrameric aggregated form (60,000 Da) of ovine cytochrome b5 and
if this was true (2), is the tetramer of cytochrome b5 the biologically active form of the
hemoprotein in vivo? To shed more light on these two questions, Engelbrecht performed an
immunohistochemical study using sheep adrenal tissue. This study indicated that the presence
of cytochrome b5 in the adrenal cortex was limited to the cytoplasm of the cells in the zona
fasciculata (figure 5.2)(5). This finding was in contrast to data obtained in similar studies of
the human adrenal cortex where cytochrome b5 was indicated at high levels in the zona
reticularis (7). In addition Engelbrecht also observed the presence of cytochrome b5 in the
nuclei of all cells in the adrenal medulla. It was concluded that, in vivo, cytochrome b5 occurs
as an aggregate in the sheep adrenal glands (5). 
72
Figure 3.15 Immunohistochemical study of a cross-section of an ovine adrenal cortex
showing positive staining in the cytoplasm of the cells of the zona fasciculata
with anti-cytochrome b5 serum (C: Capsule; ZG: zona glomerulosa; ZF: zona
fascilulata; ZR: zona reticularis). Reproduced from (5).
We subsequently showed, with anti-cytochrome b5 serum raised against full-length, intact
cytochrome b5 and using the more sensitive chemiluminesence Western blot detection
system, that the serum does in fact recognise the tetrameric as well as the monomeric forms
of ovine liver cytochrome b5 (Chapter 4, figure 4.3). This finding showed that the monomeric
form, although present, did not constitute a major proportion of the cytochrome b5 in this
preparation. The question of the aggregation state of cytochrome b5 in vivo was therefore not
conclusively answered. A method to discriminate between the monomeric and aggregated
form of the cytochrome in vivo had to be developed to determine unequivocally if
cytochrome b5 does indeed exist as a tetramer in vivo. 
The study of protein-protein interaction in vivo has always been a challenging one. Modern
developments in fluorescent technology has led to exciting new methods, such as FRET
(fluorescence resonance energy transfer), in which energy is transferred from one 
fluorophore-labeled protein (the donor) to another (the acceptor) with a resultant emission of
light of a certain wavelength. This technology cannot, however, be effectively applied in the
study of cytochrome b5 aggregation as the so called "donor" and "acceptor" molecules are
identical and it is not possible to ensure a homogenous aggregation state for cytochrome b5 in
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vitro. As an alternative to FRET, an immunochemical approach for the investigation of
cytochrome b5 aggregation in vivo was followed. A method for the separation of
immunoglobulins, specifically recognising the monomeric and multimeric forms of
cytochrome b5, was developed and these immunoglobulins were subsequently used to
investigate the aggregation state of cytochrome b5 in vivo.
Trypsin treated cytochrome b5 was used to elicit an immune response in rabbits to investigate
the possibility of raising a monomeric specific antibody. As an alternative, the possibility of
purifying the monomer-specific antibody from the whole serum was also investigated. The
preparation of an affinity chromatography matrix for the isolation of monomeric cytochrome
b5 specific antibodies was not considered, due to the aggregation of intact cytochrome b5 in
aqueous solution. The application of a nitrocellulose membrane as an affinity matrix was thus
explored. Since monomeric cytochrome b5 could effectively be separated from other protein
aggregates by SDS PAGE, the separated proteins could subsequently be transferred to a
nitrocellulose membrane traditionally used in Western blot analyses. The two forms of
cytochrome b5 (monomeric and tertrameric), immobilised on the nitrocellulose membrane,
could subsequently be separated from one another yielding membrane strips containing either
the mono or the tetrameric forms of cytochrome b5. The individual strips could now be used
to affinity-isolate the different aggregated forms of the hemoprotein.
1.2 MATERIALS AND METHODS
Isolation of cytochrome b5
Cytochrome b5 was purified from fresh sheep liver as described by Swart et al. (8) and
subjected to electrospray mass spectrometry (ESMS) as previously described (4). Truncated
cytochrome b5 was prepared by tryptic digestion from purified cytochrome b5 as described by
Lombard et al. (4). Purified cytochrome b5 was analysed by SDS PAGE according to the
method of Laemmli (9), using a 15% resolving gel.
Immunochemical analyses of cytochrome b5 aggregates 
Rabbits were immunised with purified truncated and full length, intact cytochrome b5
according to the method of Bellstedt et al. (6). Rabbit sera containing either anti-truncated or
anti-full length cytochrome b5 immunoglobulins were used in Western blot analyses. The
binding of the respective antibodies to the truncated and full length forms of cytochrome b5,
as well as the binding to the monomeric and aggregated forms in liver microsomes was
investigated. Cytochrome b5 samples were dialysed against 10mM Tris acetate, pH 8.1,
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0.1mM EDTA containing 0.25% sodium deoxycholate to prepare the monomeric form.
Cytochrome b5 predominantly in the aggregate form, were prepared by dialyses against
buffer without deoxycholate. Liver microsomes, truncated and full length cytochrome b5 was
subjected to SDS PAGE using a 15% resolving gel. Two gels were prepared for Western blot
analyses. The separated proteins were subsequently transferred to nitrocellulose membranes
by applying a current of 1 mA/cm2 membrane area for one hour in a transfer buffer (39 mM
glycine, 48 mM Tris, 0.03% w/v SDS, 20% Methanol) using a horizontal semi-dry transfer
system. The membranes were rinsed in PBS and reversibly stained with a Ponceau S solution
(Sigma) to determine the efficiency of the transfer. The Ponceau S dye was subsequently
removed from the membranes by rinsing in PBS.
The membranes were incubated in blocking buffer (154 mM NaCl, 0.5% w/v Casein, 10 mM
Tris-HCl, 0.02% Thiomersal, pH 7.6) for 30 min at 25°C to minimise non-specific binding.
Anti-cytochrome b5 serum was added to the blocking buffer to a final serum dilution of
1:2000 and the membranes incubated for 90 minutes at 25°C. The membranes were
subsequently washed four times for 5 min with PBS-Tween (0.1% v/v Tween 20 in PBS).
Horseradish peroxidase labelled anti-rabbit antibody (Sigma) was added to the blocking
buffer to a final dilution of 1:80,000 and the membranes were incubated for 60 min at 25°C.
The membranes were washed as described above before adding the chemiluminesence
substrate (West DuraTM, Pierce Chemical Co., Rockford, Ill, USA) and exposured to auto
radiographic film.
Aggregation of purified full length cytochrome b5 in adrenal microsomal preparations
Purified cytochrome b5 and ovine adrenal microsomes were dialysed overnight against PBS.
Cytochrome b5 aliquots of 5 µg, 10 µg and 15 µg were subsequently added to microsomal
samples (50 µg total protein) and incubated overnight at 4°C while agitating gently. Samples
were subjected to SDS PAGE, using a 12.5% resolving gel. Following electrophoresis, a
Western blot analyses was carried out as described above using rabbit anti-full length
cytochrome b5 serum diluted 1:2,000. 
Affinity purification of immunoglobulins from rabbit anti-full length cytochrome b5 serum 
Purified cytochrome b5 was electrophoresed using a 12.5% resolving gel, transferred to a
nitrocellulose membrane and visualised using Ponceau S staining as previously described.
Two horizontal strips corresponding to the bands representing the molecular weight of the
tetrameric form of cytochrome b5 at 60,000 Da (aggregate strip) and the monomeric form, at
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16,000 Da (monomer strip) were excised from the membrane. The individual strips were
placed in a capped 10 ml tube, washed in PBS to remove the Ponceau S and incubated in
blocking buffer for 30 minutes. Anti-full length cytochrome b5 serum was added to the
blocking buffer to a final serum dilution of 1:500 and the aggregate strip was subsequently
incubated for 90 minutes at 25°C while agitating gently. The immunoglubulins bound to the
aggregate strip were removed from the membrane by incubating the strip in 5 ml 0.2 M
glycine, pH 2.5 for 4 minutes at 25°C, while agitating gently. The solution containing the
antibodies was transferred to a tube containing 0.5 ml 1 M Tris-HCl, pH 8.0 and the pH
adjusted to 7. This process was repeated three times after which the monomer strip was
incubated in the serum. The membrane was subjected to the same procedure as described
above to isolate the immunoglubulins bound to the monomer strip. The purified
immunoglobulins were stored at -20ºC until used undiluted in Western blot analyses.
Immunochemical analyses of cytochrome b5 using affinity purified immunoglobulins
Truncated cytochrome b5 and full length cytochrome b5, in the monomeric and aggregated
forms, were separated by SDS PAGE or non-denaturing PAGE and transferred to
nitrocellulose membranes as described above. Membranes were subjected to Western blot
analyses using the isolated rabbit anti-cytochrome b5 aggregate and monomer
immunoglobulin fractions. Microsomes, prepared from sheep liver, testes and adrenal tissue
as previously described (8), were subjected to SDS PAGE or non-denaturing PAGE and
Western blot analyses as described above to identify monomeric and aggregate forms of
cytochrome b5 in vivo.
1.3 RESULTS AND DISCUSSION
Results
Intact cytochrome b5 used to prepare the truncated form of the protein, along with truncated
cytochrome b5, was assessed by SDS PAGE analyses using conditions favouring the
monomeric state of the intact, full length protein (figure 5.3). The full length and truncated
forms of cytochrome b5 both exhibited single bands at molecular masses corresponding to the










Figure 3.9 SDS PAGE analyses of purified cytochrome b5. lane I: molecular weight
markers; lane II: intact ovine liver cytochrome b5 (5 µg) and lane III: truncated
cytochrome b5 (5 µg).
ESMS analyses of the purified full-length cytochrome b5 revealed a single specie with a
molecular mass of 15,255 Da representing the protein without a heme moiety, since the heme
group is detached under conditions used during ESMS analyses. Previous analyses of the
different forms of purified cytochrome b5, carried out in our laboratory on a Micromass
Quadropole-Time of Flight mass spectrometer (Q-ToF MS), identified the molecular mass of
15,249 Da for apo cytochrome b5 (without the heme group) and 15,865 Da for holo
cytochrome b5 (with the heme group). No other protein species were detected (figure 5.4).
Q-Tof MS analyses of the truncated form of cytochrome b5 yielded molecular masses of
9,812 Da and 10,184 Da and subsequent fragmentation studies showed that both species were
derived from the same protein (4).
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Figure 3.10 ESMS analyses of (A) purified full-length cytochrome b5 indicating the
molecular mass of apo cytochrome b5 and (B) truncated cytochrome b5. No other
protein species were detected, indicating the existence of a single protein in the
sample.
The specificity of the antibodies in recognising the monomeric or tetrameric form of the
protein was ascertained by immunostaining using rabbit sera containing either anti-truncated
or anti-full length cytochrome b5 antibodies. The rabbit anti-truncated cytochrome b5 serum,
obtained when immunising with trypsin treated cytochrome b5, recognised only the truncated
form of the protein (figure 5.5A). The anti-full length cytochrome b5 serum, obtained when
immunising with the full length protein, recognised both the aggregate and monomeric forms
of cytochrome b5 (figure 5.5B). In addition to the monomeric and tetrameric forms observed,
positive immunostaining was observed for the dimeric form (~30,000 Da) of cytochrome b5.
Furthermore, in liver microsomes the antibody recognised only the multimeric form of the
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Figure 3.11 Western blot analysis of cytochrome b5. A: nitrocellulose membrane blotted with
anti-truncated cytochrome b5 serum (1:2,000) and B: nitrocellulose membrane
blotted with anti-full length cytochrome b5 serum (1:2,000). Lane I: truncated
cytochrome b5; lane II: full-length cytochrome b5 dialysed against a
deoxycholate-free buffer; lane III: full-length cytochrome b5 dialysed against a
deoxycholate containing buffer (0.25%) and lane IV: sheep liver microsomes 
The possible aggregation of cytochrome b5 was investigated in microsomal preparations to
ascertain whether monomeric and/or multimeric forms of cytochrome b5 existed in
equilibrium in the endoplasmic reticulum. Increasing concentrations of full length
cytochrome b5 was added to ovine adrenal microsomes and the presence of aggregates was
determined by Western blot analyses using anti-full length cytochrome b5 serum. Although
no monomeric form was detected in adrenal microsomes, only a faint band indicative of
immunostaining of the monomeric form was observed at ~15,000 Da in the purified full
length cytochrome b5 preparation following dialyses with PBS (figure 5.6). Analyses clearly
showed that the addition of full length cytochrome b5 did not shift the equilibrium from the
aggregated tetrameric form to the monomeric form of the protein. Although some
non-specific binding was evident, no monomeric form of cytochrome b5 was identified in
adrenal microsomes. The intensity of the chemiluminescent signal corresponding to a
molecular mass of 60,000 Da increased (lanes III to V) indicating that the full length
cytochrome b5 remained in the aggregated state at higher concentrations when associated
with the microsomal membrane.
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Figure 3.12 Western blot analyses of aggregation of full-length cytochrome b5 in ovine
adrenal microsomes. Lane I: adrenal microsomes (50 µg); lane II: full-length
cytochrome b5 (5 µg); lanes III - V: 5µg, 10µg and 15µg full-length cytochrome
b5 in microsomes (50 µg). Nitrocellulose membrane blotted with antiserum
against the intact form of cytochrome b5 serum, 1:2000. 
Non-denaturing gel electrophoreses was carried out with subsequent Western blot analyses
using antibodies against both the purified intact and the truncated cytochrome b5 forms
(figure 5.7). Anti-truncated cytochrome b5 serum recognised two species in the lane
containing the trypsin truncated form of the protein. The antiserum against the purified intact
cytochrome b5 exhibited positive immunostaining in both the deoxycholate-containing and
deoxycholate-free samples of the purified intact forms of the protein. No difference in the
distribution of species were observed between the two samples of the intact protein. This is in
contrast with the results obtained from Western blot analyses of cytochrome b5 subjected to
SDS PAGE, where a definite preference for the monomeric form of cytochrome b5 was
observed in the presence of deoxycholate (figure 5.3)
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Figure 3.13 Western blot analyses of proteins separated by non-denaturing PAGE. A:
nitrocellulose membrane blotted with anti-full length cytochrome b5 serum and
B: nitrocellulose membrane blotted with anti-truncated cytochrome b5 serum.
Lane I: ovine adrenal microsome; lane II: ovine liver microsomes; Lane III:
ovine testis microsomes; lane IV: full length cytochrome b5 (PEG precipitated
microsomes); Lane V: full length cytochrome b5 (CaCl2 precipitated
microsomes); Lane VI: truncated cytochrome b5. A total of 50 µg protein was
loaded per well. Antibody dilution 1:2000.
Since full-length cytochrome b5 is present in different aggregate forms when not buffered in
solution, the purified protein was dialysed against deionised water prior to performing
electrophoresis, thus ensuring an equilibrium between the monomeric and aggregated states.
The proteins were transferred onto a nitrocellulose membrane and stained reversibly with
Ponceau S to visualise the monomeric and aggregate forms (figure 5.8). 
60kD
16kD
Figure 3.14 Nitrocellulose membrane with immobilised full-length cytochrome b5.
Electrophoresed proteins, 50µg/well, were transferred and stained with Ponceau
S. The tetrameric specie (60,000 Da) and the monomeric specie (16,000 Da) are
indicated.
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Immunoglobulins were subsequently isolated from rabbit anti-full length cytochrome b5
serum using aggregate and monomer strips. The specificity of these immunoglobulins was
determined by ascertaining whether the purified immunoglobulins would bind the monomeric
or the multimeric forms of full length cytochrome b5. Both the monomeric and the multimeric
forms were prepared by dialysing full length cytochrome b5 against a deoxycholate free
buffer to enhance aggregation, and against a deoxycholate containing buffer to prevent
aggregation. The dialysed preparations and trypsin truncated cytochrome b5 were
electrophoresed, transferred to nitrocellulose membranes and used in the analyses of the
affinity-purified immunoglobulins (figure 5.9A and B). The antibodies isolated with the
aggregate strip recognised the monomeric as well as multimeric forms of cytochrome b5. No
signal was observed for the trypsin truncated form of the hemoprotein. Antibodies isolated
with the monomer strip recognised only the monomeric as well as truncated forms of
cytochrome b5. The analyses clearly shows that the presence of deoxycholate markedly
increased the monomeric form of the protein. 
The affinity purified antibodies were subsequently used to investigate the presence of the
monomeric and multimeric forms of cytochrome b5 in ovine adrenal, liver and testicular
tissue. It is apparent that the immunoglobulins isolated with the aggregate strip recognised
the tetrameric form of cytochrome b5 as the major component of the different microsomal
preparations as well as a 30,000 Da aggregate in adrenal and liver microsomes (figure
5.10A). In contrast, the immunoglobulins prepared with the monomer strip did not recognise
the tetrameric form in any of the preparations (figure 5.10B). 
In the adrenal and liver microsomes, the antibody against the monomeric form of cytochrome
b5 did not exhibit a significant signal for the monomeric or aggregated forms of cytochrome
b5. In the testicular microsomes, however, clear signals corresponding to a monomer were
visible at 16,000 Da and corresponding to a dimer at 30,000 Da. The identity of the proteins
immunprecipitating at a molecular mass of ~35,000 Da in the ovine testes microsomes is
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Figure 3.15 Characterisation of affinity purified rabbit anti-full length cytochrome b5
immunoglubulins. A: Western blot analyses of affinity purified antibodies
against the multimeric forms of cytochrome b5 and B: Western blot analyses of
affinity purified antibodies against the monomeric form of cytochrome b5. Lane
I: full-length cytochrome b5 dialysed without deoxycholate; lane II: full-length
cytochrome b5 dialysed against in deoxycholate containing buffer and lane III:








I II IIII II III
Figure 3.16 Western blot analyses of the monomeric and aggregated forms of cytochrome b5
in microsomal tissue. A: nitrocellulose membrane blotted with affinity purified
antibodies against multimeric cytochrome b5 and B: nitrocellulose membrane
blotted with affinity purified antibodies against monomeric cytochrome b5. Lane
I: ovine adrenal microsomes; lane II: ovine liver microsomes and lane III: ovine
testes microsomes. Affinity purified immunoglobulins used undiluted.
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Discussion
It is evident from the data presented and current literature that cytochrome b5 aggregation
occurs. Extensive research regarding the structure of cytochrome b5 in aqueous solutions
showed that the degree of aggregation is dependent on the detergent strength and ionic
conditions. However, even under conditions favouring the monomeric from of the protein
viz. low salt and high detergent concentrations, a degree of aggregation was observed (4, 10).
Investigation into the structure/function relationship of cytochrome b5 and the influence of
aggregation states on role of cytochrome b5 as a redox partner would be greatly facilitated by
the availability of specific antibodies recognising not only the monomeric form but also the
multimeric forms. The successful preparation of a homogenous solution of monomeric full
length cytochrome b5 is hampered by the spontaneous aggregation of the protein thus
impeding the preparation of cytochrome b5 in its monomeric state for immunisation purposes.
Immunisation protocols and solutions used in the preparation of the antigen favour
cytochrome b5 aggregation and therefore the host will be presented with both the monomeric
and aggregate forms of cytochrome b5.
The truncated form of cytochrome b5 was prepared as an antigen in an attempt to raise
antibodies against the monomeric form of cytochrome b5 only. This antiserum showed
positive immunostaining with its complimentary protein only. The full length cytochrome b5
(monomer or aggregate) was not recognised by truncated cytochrome b5 antiserum. Although
the antibody against the truncated form of cytochrome b5 could not be used to distinguish
between the monomeric and aggregated forms of the protein, valuable information about the
aggregation of cytochrome b5 was gleaned from this data. Since no higher molecular mass
aggregates were observed in solutions of trypsin truncated protein it is apparent that the
hydrophobic membrane binding region of cytochrome b5 is essential for the aggregation of
cytochrome b5. In addition, the hydrophobic membrane binding domain plays an important
role in the folding of cytochrome b5 and it is clear that different protein domains are exposed
as epitopes in the truncated form as opposed to those exposed in the full length native
protein. This is an interesting observation since the truncated cytochrome b5 exhibits spectral
properties identical to those exhibited by the intact native protein. 
Cytochrome b5 was analysed using non-denaturing gel electrophoresis to determine the native
state of protein as reported in Chapter 3. No definitive conclusions about the aggregation of
cytochrome b5 could be drawn from these results as no molecular mass markers are available
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for the characterisation of proteins using non-denaturing conditions. Having raised antibodies
against purified cytochrome b5, a method of positively identifying cytochrome b5 was now
available. The two species recognised by the anti-truncated cytochrome b5 correlate with the
species observed in the non-denaturing PAGE analyses reported in Chapter 3 figure 3.5, thus
allowing the positive identification of both species as trypsin truncated cytochrome b5.
Although SDS PAGE analyses showed a single specie, ESMS analyses results indicate the
presence of two species (Chapter 3, figure 3.2B). Non-denaturing gel electrophoresis thus
provide a means of separating the two trypsin truncated species of cytochrome b5, in the
absence of denaturing agent, for subsequent elution from the gel in an active form.
The lack of difference in distribution patterns of the two intact forms of cytochrome b5 when
performing a Western blot analysis with anti-intact cytochrome b5 shows that both the
denaturing conditions of SDS PAGE and the presence of a detergent such as deoxycholate
5 to prevail.
Although positive staining was observed in the lanes representing the various ovine
microsomal fractions on a stained non-denaturing poly-acrylamide gel (Chapter 3, figure
3.5), no positive immunostaining was observed in any of these lanes when blotted with an
antiserum against full length purified cytochrome b5. Under non-denaturing conditions
cytochrome b5 was not released from the microsomal membrane and did not penetrate the
poly-acrylamide gel. Although cytochrome b5 is released from the microsomal membrane
under the denaturing conditions of SDS PAGE the protein still exists in the aggregated form
in the absence of a detergent. It may be concluded that that the conditions resulting in the
release of the protein from the membrane are insufficient to prevent aggregation. This data
strongly suggests that ovine cytochrome b5 exists as an aggregate in vivo. 
In figure 5.7 positive immunostaining was observed in the lanes representing ovine liver
microsomes when blotted with both the antisera against the intact and truncated cytochrome
b5. This observation reiterates the necessity of a pre-immune serum. Although pre-immune
serum indicated no non-specific binding in Western blot analyses following protein
separation on a SDS PAGE, non-specific immunostaining can still occur in Western blot
analyses following protein separation on a non-denaturing gel. Proteins are denatured during
sample preparation in SDS PAGE, thus destroying enzyme activity. Enzymes which could
potentially compete with peroxidase for the chemiluminesent substrate would thus remain
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active. In non-denaturing gel electrophoresis, certain hydrogen peroxide utilising enzymes,
such as catalase, could yield false positive immunostaining.
The results presented in this chapter proves that ovine cytochrome b5 exists in a monomeric
as well as in a teterameric form, with the tetrameric form prevailing under most conditions.
The two species differ with respect to their immunogenicity and can also be distinguished
immunochemically from the trypsin truncated form of the protein. These results emphasize
the importance of the membrane binding carboxyl terminal of cytochrome b5 in the
maintenance of the tertiary structure of the protein as well as the formation of possible
quartenary structures. We have previously shown that the cytochrome b5 in ovine adrenal
microsomes is predominantly in the tetrameric form. Other aggregation states with negligible
amounts of monomeric cytochrome b5 are also present. Addition of purified ovine
cytochrome b5 to these microsomal preparations yielded only the aggregated form of the
protein.
Previous studies in our laboratory used SDS PAGE purified preparations of cytochrome b5,
corresponding to a molecular mass of 16,000 Da for immunisation. This antiserum, however,
also detected aggregate forms of the hemoprotein. Monomer- and aggregate-specific
cytochrome b5 antibodies were subsequently isolated from whole serum by transferring the
cytochrome b5 species, separated by SDS PAGE, directly from the gel onto a nitrocellulose
membrane. The affinity purified immunoglobulin fraction subsequently obtained from the
aggregate strip, recognised and bound both the monomeric and multimeric forms of purified
cytochrome b5. The truncated form of the protein was not detected by these
immunoglobulins. In contrast, the immunoglobulin fraction purified from the monomer strip
did not recognise the higher molecular mass (>16,000 Da) cytochrome b5 aggregates.
Interestingly, the immunoglobulins from the monomer strip recognised the truncated form of
cytochrome b5 even though a blot with the whole serum failed to detect any truncated protein.
This finding can be explained by considering the immunoglobulins present in solution — the
immunoglobulin concentration was ~8 fold higher in the affinity purified immunoglobulin
preparations than in whole antiserum. Although the concentration of immunoglobulins
obtained from the monomer and aggregate strips are comparable, marked differences were
shown regarding specificity of the immunoglobulins for the monomer, aggregate and
truncated forms of cytochrome b5, again showing the pronounced influence of the membrane
binding domain on the folding of full length purified cytochrome b5.
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The affinity purified immunoglobulins were subsequently used to investigate the aggregation
states of cytochrome b5 in ovine adrenal-, liver- and testicular tissue. The immunoglobulins
obtained from the aggregate strip clearly recognised a 60,000 Da form of ovine cytochrome
b5 in all three tissue types investigated. However, marked differences were observed in the
lower aggregation states of the hemoprotein. The monomeric form of the cytochrome b5 was
observed in testicular microsomes only. The immunoglobulins isolated from the monomer
strip did not recognise the tetrameric (60,000 Da) form of cytochrome b5 in any of the tissue
types investigated. This result clearly shows that the antigenic properties, and therefore the
three dimensional structure of the monomeric and tetrameric forms of cytochrome b5 differ
substantially. It can be deduced that, in vivo, cytochrome b5 occurs predominantly as a
tetramer and not a monomer in liver and adrenal tissue. This difference in aggregation states
in microsomal samples indicates that it is unlikely that the observed aggregation is the
product of SDS PAGE sample preparation, as all microsomal samples were prepared the
same. Furthermore, although aggregates with molecular masses greater than 16,000 Da are
also present, the affinity purified immunoglobulins indicate that it is only in testicular
microsomes that cytochrome b5 exists as a monomer. It is evident from data presented in this
study that, in steroidogenic tissue, cytochrome b5 is present in different aggregate forms. This
finding presents an interesting avenue for future investigations since the predominant form
and physiological role of cytochrome b5 in steroidogenic tissue is uncertain. Cytochrome b5
influences steroid metabolism in the testes and the adrenal in that it modulates the catalytic
activity of the cytochrome P450c17 (11, 12). Cytochrome P450c17 exhibits both hydroxylase
and lyase activities for steroid hormone precursors which is influenced and possibly
regulated, in part, by cytochrome b5 in these two tissue types (8, 13, 14). It is possible that the
aggregation state of cytochrome b5 may modulate the influence the protein has as a redox
partner or allosteric effector on the catalytic activity of cytochrome P450c17. 
Valuable information about the function of cytochrome b5 may be gleaned from knowledge
pertaining to the localisation as well as the aggregation state of the protein. Contributions
towards the elucidation of the structure/function relationship of cytochrome b5 have been
made by immunochemical investigations. Our data clearly show that the distribution of the
native form of the protein in vivo can only be assessed with aggregate specific
immunoglobulins.
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In adrenal and gonadal steroidogenesis cytochrome b5 influences the activity of the
cytochrome P450-dependant steroid 17α-hydroxylase (cytochrome P450c17) reaction. As an
electron transport protein, cytochrome b5 can supply the second of two electrons to the
enzyme — the first electron is predominantly supplied by NADPH via cytochrome
P450-reductase. The flow of electrons from NADH to cytochrome P450 via cytochrome b5 is
not as fast as the direct input of an electron from NADPH (15). Should the second electron
not be supplied fast enough though, uncoupling of cytochrome P450 with its substrate can
take place with the subsequent release of superoxide. Tetrameric cytochrome b5 in the
phospholipid bilayer could thus provide an immediate source of four electrons in close
contact with cytochrome P450, limiting the chances of uncoupling of the reaction .
The influence of purified full length and trypsin truncated ovine cytochrome b5 on ovine
adrenal steroidogenesis was subsequently investigated.
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CHAPTER 6
INFLUENCE OF PURIFIED CYTOCHROME b5 ON OVINE
ADRENAL STEROIDOGENESIS 
1.1 INTRODUCTION
Steroidogenesis refers to the biosynthesis of steroids from cholesterol, the biosynthetic
source of all steroid hormones. The primary organs involved in the biosynthesis of steroids
are the placenta, the gonads and the adrenal glands (1). Steroid hormones are clinical and
physiological regulators of physiological processes. Five groups of steroid hormones, which
are structurally similar and arise from a common series of pathways, are generally recognised
according to their physiological behaviour. These groups are mineralocorticoids,
glucocorticoids, estrogens, progestins and androgens. The pathways by which these
hormones are produced from cholesterol were initially studied by investigating the structures
of the steroids themselves. During the past forty years, studies of enzyme kinetics and of
steroidal precursor-product relationships have shown that a large number of distinct enzymes
are involved in the conversion of cholesterol and its esters to active steroid hormones. Most
of these steroidogenic enzymes are members of the cytochrome P450-dependent group of
oxidases (2).
Three of the above mentioned groups of steroid hormones are secreted by the adrenal glands
– the mineralocorticoids, which act on the renal tubules to retain sodium and thus regulate the
electrolytes and water concentration in mammals; glucocorticoids, which regulate the
metabolism of proteins, carbohydrates and lipids and the androgens, which induce male
secondary characteristics (2, 3, 4). 
1.2 THE ADRENAL GLAND
Mammals posses a pair of adrenal glands, each atop a kidney. Although they are
anatomically connected, the adrenal glands function independently from the kidneys. The
gland consists of two components, an inner medulla derived from the neural crest and the
outer cortex derived from the coelom (5) (figure 6.1). 
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Figure 6.1 Cross-section of the adrenal gland showing the different layers in the gland. In
the centre is the medulla (D), surrounded by the cortex. The cortex consists of
the zona glomerulosa (A), the zona fasciculata (B) and the zona reticularis
(C). (6)
Even though the medulla and cortex form part of the same gland, they are controlled by
different systems – the medulla is controlled by the sympatic nervous system through
nerve-impulses, while the adrenal cortex is an endocrine gland. Adrenocorticotropic hormone
(ACTH) from the pituitary gland activate the adrenal cortex to release corticosteroids.
Different parts of the cortex produce different hormones. The structure of the gland is
discussed in more detail to gain a better understanding of the functioning of the adrenal
gland.
The adrenal medulla is composed of chromaffin cells, connective tissue and numerous blood
vessels and nerves. The chromaffin cells are organised in chords, surrounded by blood
vessels. Features of these cells include abundant granular endoplasmic reticuli and a
well-developed Golgi complex. Epinephrine and the other norepinephrine are released from 2
types of cells usually under conditions of stress and cause an increase in heart rate and blood
pressure and the stimulation of the conversion of glycogen to glucose, to name but a few
effects (6).
The cortex is encapsulated by connective tissue (capsule) and consists of three histologically
defined zones:
i) The outer zona glomerulosa is the first zone directly below the capsule and consists of
small pyramidal cells arranged in rounded clusters and curved columns that are continuous
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with the cords of cells in the zona fasiculata. The cells have a relatively small cytoplasm
containing lipid droplets and abundant smooth endoplasmic reticulum. Mineralocorticoids are
produced in this zone.
ii) The intermediate zona fasciculata consists of large polyhedral cells arranged in cords
separated by sinusoids. In the cytoplasm there are numerous lipid droplets containing neutral
fats, fatty acids, cholesterol and phospholipids, utilised as precursors for the steroid
hormones. The cells have abundant smooth endoplasmic reticuli, mitochondria with tubular
cristae and a well-developed Golgi complex. Glucocorticoids have their origin in this zone.
iii) The inner zona reticularis consists of rounded cells arranged in branching cords. The
cytoplasm contains relatively few lipid droplets. As in the cells of the other layers, abundant
smooth endoplasmic reticuli are present in these cells. Gonadocorticoids are produced in this
zone, although in such insignificant small amounts, that it is not really considered a function
(6). 
The secretory activities of the inner two zones are controlled by the adenohypophysis through
the secretion of adrenocorticotropic hormone (ACTH). ACTH stimulates the flow of blood
through the adrenal gland, promotes growth of the cortex and stimulates the secretion and
release of corticosteroids. The release of ACTH is controlled through a feedback system
involving the higher brain centres, the hypothalamus and the adenohypophysis (figure 6.2).
Low plasma levels of corticosteroids trigger the hypothalamus to release
corticotropin-releasing factor (CRF), which in turn stimulates the adenohypophysis to release










Figure 6.2 Schematic representation of neuro endocrine control of the adrenal cortex.
Low levels of hormones or metabolic needs can stimulate the system. High
levels of corticosteroids or the physiological action itself can inhibit the
further release of hormones through negative feedback.
1.3 BIOSYNTHESIS OF ADRENAL STEROID HORMONES 
Cytochrome P450 plays an important role in adrenal steroidogenesis, catalysing the
biosynthesis of androgens, mineralo- and glucocorticoids from cholesterol, the steroid
hormone precursor.
Although steroidogenic tissue can synthesise cholesterol de novo, human steroidogenic cells
derive most of its cholesterol from plasma low density lipoproteins (LDL) (7,8). The
rate-limiting enzyme in cholesterol synthesis is 3-hydroxy-3-methylglutaryl coenzyme A
(HMGCoA) reductase. This enzyme will be suppressed if the levels of LDL in the human
adrenal cells are sufficient (9). Its activity will be stimulated by the same tropic hormones
that stimulate steroidogenesis, together with a stimulation of LDL receptors and uptake of
LDL cholesterol. The uptake of LDL cholesterol esters takes place by means of receptor
mediated endocytosis, followed by conversion to free cholesterol for immediate use in
steroidogenesis or direct storage (8).
The storage of cholesterol in lipid droplets as cholesterol esters is controlled by the action of
two opposing enzymes, namely cholesterol esterase and cholesterol ester synthetase. Tropic
hormones such as ACTH stimulate esterase activity while inhibiting the synthetase activity,
effectively increasing the availability of free cholesterol for steroidogenesis (10).
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Rat steroidogenic tissue differs from human tissue in the respect that it receives most of its
cholesterol from high density lipoproteins (HDL) instead of LDL. The uptake of HDL differs
from LDL uptake as it is taken up through a mechanism that does not involve the
internalisation of the intact lipoprotein particle (11).
Free cholesterol is insoluble in the aqueous cytosolic environment. ACTH induces a sterol
carrier protein 2 (SCP-2) which transports the free cholesterol from the cytosol to the
mitochondria (12,13). The flux of cholesterol over the mitochondrial membranes to the
cytochrome P450scc (side-chain cleavage) was thought to be stimulated by a 30-amino acid
steroidogenesis activator peptide (14). This peptide has a short half-life and is very sensitive
for cycloheximide. This was shown when an accumulation of cholesterol was observed in the
outer membrane of the adrenal mitochondria of rats treated with cycloheximide (15). It has
since then been proven that the import of cholesterol into the mitochondria is facilitated by
the steroidogenic acute regulatory protein (StAR) (16).
Cholesterol is converted to pregnenolone by cytochrome P450scc in the mitochondria, which
is accomplished in three sequential reactions on a single active site. Cholesterol undergoes
20-hydroxylation, 22-hydroxylation and finally scission of the 20,22 C-C bond to yield
pregnenolone and isocaproaldehyde (figure 6.3) (2). Each of these reactions requires a pair of
electrons. The StAR-P450scc system is rate-limiting and hormonally regulated and it can
thus be said that it is the quantitative regulator of steroidogenesis (17).
The pregnenolone that is formed subsequently diffuses to the endoplasmic reticulum. If
cytochrome P450c17 is not present, like in the zona glomerulosa, C-21 17-deoxysteroids
(e.g. Aldosterone) products are formed. C-21 17-hydroxysteroids are formed (e.g. cortisol)
when just the 17α-hydroxylation activity is present. In the presence of both the hydroxylation
and lyase activity, C-19 precursors of the sex steroids are formed (figure 6.3). Although
cytochrome P450c17 is not the only cytochrome P450 that can catalyse more than one
reaction, it is to date the only one described in which these activities are regulated
differentially by a physiological process. Cytochrome P450c17 can therefore be seen as the
qualitative regulator of steroidogenesis, as it determines which steroids are going to be
synthesised (2, 3, 17).
The relative activities of 3β-hydroxysteroid dehydrogenase-D5-isomerase (3βHSD) and
cytochrome P450c17, will determine pregnenolone metabolites (figure 6.3). Pregnenolone
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will be preferentially oxidised and isomerized to progesterone when just the
17α-hydroxylation activity is present, which in turn will be hydroxylated at the C-21 position
to yield 11-deoxycorticosterone if the 21-hydroxylase activity is higher than that of the
17α-hydroxylation activity. In contrast pregnenolone can undergo 17α-hydroxylation to yield
17-hydroxypregnenolone and be converted to dehydroepiandrosterone (DHEA), providing
that the lyase activity is higher than the 3βHSD activity. Likewise, progesterone can undergo
17α-hydroxylation to form 17-hydroxyprogesterone which in turn can, under the influence of
17,20-lyase activity, be converted to androstenedione. Through 3βHSD activity
17-hydroxypregnenolone and DHEA can be converted to 17-hydroxyprogesterone and
androstenedione respectively. 17-Hydroxyprogesterone can be metabolised by means of
hydroxylation of the C-21 by cytochrome P450c21 to 11-deoxycortisol (2,3,17). 
Both 11-deoxycorticosterone and 11-deoxycortisol are transferred back to the mitochondria
where conversion to corticosterone and cortisol, respectively, by the 11β-hydroxylation
activity of cytochrome P45011β takes place. 11-Deoxycorticosterone can be converted to
























































































































Figure 6.3 Schematic representation of adrenal steroidogenesis. The dotted line indicate
the mitochondrial membrane while the inner solid line indicates the
endoplasmic reticulum membrane. C17: cytochrome P450c17; 3βHSD:
3β-hydroxysteroid dehydrogenase-D5-isomerase; C21: cytochrome P450c21
(3)
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1.4 CYTOCHROMES P450 
The term “Cytochrome P450” refers to a group of heme containing proteins that have a
sulphur atom ligated to the heme iron and that, upon reduction, form carbon monoxide
complexes with a characteristic absorption maximum at 450nm (18, 19) (figure 6.4).
Cytochrome P450s form part of a group of enzymes that insert one atom of atmospheric
oxygen into their substrate and the other one into water, termed monooxygenases.
Cytochrome P450-dependent monooxygenase systems are widely distributed in animals,
plants and protists and catalyse a wide range of reactions. The substrates for some of these
reactions include steroids, eicosanoids, fatty acids, lipid hydroperoxides, retinoids, acetone
and xenobiotics (18, 20, 21).
Figure 6.4 Carbon monoxide difference spectra of rat liver microsomes. The solid line
represents the spectrum for carbon monoxide with diphosphopyridine
nucleotide (DPNH) reduction. The dashed line represents the spectrum for
carbon monoxide with dithionite reduction (Redrawn 22).
1.5 CATALYTIC CYCLE OF CYTOCHROME P450-DEPENDENT
HYDROXYLATIONS 
Cytochrome P450s all reduce atmospheric O2 with electrons originating from NADPH.
Cytochrome P450c17, for instance, receives electrons from a membrane-bound flavoprotein,
P450 reductase. P450 reductase is in turn reduced by two electrons from NADPH. Electron
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transfer from P450 reductase to cytochrome P450 is sequential (one electron at a time). The
transfer of the first electron is fast while the transfer of the second one is slower (2, 23). This
second electron may also be provided by cytochrome b5.
The catalytic reaction cycle of cytochrome P450 occurs in a number of stepwise reactions
(19) (figure 6.5):
1. the binding of the substrate;
2. one-electron reduction of the ferric enzyme-substrate complex; this reducing equivalent is
supplied by NADPH to the mitochondrial and the microsomal cytochrome P450s;
3. binding of molecular oxygen to the ferrous enzyme-substrate complex; superoxide can be
produced at this step;
4. transfer of the second electron from either cytochrome P450-reductase or from
cytochrome b5, the oxygen complex may dissociate to ferric cytochrome P450 and
superoxide if the electron transfer is slow (mentioned in previous step);
5. protonation of the distal oxygen atom by a hydrogen atom. The production of hydrogen
peroxide at this step is possible;
6. cleavage of the oxygen-oxygen bond to yield a reactive iron-oxo intermediate;
7. insertion of the activated oxygen atom into a carbon-hydrogen bond of the substrate, and
8. dissociation of the product and the regeneration of the ferric cytochrome P450.
























Figure 6.5 Proposed scheme for the mechanism of action of cytochrome P450 in
hydroxylation reactions. RH represents a substrate and ROH the
corresponding product (19).
1.6 ELECTRON TRANSPORT TO CYTOCHROME P450
6.6.1 Electron transfer in mitochondria
Cytochrome P450scc functions as the terminal oxidase in the mitochondrial electron
transport system. Electrons from NADPH are accepted by adrenodoxin reductase, a
flavoprotein which is loosely associated with the mitochondrial inner membrane.
Adrenodoxin reductase passes these electrons on to adrenodoxin, an iron-sulphur protein in
solution in the mitochondrial matrix. Adrenodoxin transports the electrons to cytochrome
P450scc (24, 25) (figure 6.6). The adrenodoxin-adrenodoxin reductase system serves as a










Figure 6.6 Electron transport to mitochondrial cytochromes P450 (2).
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Adrenodoxin forms a 1:1 complex with adrenodoxin reductase, dissociates, and then forms a
1:1 complex with cytochrome P450scc, cytochrome P450c11 or aldosterone synthase. The
selectivity of the reaction seems to be determined by the presence of the substrate bound to
the cytochrome P450 moiety (27).
6.6.2 Electron transfer in the endoplasmic reticulum
Cytochrome P450 reductase, a membrane associated flavoprotein, receives two electrons
from NADPH, which is passed on to cytochrome P450c17 or cytochrome P450c21 one at a
time (28, 29) (figure 6.7). The transfer of the first electron is fast and the second slower. The
second electron may, however, be supplied by cytochrome b5. The formation of a complex
between cytochrome P450, cytochrome P450 reductase and cytochrome b5 is facilitated by
certain phospholipids, resulting in more efficient electron transfer. It has been reported that
there are higher concentrations of cytochrome P450c17 and cytochrome P450c21 in the
endoplasmic reticulum than cytochrome P450 reductase and the enzymes must therefore
compete for reducing equivalents. Since phospholipids play a role in complex formation, they













Figure 6.7 Electron transport to microsomal cytochromes P450 (2).
The availability of electrons seem to determine whether cytochrome P450c17 carries out only
17α-hydroxylation, or 17,20-bond scission as well. If the ratio of reductase or cytochrome b5
to cytochrome P450c17 increase in vitro, the ratio of 17,20-lyase activity to
17α-hydroxylation increases. Competition for available substrate between the
21-hydroxylation or 17,20-lyase reaction does not seem to influence the hydroxylase and
lyase reactions, as there is no significant increase in androstenedione levels if
21-hydroxylation is eliminated (32, 33).
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The increase in the ratio of cytochrome P450 reductase to cytochrome P450 increased the
17,20-lyase activity in both the adrenal and the testes. The porcine testis contains 3-4 times
more reductase than the porcine adrenal. This ratio seems to be the most important factor in
determining whether a steroid will undergo 17,20-bond scission after 17α-hydroxylation
(33).
1.7 THE ROLE OF CYTOCHROME b5 IN CYTOCHROME P450 CATALYSED
REACTIONS
6.7.1 Influence of cytochrome b5 on cytochrome P450 catalysed reactions
The involvement of cytochrome b5 in cytochrome P450 reactions was first suggested by
Hildebrandt and Estabrook (23) in 1971. Ever since, it has been a subject of dispute. Some
investigators found that cytochrome b5 had no effect on cytochrome P450 reactions, while
others found that cytochrome b5 was almost obligatory for catalysis involving certain
substrates. Enzyme activity could only be shown in reconstituted systems with cytochrome
P450 and cytochrome P450 reductase, which argued against the obligatory role of
cytochrome b5. On the other hand, antibodies against cytochrome b5 or cytochrome P450
reductase, used in a microsomal system with NADH, showed that cytochrome b5 had an
influence on the reaction mechanism (34).
Although this controversy still continues, the focus has shifted towards whether electron
transfer from cytochrome b5 to cytochrome P450 is necessary for the stimulatory effect.
Cytochrome b5 has a complex interaction with cytochrome P450, influenced by the type of
cytochrome P450 involved as well as the substrate. It was shown that cytochrome b5 can
either be an obligatory component of a given reaction or a modulator of a reaction that would
take place in the absence of cytochrome b5. Furthermore, cytochrome b5 can have either a
stimulatory or an inhibitory modulating effect dependant on the type of cytochrome P450 and
the substrate involved. An absolute requirement for cytochrome b5 has been shown for the
metabolism of methoxyflurane for example (35). Other examples of such dependence are the
metabolism of p-nitroanisole (36), 7-ethoxycoumarin (37), p-nitrophenetole (38),
prostaglandins A1, E1, E2 (39), arachidonate (40) and testosterone (41). In contrast, the
presence of cytochrome b5 inhibited the NADPH-supported metabolism of benzphetamine
(42).
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In liver microsomes, drug metabolism was stimulated by the addition of NADH implicating
the cytochrome b5-cytochrome b5 reductase system in these P450-mediated reactions (43). A
second observation, in which cytochrome b5 could be reduced by NADPH, indicated that
cytochrome b5 could receive electrons from cytochrome P450 reductase (44). Pandey et al.
(45) reported that serine phosphorylation of cytochrome P450c17 enhanced the 17,20 lyase
activity independent of cytochrome b5, while having no effect on the 17α-hydroxylase
activity. It was postulated that the enhancement of 17,20 lyase activity by phosphorylation is
most probably due to an increased interaction between NADPH-cytochrome P450
oxidoreductase and cytochrome P450c17. These studies linked cytochrome b5 to the
cytochrome P450 monooxygenase system.
6.7.2 Mechanism of action of cytochrome b5
The proposed mechanism of the positive modulating action cytochrome b5 imposes on the
cytochrome P450 monooxygenase system is summarised below.
6.7.2.1. Transfer of second electron 
After studying the addition of NADH to a microsomal system, Hildebrandt and Estabrook
(23) concluded that the second and rate-limiting electron in the cytochrome P450 reaction
cycle could be provided by cytochrome b5. In microsomal assay systems NADH has a
synergistic effect on the hydroxylation of many cytochrome P450 substrates. In reconstituted
systems, this was shown to be mediated by the cytochrome b5-/cytochrome b5 reductase
pathway (46). With cytochrome P450 reductase being able to reduce cytochrome b5, neither
cytochrome b5 reductase nor NADH were necessary in most cases for the stimulation of the
reaction. Electrons could thus flow from NADPH (or NADH), through cytochrome P450
reductase, to cytochrome b5 and cytochrome P450 (47) (figure 6.8). Thermodynamically, it is
highly unlikely that cytochrome b5 will be able to reduce the ferric form of cytochrome P450.
However, the oxyferrous form (one electron reduced form), with its midpoint potential of ~50
















Figure 6.8 Schematic representation of the input of the second electron of cytochrome
P450, facilitated by cytochrome b5. The dotted line indicates the decreased
uncoupling pathway during enhanced coupling (49).
6.7.2.2. Enhancement of coupling
In addition to the products of monooxygenation, hydrogen peroxide is produced during the
catalysis of the monooxygenation of various substrates (50). The addition of cytochrome b5
causes enhanced coupling of NADPH oxidation to substrate oxidation resulting in a decrease
in the release of superoxide, which dismutates to hydrogen peroxide. At the same time it does
not cause an increase in the consumption of NADPH, but rather a decrease, thereby
increasing the formation of product (51). Stoichiometric measurements have related NADPH
and oxygen consumption with hydrogen peroxide and product formation and shown that the
addition of cytochrome b5 enhances product formation at the expense of hydrogen peroxide
formation (52) (figure 6.8). It is thought that cytochrome b5 provides the second electron
faster than the rate of superoxide anion release (uncoupling) and thus allowing more product
to be formed.
6.7.2.3. Two electron acceptor complex 
Cytochrome b5 forms a tight, equimolar complex with cytochrome P450 through ionic
interactions between the heme and polypeptide carboxyl groups of cytochrome b5 and
positively charged residues of cytochrome P450 (52). This complex can accept two electrons
during a single interaction with NADPH cytochrome P450 reductase. As soon as cytochrome
P450 is reduced by the reductase, cytochrome b5 rapidly takes the electron from the ferrous
cytochrome P450 enabling cytochrome P450 to accept a second electron immediately. Before
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dissociating from the complex, cytochrome P450 reductase can therefore transfer two
electrons rapidly. The oxycytochrome P450 oxidises the ferrous cytochrome b5 when
cytochrome P450 interacts with oxygen (figure 6.9). In the absence of cytochrome b5,
cytochrome P450 would have to dissociate from the reductase, interact with the oxygen and














Figure 6.9 Suggested two-electron acceptor complex consisting of cytochrome b5 bound
to cytochrome P450 (49).
6.7.2.4. Cytochrome b5-dependent allosteric influence 
The suggested role of cytochrome b5 as effector in the cytochrome P450 monooxygenase
reactions is based partly upon the facilitation by cytochrome b5 in the breakdown of the
oxycytochrome P450 complex into its products and ferricytochrome P450. Cytochrome b5
(and putidaredoxin) was shown to be such an effector for oxycytochrome P450cam,
irrespective whether the effector was in the oxidised or reduced state (54). In the absence of
an effector, oxycytochrome P450cam auto-oxidized to ferric cytochrome P450 and superoxide.
Apo-cytochrome b5 was shown to be just as effective as an effector as the holo-cytochrome b5
(54).
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Another system where this effect was shown, was in cytochrome P4503a4 catalysed reactions
(55). Here too apo-cytochrome b5 was just as effective in supporting the reduction of
cytochrome P4503a4 and product formation as holo-cytochrome b5 (56). This indicated that
cytochrome b5 did not need to undergo redox changes or to transfer an electron to
cytochrome P450.
The stimulation of 17,20-lyase activity of human cytochrome P450c17 by cytochrome b5
follows a similar trend. Miller et al. (57) hypothesised that human cytochrome b5 acts
principally as an allosteric effector which interacts primarily with the cytochrome P450c17
oxido-reductase complex to stimulate 17,20-lyase activity without direct electron transfer.
NADPH donates two electrons to the FAD domain of cytochrome P450 oxidoreductase (in
contact with the microsomal membrane), which passes the electrons to the FMN moiety. The
FMN domain of oxidoreductase, which is connected to the FAD domain by a connecting
domain and a hinge region, must rotate ~90º to dock with the redox-partner binding site of
cytochrome P450c17. The interaction of cytochrome P450c17 and oxidoreductase is adequate
to support 17α-hydroxylation, but the complex rarely adopts the geometry required to
catalyse the 17,20-lyase reaction. The presence of either holo- or apo-cytochrome b5 favours
the interaction of oxidoreductase and cytochrome P450c17 in an orientation that satisfies the
more stringent conformation restrictions required by the 17,20-lyase reaction, facilitating
productive electron transfer from oxidoreductase to cytochrome P450c17 and subsequent















Figure 6.10 Proposed function of cytochrome b5 in cytochrome P450c17 activity. I: The
oxidoreductase complex receives two electrons from NADPH. II: The FMN
moiety rotates to be able to dock with its redox partner to facilitate
17-hydroxylation activity. III: The presence of cytochrome b5 enables the
oxidoreductase and C17 to adopt the more stringent conformation required for
17,20-lyase activity (57).
105
A report in 2001 challenged the allosteric effect of apo-cytochrome b5 on cytochrome
P4503a4 (58). The stimulatory effect observed for apo-cytochrome b5 was attributed to the
excess heme, present in the cytochrome P4503a4 (and cytochrome P450c17) preparation,
converting the apo- form to the stimulatory holo-form of cytochrome b5. Excess heme in the
cytochrome P4503a4 preparation amounted to ~35% of the cytochrome P450 level. The
stimulatory effect of apo-cytochrome b5 was removed when a heme scavenger, in the form of
apo-myoglobin, was added (58). However, another report, re-examining the stimulatory
effect of apo-cytochrome b5 on cytochrome P4503a4, showed an excess heme of only ~5%,
which cannot account for the observed decrease in the stimulatory effect. Furthermore it was
shown that the addition of apo-myoglobin did not inhibit the stimulatory effect (59).
Although the detailed mechanism remains unknown, it seems as if the apo-cytochrome b5
does have an effect on cytochrome P450 activity.
1.8 INFLUENCE OF CYTOCHROME b5 ON STEROIDOGENESIS
6.8.1 Human steroidogenesis 
In steroidogenesis, cytochrome P450c17, can either hydroxylate its substrate to form
precursors for glucocorticoids, or form precursors for sex steroids through its lyase activity.
Cytochrome b5 has been suggested to contribute in the differential regulation of these two
pathways by promoting the lyase activity in reproductive tissues. Cytochrome b5 is expressed
in high levels in tissues such as the testes and the zona reticularis of the adrenals (34).
Aldosterone, cortisol and the so-called adrenal androgens, dehydroepiandrosterone (DHEA)
and DHEA sulphate (DHEAS) are synthesised in the human adrenal cortex. In the adult
adrenal gland, the zona glomerulosa produces aldosterone, the zona fasciculata cortisol and
the zona reticularis both DHEA and DHEAS (60). The enhancement of 17,20-lyase activity
by cytochrome b5 to form DHEA or androstenedione is well documented. Interestingly
cytochrome b5 also stimulates the formation of androstenedione from
17α-hydroxyprogesterone. In humans the substrate for the 17,20-lyase reaction is almost
exclusively 17α-hydroxypregnenolone with negligible androstenedione formation from
17α-hydroxyprogesterone. This enhancement of 17α-hydroxyprogesterone metabolism and
subsequent androstenedione formation by cytochrome b5 may possibly prevent the build-up
of a dead-end product which may even inhibit cytochrome P450c17 (61,62).
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The fetal human adrenal is histologically different from the adult adrenal with respect to the
zonation of the gland. It can be divided into the fetal zone, the neocortex (also called the
definitive zone) and the transitional zone. The fetal zone is found only during the fetal
development and is responsible for the high steroidogenic capacity of the fetal adrenal. The
neocortex develops into the cortical tissue of the adult adrenal. The transitional zone is
hypothesised to produce cortisol during the last part of gestation. Cytochrome b5 synthesis
was observed in the dehydroepiandrosterone sulphate (DHEAS) producing fetal zone
throughout gestation as well as in the transitional zone. Significant cytochrome b5 synthesis
could not be detected in the neocortex until the second half of gestation (63).
Postnatally, the neocortex and transitional zone expand to form the zona glomerulosa and the
zona fasciculata. The fetal zone involutes, which coincides with a drop in circulating levels
of DHEA(S) for the period of one to five years of age. The zona reticularis of the human
adrenal at this age seems to be poorly developed. From the age of five to seven years, the
zona reticularis starts to expand and continues through puberty, with an increase in
cytochrome b5 synthesis. This high level of cytochrome b5 synthesis is maintained through
adulthood (60). It can thus be concluded that the relative synthesis of cytochrome b5 appears
to be paramount in determining the adrenal capacity in DHEAS production.
Other adult steroidogenic tissues where cytochrome b5 was co-localized with cytochrome
P450c17, were the Leydig cells of the testes, theca internal cells of the follicle, theca lutein
cells and isolated cell clusters in the ovarian stroma, although co-localization of cytochrome
b5 and cytochrome P450c17 were shown in the Leydig cells of the fetal testes, it could not be
detected in the midgestational fetal ovary (64). The presence of cytochrome b5 and
cytochrome P450c17 in isolated cell clusters in the ovarian stroma may account for continued
post-menopausal androgen production in the ovary. Midgestational ovaries only produce
nominal amounts of steroids (65), which correlates with the observed low immunoreactivity
for cytochrome b5 and cytochrome P450c17. The presence of both enzymes in the Leydig
cells of the human fetal testes may provide a possible explanation for the observed increase
in catalytic efficiency for the ∆5-steroidogenic pathway in this tissue (66).
6.8.2. Guinea pig steroidogenesis 
Cytochrome b5 may control the dual activities of cytochrome P450c17 in guinea pig adrenal
steroidogenesis since the lyase activity decreased when the cytochrome b5 was removed from
the cytochrome P450 fraction in guinea pig adrenal microsomes (67). Shinzawa et al. (68)
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suggested that the effect of added cytochrome b5 on the cytochrome P450c17 catalytic
activity was not due to electron transfer, but rather due to a shift in optimal pH for the two
reactions being catalysed. They observed a shift in the optimal pH for the 17α-hydroxylation
reaction, pH ~7, and for the lyase reaction, pH ~6.6. In contrast, they showed that both
activities decreased with the addition of cytochrome b5 at a pH < 5.3.
6.8.3. Porcine steroidogenesis 
16-Androstene steroids are C19 steroids, produced primarily by the Leydig cells in porcine
testis. They enter circulation via the spermatic vein and are subsequently concentrated in the
fatty tissue (69). Androstenone, a C19 steroid, has a distinctive strong musk-like odour and is
the primary cause for ‘boar taint’ (70). Currently, most pig boars in North America are
castrated to avoid boar taint, which leads to complications, as these animals grow at a slower
rate.
The first step in the synthesis of 16-androstene steroids from pregnenolone is the formation
of 5,16-androstadien-3β-ol. This reaction is catalysed by the andien-β synthase system in a
cytochrome P450-dependent reaction. It has been shown that cytochrome b5 is essential for
andien-β synthase activity in vivo (69) and that high levels of cytochrome b5 have a
stimulatory effect on adrenal steroidogenesis (71). Two immunoreactive cytochrome b5
species have been found in the porcine testis (70). One of these has a molecular mass that
correlates with soluble cytochrome b5 (~12,000 Da), while the other correlates with intact
testicular cytochrome b5 (~16,000 Da). It has been shown that an increase in cytochrome b5
levels, in particular the low molecular weight species, is associated with a higher level of
16-androstene production in porcine testis (70). This is the first suggestion that the
soluble-like form of cytochrome b5 plays a role in steroidogenesis. No correlation could be
drawn between the levels of the lower molecular weight form and the sexual maturity of the
pigs. It can thus be concluded that the levels of this form of cytochrome b5 are determined
genetically. In comparison to the adrenal gland, the cytochrome b5 content in the testis is
about five times higher that that in the adrenal gland (33) (Table 6.1). This is also an
indication of the role cytochrome b5 plays in androgen synthesis. 
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Table 6.1 Levels of cytochrome P450 and cytochrome b5 in porcine adrenal and porcine
testicular microsomes (33). a CO difference spectra ; b Enzyme assays.
0.840.16Cytochrome b5 (nmol/mg protein)b
0.720.78Cytochrome P-450 (nmol/mg protein)a
TestisAdrenalEnzyme
6.8.4. Rat steroidogenesis 
As is evident, cytochrome P450c17 catalyses the reactions at the branch point of
glucocorticoid and sex hormone biosynthesis. Glucocorticoids play an important role in stress
responses, carbohydrate metabolism and general metabolite homeostasis. Androgens on the
other hand play an important role in reproductive biology, such as the development of
secondary male characteristics. Cytochrome P450c17 is expressed in the adrenal of most
species, but is absent in rat, mouse and rabbit adrenals (72). Treatment with ACTH though
stimulates the rabbit adrenal to produce cytochrome P450c17 (73). In rat adrenals
corticosterone is produced as the main glucocorticoid in the absence of cytochrome P450c17.
No androgens or cortisol is synthesised. 
In rat testis the outer mitochondrial membrane form of cytochrome b5 was detected in both
the mitochondria and endoplasmic reticulum. No microsomal cytochrome b5 could be
detected in rat testes. Mitochondrial outer membrane cytochrome b5 was co-localized with
cytochrome P450c17 in the Leydig cells of the rat testes. The influence of the microsomal
form on the catalytic activity of cytochrome P450c17 was different from that observed with
the mitochondrial outer membrane form of cytochrome b5 (74). Mitochondrial outer
membrane cytochrome b5 exhibited a preferential elevation of the 17α-hydroxylation activity
in a concentration-dependent manner. The microsomal form showed a preference for the
lyase activity at low concentrations. At progesterone concentrations comparable to the
physiological cholesterol availability, mitochondrial outer membrane cytochrome b5 elevated
the production of 17α-hydroxyprogesterone primarily and subsequently facilitated the
conversion of the formed intermediate to androstenedione. It thus seems that the
mitochondrial outer membrane form, rather than microsomal cytochrome b5, serves as an
activator for androgen biosynthesis in rat Leydig cells (74).
6.8.5. Sheep adrenal steroidogenesis 
In a study by Swart et al. (75) it was shown that the addition of cytochrome b5 had an
inhibitory effect on cytochrome P450c17 while the activity of cytochrome P450c21 appeared
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to be unchanged. These results were in contrast to results obtained with guinea pig
microsomes where both cytochrome P450c17 and cytochrome P450c21 activities were
stimulated by the addition of cytochrome b5. In a subsequent study it was shown that the
presence of cytochrome b5 in ovine adrenal microsomes did not confer lyase activity on the
ovine adrenal cytochrome P450c17 (76). As mentioned previously, earlier studies have
shown that cytochrome b5 has the ability to amplify greatly the lyase activity of cytochrome
P450c17 not only in humans (77, 78) but also in other species (79). Cytochrome b5 is present
in ovine adrenal microsomes at a concentration of 0.22 nmol/mg protein and the cytochrome
P450:cytochrome b5 ratio is approximately 5:1, this ratio compares well to figures previously
reported for ovine gonadal tissue where adequate ∆5-lyase activity was demonstrated (80).
Immunostaining analysis of ovine adrenal microsomes showed that cytochrome b5 is present
in comparable amounts in ovine testes, adrenal and liver tissue (Chapter 4, figure 4.3). The
maintenance of a tetrameric state after SDS PAGE employing standard denaturing
conditions, suggest strong quaternary structural interactions and resistance to anionic
detergents and mercaptoethanol. In addition the signal obtained for cytochrome b5 in ovine
tissue exhibits the same intensity of the tetrameric aggregate as bovine adrenal microsomal
cytochrome b5 shown in the same blot. 
It is evident that ovine adrenal microsomes could not convert pregnenolone or progesterone
to C19-androgen precursors (76). However, the absence of cytochrome P450c17 lyase activity
towards ∆5-steroids does not occur due to a lack of cytochrome b5 in the ovine adrenal cortex.
It can therefore be deduced that the inability of sheep cytochrome P450c17 to exhibit lyase
activity is due to the presence or absence of a modulating substance other than cytochrome b5
or that the concentration of a certain aggregation state of cytochrome b5 (monomeric, dimeric
or tetrameric) might be critical for lyase activation. As a significant portion of the work
described in this section was carried out as part of this PhD study, the paper containing the
full text of these findings is included in Appendix B. In this paper (76) the purification,
characterisation and quantification of cytochrome b5 in sheep adrenals as well as the
immunological study was a part of this PhD investigation.
The results obtained from our previous investigation into the hydroxylase and lyase activity
of ovine cytochrome P450c17 prompted a further investigation into the influence of purified
and trypsin truncated cytochrome b5 on sheep adrenal steroidogenesis.
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1.9 AN INVESTIGATION INTO THE INFLUENCE OF PURIFIED
CYTOCHROME b5 ON OVINE ADRENAL STEROIDOGENESIS
6.9.1. Introduction
The aim of this study was to investigate the influence of purified cytochrome b5 on sheep
adrenal steroidogenesis. In an earlier study the question was raised whether cytochrome b5
exists in a monomeric or multimeric form in vivo (81). The intact and trypsin truncated forms
of cytochrome b5 were subsequently prepared for use in an adrenal microsomal assay system.
The truncated cytochrome b5 remains active since the proteins contains the heme moiety as
previously shown with absorption spectra and ESMS analyses. The possibility of direct
electron transfer by cytochrome b5 in adrenal steroidogenesis can therefore be investigated
using the truncated form of cytochrome b5.
6.9.2. Experimental
6.9.2.1 Preparation of ovine adrenal microsomes. Ovine adrenal microsomes were prepared
as previously described (82). Cytochromes P450 and b5 concentrations of the adrenal
microsomes were determined according to the methods described by Estabrook and
Werringloer (83). Full length as well as trypsin truncated ovine cytochrome b5 were prepared
as described in Chapter 3.
6.9.2.2 Steroid metabolism assay. Pregnenolone and progesterone conversion was assayed in
adrenal microsomes as described by Swart et al. (75).
The appropriate volume of progesterone or pregnenolone were pipetted onto small filter
paper squares to yield a final concentration of 6 µM. Tritiated progesterone or pregnenolone
in ethanol was pipeted onto the same filter paper to yield a total count of 100,000 cpm/ml in
the final reaction mixture. The filter paper squares were dried under a stream of nitrogen gas
in 5 ml disposable glass tubes.
All reactions were carried out in 50 mM Tris buffer, pH 7.4, containing 1% BSA and 50 mM
NaCl. Reaction mixtures contained MgCl2 (10 mM), isocitrate (2 mg/ml), NADPH (1 mM),
isocitrate dehydrogenase (0.2 U/ml) and microsomal suspension (0.35 µM cytochrome
P450). All the components were pipeted onto the dried filter paper, with the exception of the
isocitrate dehydrogenase and the NADPH, and pre-incubated for 5 minutes at 37ºC in a water
bath with constant agitation. The reaction was initiated by the addition of the isocitrate
dehydrogenase and NADPH to yield a final reaction volume of 0.5 ml. Aliquots of 50 µl of
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the reaction mixture were removed at specific time intervals and added to 450 µl distilled
water and 5 ml cold methylene chloride. The mixture was vortexed and immediately placed
on ice. Steroids were vortexed for 1 minute in the methylene chloride/water mixture followed
by centrifugation to separate the organic and aqueous phases. The aqueous phase was
aspirated off and the organic phase dried under a stream of nitrogen. The residue was
redissolved with 100 µl HPLC grade methanol. These samples were analysed on a Novapak®
HPLC C-18 column on a Waters (Milford, MA) high performance liquid chromatograph
coupled to a WispTM automatic injector (Waters) and a Flo-one liquid scintillation
spectrophotometer (Radiomatic, FL).
The mobile phase for the HPLC analyses consisted of solvent A (35% H20:65% methanol)
and solvent B (100% methanol). The solvent gradient formation for the HPLC analyses is
depicted in table 6.2.
Table 6.2: Chromatographic gradient elution of steroids.
Time Flow % A % B Curve 
 (min) (ml/min) Type
0.00 1.00 100 0 6
8.00* 1.00 100 0 6
15* 1.00 100 0 6
20* 1.00 0 100 6
25* 1.00 0 100 6
30.00 1.00 100 0 6
35.00 1.00 100 0 6
* Radioactive flo detector and scintilation fluid pump on
6.9.2.3 Difference spectra. Difference spectra were recorded according to the method
described by Estabrook and Werringloer (83).
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6.9.3. Results
The cytochrome P450 and cytochrome b5 concentrations in the adrenal microsomes were
spectrophotometrically assayed. Cytochrome P450 in CO-sparged microsomal samples were
reduced with sodium dithionite and cytochrome b5 with NADH. Difference spectra were
recorded (figure 6.11) from which the concentrations were determined by applying the
respective milimolar extinction coefficients.




















Figure 6.11 Difference spectra of cytochrome P450 (A), exhibiting an absorption
maximum at 450 nm, and cytochrome b5 (B), exhibiting an absorption
maximum at 424 nm, in sheep adrenal microsomes. 
HPLC analyses of pregnenolone and progesterone conversion assays are shown in figure
6.12. In the microsomal system pregnenolone was metabolised by cytochrome P450c17,
3βHSD and cytochrome P450c21 to the respective steroid metabolites. Cytochrome P450c17
and cytochrome P450c21 metabolised progesterone to 17OH progesterone,
deoxycorticosterone and deoxycortisol respectively. No androstenedione was detected when
progesterone was used as substrate.
113











































Figure 6.12 A: Radio chromatogram of the elution profile of steroid metabolites formed in
pregnenolone metabolism (10 µM). B: Radio chromatogram of the elution
profile of tritiated steroid metabolites formed in progesterone metabolism (10
µM). A: Deoxycortisol B: Androstenedione C: Deoxycorticosterone D: 17OH
Progesterone E: DHEA & 17OH Pregnenolone F: Progesterone G:
Pregnenolone.
Prior to determining the effect of cytochrome b5 on adrenal steroidogenesis, a pregnenolone
conversion assay was carried out. In this assay different cytochrome b5 concentrations were
added to the reaction mixture, thus establishing the cytochrome b5 concentration affecting the
metabolic outcome. Increasing ratios of intact full length cytochrome b5:endogenous
cytochrome b5 showed that cytochrome b5 added to a final concentration of ~1 µM yielded
maximum stimulation of steroid conversion (figure 6.13). As the concentration of the added
cytochrome b5 is increased, there is an increase in the levels of androstenedione and a
decrease in the levels of deoxycortisol. These results suggest a change in cytochrome
P450c17 activity.
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Figure 6.13 Influence of cytochrome b5 on pregnenolone (10 µM) conversion. Increasing
ratios of intact full length cytochrome b5, 1:1 to 10:1, was added to the
microsomal system. ([P450] = 0.35 µM; [cytochrome b5] = 0.07 µM). :
Androstenedione, : Deoxycortisol. (Error bars indicate ±SD, n=3)
The influence of cytochrome b5 on progesterone and pregnenolone metabolism by ovine
adrenal microsomes was subsequently investigated. Pregnenolone metabolism supplies all the
substrates for the progesterone metabolism pathway. Progesterone metabolism was therefore
first characterised before looking at the 17,20-lyase activity of cytochrome P450c17. In
adrenal microsomes cytochrome P450c17 converts progesterone to 17 hydroxyprogesterone.
Cytochrome P450c21 converts progesterone and 17 hydroxyprogesterone to
deoxycorticosterone and deoxycortisol respectively. The metabolism of progesterone,
without added intact full length cytochrome b5 clearly showed that the major metabolite was
deoxycortisol (figure 6.14A). Progesterone metabolism was subsequently assayed in the
presence of trypsin truncated cytochrome b5. Although the trypsin truncated cytochrome b5
contains no membrane binding domain, it is still active with respect to electron transfer. No
notable change in progesterone metabolism in ovine adrenal microsomes was observed in the
presence of the truncated protein (figure 6.14B).
Addition of intact full length cytochrome b5 increased the production of deoxycorticosterone
~100%. In the presence of intact full length cytochrome b5 the ratio of
deoxycortisol:deoxycorticosterone was 2, while in the presence of truncated cytochrome b5
these metabolites were present in an equimolar ratio after 14 minutes (figure 6.14C). The
level of 17-OH progesterone was ~60% lower than in the control and in the presence of
trypsin truncated cytochrome b5.
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Figure 6.14 Influence of cytochrome b5 on progesterone (10µM) metabolism in adrenal
microsomes. A: in the presence of endogenous cytochrome b5, B: in the
presence of 1 µM truncated cytochrome b5, C: in the presence of 1 µM intact
cytochrome b5. DOCL: Deoxycortisol; DOC: Deoxycorticosterone; 17-OH
PROG: 17OH Progesterone (Error bars indicate ±SD, n=3)
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Pregnenolone metabolism was investigated in the presence of truncated and full length
cytochrome b5. The addition of truncated cytochrome b5 had no influence on pregnenolone
conversion with the ratio of steroid metabolites remaining the same as in the control reaction
(table 6.3). 














In the absence of added cytochrome b5, it can be seen that deoxycortisol is the major
metabolite at the end of the incubation period (figure 6.15A). It was not possible to separate
dehydroepiandrosterone (DHEA) and 17-OH pregnenolone on the chromatographic system
used to separate the steroid metabolites. Both components eluted as a single peak and are thus
indicated together in the results. It is worthy to note that at five minutes with 80% of the
pregnenolone substrate metabolised the DHEA/17-OH pregnenolone fraction constitutes the
largest portion of the steroid metabolites and decreases thereafter. Negligible amounts of
androstenedione are, however, formed.
Deoxycortisol is the major steroid metabolite formed when pregnenolone is metabolised in
the presence of endogenous cytochrome b5. Upon the addition of full length cytochrome b5,
deoxycortisol levels decrease and an increase of ~30% is observed in the androstenedione
formation (figure 6.15B).
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Figure 6.15 Influence of cytochrome b5 on pregnenolone (10 µM) metabolism in adrenal
microsomes. A: no added cytochrome b5 and B: addition of 1 µM intact full
length cytochrome b5. 17-OH Preg: 17 hydroxy pregnenolone; DHEA:
dehydroepiandrosterone; A4: androstenedione and DOCL: deoxycortisol
(Error bars indicate ±SD, n=3)
6.9.4. Discussion
Earlier work by Meadus et al. (69) on porcine and bovine steroidogenesis showed that the
cytochrome P450 to cytochrome b5 ratio in testicular tissue was 1:1 and 5:1 respectively in
the adrenal gland. This ratio is in line with the value obtained in the ovine adrenal
microsomes used in this study. The ratio of cytochrome P450 to cytochrome b5 in the ovine
adrenal microsomes used were 5:1 (14.95 µM:3.19 µM). In this study the addition of
cytochrome b5 to a 1:2 (cytochrome P450:cytochrome b5) ratio yielded maximum stimulation
of steroid conversion and subsequently influenced the adrenal steroid metabolite profile. At
higher cytochrome b5 levels (>1:10) an inhibitory effect was observed (results not shown). A
similar inhibitory effect was observed in both human and yeast microsomes, although at
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ratios of cytochrome P450: cytochrome b5 higher than 1:30 (57). This inhibitory effect was
5 and cytochrome P450.
It is apparent from results shown in figure 6.13 that cytochrome b5 has a profound effect on
adrenal steroidogenesis. Analyses of pregnenolone metabolites showed that there was a
decrease in deoxycortisol production with a concomitant increase in androstenedione
production as the cytochrome b5 levels were increased. At a cytochrome b5:endogenous
cytochrome b5 ratio of 7:1 to 10:1 maximum stimulation of the lyase activity was observed.
During the metabolism οf ∆4-steroids, the ratio of deoxycorticosterone increased with the
addition of cytochrome b5. While the 17 hydroxyprogesterone metabolite decreased, the
amount of deoxycortisol formed remained unchanged, suggesting that the cytochrome
P450C21 activity is stimulated by cytochrome b5 and cytochrome P450c17 hydroxylase
activity is unaffected. These results were similar to those obtained earlier by Swart et al. (75).
During the metabolism of ∆4-steroids no androstenedione was detected, confirming the
absence of 17,20-lyase activity of ovine cytochrome P450c17 in ∆4-steroid conversions. This
may be due to the fact that the 17,20-lyase catalytic efficiency with a ∆4-substrate is nearly a
hundred fold slower than the same reaction with a ∆5-substrate (57). The trypsin truncated
form of cytochrome b5 did not have any effect on ovine adrenal microsomal steroidogenesis.
This result reiterates the importance of the membrane binding domain of cytochrome b5 for
normal protein-protein interaction as far as this hemoprotein is concerned. Recombinant
DNA-technology is often an attractive, and sometimes essential, alternative to the isolation
and purification of proteins from animal or plant tissue. The cloning strategies used often
dictate modifications specifically of the membrane binding domains of proteins, facilitating
heterologous expression and/or subsequent purification. This study has shown that the
deletion or modification of the membrane binding domain of cytochrome b5 has a marked
influence on the interaction of the modified protein with itself and other proteins, thus
affecting the outcome of steroidogenesis. It is therefore important that this aspect should be
considered when making deductions pertaining to structure-function relationship of
cytochrome b5 when using recombinant modified cytochrome b5 and its associated antibodies.
It is evident from the data presented that the addition of full length cytochrome b5 to ovine
adrenal microsomes stimulates the 17,20-lyase activity of cytochrome P450c17 in ∆5-steroid
metabolism. Conversion of pregnenolone to progesterone is negligible both in the control and
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in the presence of added cytochrome b5. The 17-OH pregnenolone intermediate formed in the
absence of added cytochrome b5 is converted to 17-OH progesterone and subsequently to
deoxycortisol, the major metabolite formed. The decrease in the 17OH-pregnenolone/DHEA
fraction and the low levels of androstenedione formed shows that the lyase activity in the
absence of added cytochrome b5 was low, favouring the 3βHSD and cytochrome P450c21
catalyses of 17-OH pregnenolone. Addition of 1 µM of cytochrome b5 yielded a dramatic
increase in androstenedione production with a concomitant decrease in deoxycortisol
production. The decrease 17OH-pregnenolone/DHEA fraction together with the decrease in
the formation of deoxycortisol is most probably due to the stimulation of the lyase activity of
cytochrome P450c17.
 It is clear, from the data presented in this study, that cytochrome b5 has an effect on ovine
adrenal steroidogenesis at higher than physiological cytochrome P450:cytochrome b5 ratios.
These results are similar to results obtained in other species (84).
Although we showed the stimulatory effect of cytochrome b5 on the lyase activity of
cytochrome P450c17, it remains uncertain whether the monomeric and aggregated forms of
cytochrome b5 both have the same effect on the lyase activity. Engelbrecht (85) showed, in
Western blot analyses, that antibodies recognising only the aggregate form of cytochrome b5
also recognised cytochrome b5 in ovine adrenal tissue sections. Future studies selectively
binding cytochrome b5 using monomer- and aggregate-specific antibodies in adrenal
metabolic assays, would lead to a better understanding of the conformation of the active
protein in vivo and its subsequent influence on adrenal steroidogenesis.
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In 1954 Chance and Williams (1) reported the presence of a hemoprotein in the
postmitochondrial fraction of rat liver homogenate. This hemoprotein, previously known as
cytochrome m, was subsequently renamed cytochrome b5. Several years later, in 1963,
Cooper et al. (2) showed that cytochrome b5 was also present in adrenalcortical microsomes
and that it was reduced by NADH and NADPH. Although cytochrome b5 is found in the
cytoplasm of all cells, the highest concentration is found in liver cells. Besides animal tissue,
cytochrome b5 can also be found in plants and fungi (3).
Cytochrome b5 is an ubiquitous electron transport protein found as both a membrane bound
and soluble form. Two membrane bound forms are found, viz. a mitochondrial outer
membrane associated form and an endoplasmic reticulum, or microsomal form. Although the
two forms are almost identical, they target different organelles. It was shown that a
cytochrome b5 molecule with a net negative charge at its carboxyl-terminal targets the protein
to the endoplasmic reticulum while a net positive charge targets the protein to the
mitochondria (4). The membrane bound form consists of a hydrophilic catalytic domain and a
hydrophobic membrane anchoring domain, connected by a hinge region. Membrane bound
cytochrome b5 plays an important role in various biochemical reactions, such as fatty acid
biosynthesis, hepatic cholesterologenesis, N-glycolylneuraminic acid biosynthesis and
steroidogenesis. A high degree of homology exists in the structures of soluble cytochrome b5
and the catalytic domain of the membrane bound form (5). Soluble cytochrome b5 contains no
membrane binding domain and is mainly found in the erythrocytes where it functions in
maintaining haemoglobin in a reduced state.
Consisting of six α-helices and five β-strands, cytochrome b5 is a small cylindrical protein.
As mentioned, cytochrome b5 is folded into two domains. The heme containing hydrophilic
catalytic domain, comprising the residues at the amino end of the protein, is the larger of the
two domains. A hydrophobic pocket containing the heme, with two well conserved histidine
side chains co-ordinating the heme iron, is located in this domain. This heme cleft is flanked
by four α-helices with the heme periphery exposed to the environment. On the carboxyl end
of the protein, a proline-containing hinge region of ~7 amino acids link the hydrophobic
membrane binding domain and the catalytic domain (5). Proteases can digest the protein
before or after the hinge region, releasing a soluble catalytic domain. A sequence of ten
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amino acids at the carboxyl terminal, is responsible for membrane targeting, discriminating
between the mitochondrial outer membrane and the microsomal membrane (6).
The physiological role of cytochrome b5 in the various biochemical processes is relatively
similar in most species studies thus far, with the exception of steroidogenesis, where major
differences have been reported in mammals. 
The first sheep liver cytochrome b5 study carried out in our laboratory showed that
cytochrome b5 most probably exists as an tetrameric aggregate in vivo, with a relative
molecular mass of ~60,000 Da (7). Following up this work, the membrane binding domain
was removed by means of tryptic digestion in order to solubilise the protein. The
trypsin-solubilised cytochrome b5 had a relative molecular mass of ~10,180 Da (8). A
subsequent study on the purification and characterisation of intact sheep liver cytochrome b5
reported that the relative molecular mass of cytochrome b5 is 16,200 ±500 Da, as determined
by SDS PAGE (9). These observations prompted our investigation into the characterisation
of the native form of ovine adrenal cytochrome b5 and its influence on adrenal
steroidogenesis.
Upon repeating the isolation of sheep liver cytochrome b5, as described by Engelbrecht (7),
the majority of the isolated cytochrome b5 was found to be in an aggregated form when
analysed on SDS PAGE. High concentrations of mercaptoethanol and prolonged exposure to
temperatures greater than 100°C could not dissociate the aggregate completely. An
alternative method for the isolation of cytochrome b5 was subsequently investigated to
eliminate the possible formation of aggregates due to the method of isolation. 
Liver microsomes were prepared by means of polyethylene glycol precipitation, as
alternative to the calcium chloride precipitation method previously used. In addition, the
chromatographic conditions used were modified with respect to the anion exchange columns
and buffers. The method proved to be more efficient resulting in consistently high yields of
cytochrome b5. Purified ovine cytochrome b5 dissolved in 0.25% sodium deoxycholate was
predominantly in the monomeric state. This observation correlated with published results
where only a monomeric specie was observed in the presence of high levels of detergent (9).
In the absence of sodium deoxycholate, the aggregate form was the predominant specie as
observed by SDS PAGE analyses. These results satisfied the criteria set out in the second
goal of this study.
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Although it was thus possible to obtain intact monomeric cytochrome b5 in solution, the
levels of sodium deoxycholate was too high to allow the preparation to be used either for
raising of an antibody or in biological assays. These findings raised the question whether
cytochrome b5 occurs in a monomeric or aggregated state in vivo. Monomeric and aggregated
cytochrome b5 had been observed in SDS PAGE analyses of microsomal samples, indicating
that the denaturing conditions were adequate to liberate cytochrome b5 from the phospholipid
bilayer, but inadequate to dissociate the aggregated form of cytochrome b5. 
Trypsin treatment of cytochrome b5, according to the method of Omura and Takesue (10),
yielded unsatisfactory results. This method was best suited for type III trypsin and in our
hands, the yield of truncated cytochrome b5 was very low. We developed a new method for
the preparation of truncated cytochrome b5. The advantages of this method were: (1) it was
independent of the type of trypsin used, (2) a significant increase in the truncated cytochrome
b5 yield was obtained, (3) the preparation time was reduced by 75% and (4) immobilisation of
the cytochrome b5 on the ion exchange column during trypsin treatment protected the protein
from overexposure to the trypsin. 
 Q-ToF ESMS identified two truncated forms of cytochrome b5 with different molecular
masses present in solution. A specie with a molecular mass of 10,182 Da, which correlated
with the fragment prepared with the method reported by Omura and Takesue (10), and a
smaller fragment with molecular mass of 9,816 Da was observed. An ESMS fragmentation
study revealed that both species originated from the same protein. Gibson et al. (11) also
reported two different sized species when digesting rabbit cytochrome b5 with trypsin. The
difference in size was attributed to deamination of the glutamine residue at position 3 at the
amino terminus of the protein which most likely occurred during the isolation and
purification of the protein. Results obtained during this study indicated a difference in the
amino terminal of the two truncated species of ovine cytochrome b5. The smaller of the two
trypsin-truncated cytochrome b5 species is thus, according to the results reported by Gibson
et al. (11), the product of the native form of the protein. The third goal of this study, the
successful solubilisation of cytochrome b5 by means of trypsin truncation and its subsequent
characterisation, was thus accomplished. 
HP-GPC studies showed that intact cytochrome b5 existed as both monomer and an aggregate
at low salt concentrations. The two isolated species exhibited single peaks when
rechromatographed immediately. A 24 hour incubation of the two purified species, however,
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resulted in aggregation of the cytochrome b5. Intact cytochrome b5, when incubated in PBS,
exhibited a single peak with a retention time corresponding to that of the aggregate.
Trypsin-truncated cytochrome b5 showed a single peak when analysed on HP-GPC,
irrespective of the ionic strength of the buffers used. For immunisation purposes, protein
samples were dissolved in PBS, decreasing the possibility of obtaining a monomer specific
antiserum. Since part of the fourth goal of this study was to prepare an antiserum that would
recognise the monomeric form of cytochrome b5, raising of an anti-trypsin-truncated
cytochrome b5 antibody was investigated. 
Antibodies were raised in rabbits against both the intact full-length and trypsin truncated
forms of cytochrome b5, using the method described by Bellstedt et al. (12). Western blot
analyses, using a colorometric detection of the immunoprecipitate, indicated the presence of
cytochrome b5 aggregate only (7). Using a more sensitive chemiluminescence detection
method, however, showed that the antiserum against the intact cytochrome b5 recognized
both the aggregated and the monomeric forms of the protein. Antiserum against the truncated
cytochrome b5 recognised only the truncated protein and not aggregate forms of the intact
protein. Immunological studies with the trypsin truncated form of cytochrome b5 revealed
valuable information about the aggregation of cytochrome b5. The hydrophobic,
membrane-binding region of cytochrome b5 was clearly essential for the aggregation of the
protein. In addition, the hydrophobic membrane binding domain plays an important role in
the folding of cytochrome b5 and it was evident that different domains or regions of the
molecule are exposed as epitopes in the truncated form as opposed to those exposed by the
full-length native molecule. This is an interesting observation since the truncated cytochrome
b5 exhibits spectral properties identical to the native intact protein.
An antiserum, capable of recognising both the aggregated and monomeric forms of
cytochrome b5, was prepared by immunising rabbits with purified full length ovine
cytochrome b5. The IgG fraction recognising only the monomeric from of cytochrome b5, was
subsequently affinity-purified from the whole serum. Due to the nature of purified
cytochrome b5 in solution, the immobilisation of a homogenous monomeric form of the
protein on a matrix was not possible. The monomeric and tetrameric forms of purified ovine
cytochrome b5 was therefore first separated by SDS PAGE and subsequently transferred and
immobilised onto a nitrocellulose membrane which served as an affinity matrix. Incubation
of whole serum with the immobilised monomer and aggregate forms of cytochrome b5
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allowed the isolation of two types of immunoglobulins — one type recognising the
monomeric and the other recognising the tetrameric form of the hemoprotein. Using the
immunoglobulin factions it was shown that ovine cytochrome b5 exists in a monomeric as
well as a tetrameric form, with the tetrameric form prevailing under most physiological
conditions. The two aggregation species differed, with respect to their immunogenicity, not
only from each but also from the trypsin truncated form of the protein. These results
emphasise, once again, the importance of the membrane binding carboxyl terminal of ovine
cytochrome b5 in aggregation, as well as in the tertiary and quaternary structures of the
protein.
The final goal of this study was to investigate the influence of purified ovine cytochrome b5
on ovine adrenal steroidogenesis. Although, an electron transfer protein, cytochrome b5 can
donate the second electron to cytochrome P450 during certain cytochrome P450 dependent
hydroxylation reactions, it cannot donate the first electron. It has been shown that the
addition of cytochrome b5 to a cytochrome P450 system may either inhibit, enhance or have
no effect on the metabolism of the substrate, an effect which is dependent on the
concentration of cytochrome b5 (13, 14). Since cytochrome P450 plays an important role in
steroidogenesis, it is possible that cytochrome b5 may influence steroidogenesis. It has in fact
been shown that cytochrome b5 enhances the 17,20-lyase activity of cytochrome P450c17
(15). Although the precise action of cytochrome b5 having a positive modulating effect on
cytochrome P450 is unknown, possible models, discussed in detail in Chapter 6, have been
proposed. In previous studies we showed that the cytochrome b5 constituitively expressed in
ovine adrenal endoplasmic reticulum is not sufficient to enhance the 17,20 lyase activity of
ovine cytochrome P450c17 (16). Ovine adrenal microsomes used in this study contained
cytochrome P450 and cytochrome b5 in a ratio of 5:1. This ratio is in the same order as the
ratio previously determined to be present in for bovine and porcine adrenal microsomes (17).
The addition of the trypsin truncated ovine cytochrome b5 to our ovine microsomal assay
system showed no change in the metabolism of either progesterone or pregnenolone. The
addition of the intact cytochrome b5, however, had a definite effect on progesterone
metabolism and a significant increase in deoxycorticosterone production was observed after
the addition of cytochrome b5. This finding correlated well with previous results obtained by
Swart et al. (18). Cytochrome b5 did not enhance the lyase activity of cytochrome P450c17
with progesterone as substrate. Using pregnenolone as substrate, addition of cytochrome b5
showed a definite stimulation of the 17,20-lyase activity of cytochrome P450c17.
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Androstenedione formed during this assay is formed through the metabolism of ∆5-steroid
substrates rather than through the metabolism of ∆4-steroids, since no detectable
androstenedione was formed when progesterone was used as substrate. It can be concluded
from these steroid substrate metabolism assays that the membrane anchoring domain of
cytochrome b5 is important if not essential for the protein to have an influence on cytochrome
P450 activity in ovine adrenal steroidogenesis. In addition, ovine cytochrome b5 has the
ability to stimulate only the lyase activity of ovine cytochrome P450c17 when ∆5 substrates
are used. 
During this study we proved conclusively that ovine cytochrome b5 exists as an aggregate in
vivo and that this hemoprotein enhances the 17,20 lyase activity of cytochrome P450c17. To
answer the question which form is the active, native form of ovine cytochrome b5
conclusively, it would be necessary to purify sufficient quantities of monomer and aggregate
specific antibodies, carry out immunohistochemical studies as well as inhibition studies in
microsomal assay systems. The work presented here has paved the way to answering this
question by providing methods which yields consistent results and laying the foundation for
the preparation of specific anti-monomer and anti-aggregate antibodies. 
REFERENCES
1. Chance, B. And Williams, G.R. (1954) Kinetics of cytochrome b5 in rat liver
microsomes. J. Biol. Chem. 209, 945-951
2. Cooper, D.Y. Estabrook, R.W. And Rosenthal, O. (1963) On the cytochromes in
microsomes from cortex and medulla of steer adrenals. Fed. Proc. 22, 587
3. Lederer, F. (1994) The cytochrome b5-fold: an adaptable module. Biochimie 76,
674-692
4. Borgese, N., Gazzoni, I., Barberi, M., Colombo, S. And Pedrazzini, E. (2001)
Targeting of tail-anchored protein to endoplasmic reticulum and mitochondrial
outer membrane by independent but competing pathways. Mol. Biol. Cell 12,
2482-2496
5. Schenkman, J. B. And Jansson, I. (2003) The many roles of cytochrome b5.
Pharmacol. Therapeut. 97, 139-152
6. Mitoma, J-y. And Ito, A. (1992) The carboxy-terminal 10 amino acid residues of
cytochrome b5 are necessary for its targeting to the endoplasmic reticulum. EMBO
Journal 11, 4197-4203
7. Engelbrecht, Y. (1994) A biochemical and immunological study of ovine liver
cytochrome b5. M.Sc. Thesis, University of Stellenbosch, Stellenbosch, 59-70
132
8. Roos, W.P. (1997) An investigation of the membrane-binding and aggregation of
ovine liver cytochrome b5. M.Sc. Thesis, University of Stellenbosch, Stellenbosch,
55-76
9. Arinç, E. And Çakir, D. (1999) Simultaneous purification and characterization of
cytochrome b5 reductase and cytochrome b5 from sheep liver. Int. J. Biochem. Cell
B. 31, 345-362
10. Omura, T. and Takesue, S. (1969) A new method for the simultaneous purification
of cytochrome b5 and NADPH-cytochrome c reductase from rat liver microsomes.
J. Biol. Chem. 67, 249-257
11. Gibson, B. W., Falick, A. M., Lipka J. J. and Waskell, L. A. (1990) Mass
spectrometric analysis of rabbit and bovine trypsin-solubilized cytochrome b5. J.
Protein Chem. 9, 695-703
12. Bellstedt, D.U., Human, P.A., Rowland, G.F. and van der Merwe, K.J. (1987)
Acid-treated, naked bacteria as immune carriers for protein antigens. Immunol.
Methods, 249–255.
13. White, R.E. And Coon, M.J. (1980) Oxygen activation by cytochrome P450. Ann.
Rev. Biochem. 49, 315-356
14. Hildebrandt, A. And Estabrook, R.W. (1971) Evidence for the participation of
cytochrome b5 in hepatic microsomal mixed-function oxidation reactions. Arch.
Biochem. Biophys. 143, 66-79
15. Kominami, S., Ogawa, N., Morimune, R., De-Ying, H. and Takemori, S. (1992)
The role of cytochrome b5 in adrenal microsomal steroidogenesis. Steroid. Biol.
Mol. Endocr. 42, 57-64
16. Swart, P., Lombard, N., Swart, A.C., van der Merwe,T., Murry, B.A., Nicol,M. and
Mason, J.I. (2002) Ovine steroid 17α-hydroxylase cytochrome P450:
characteristics of the hydroxylase and lyase activities of the adrenal cortex enzyme.
Arch. Biochem. Biophys. 409, 145-152
17. Meadus, W.J., Mason, J.I. And Squires, E.J. (1993) Cytochrome P450c17 from
porcine and bovine adrenal catalyzes the formation of 5,16-androstadien-3b-ol
from pregnenolone in the presence of cytochrome b5. J. Steroid Biochem. Molec.
Biol. 46, 575-572
18. Swart, P., Engelbrecht, Y., Bellstedt, D.U., de Villiers, C.A. and Dreesbeimdieke,
C. (1995) The effect of cytochrome b5 on progesterone metabolism in the ovine
adrenal. Endocr. Res. 21, 297-306 
133
ABSTRACT
This study describes the optimisation of isolation and purification procedures for ovine liver
microsomal cytochrome b5 in order to obtain sufficient material for subsequent aggregation
and immunological studies. A method utilising PEG for the precipitation of microsomes was
used and compared to calcium chloride precipitation of microsomes. PEG precipitated
microsomes yielded double the total amount of protein and had almost three times the
cytochrome b5 content of the calcium chloride precipitated microsomes. This method of
microsome preparation proved to be robust and less time consuming, making it ideal for
small and large scale preparations. Cytochrome b5 isolated from these microsomes showed
two species with apparent molecular masses of ~60,000 Da and ~16,000 Da when analysed
on SDS PAGE. The higher molecular mass specie could be converted to the lower molecular
mass specie by adding increasing amounts of deoxycholate. HPGPC also showed the
presence of two species in aqueous solution in the absence of detergents. In aqueous solution,
the levels of the high molecular mass specie could be decreased by lowering the ionic
strength of the buffer. Only the high molecular mass specie could be observed when the
cytochrome b5 sample was dissolved in PBS prior to HPGPC. ESMS showed only a single
specie with a molecular mass of 15,263 Da for the purified protein, indicating that the higher
molecular mass specie is a tetrameric aggregate of the protein. The hydrophobic membrane
binding domain was removed by means of tryptic digestion in order to establish the role of
the carboxyl terminal in ovine cytochrome b5 aggregation. Due to the low yield of truncated
protein obtained by existing methods of tryptic digestion, a novel process was developed to
prepare truncated cytochrome b5 from the intact purified protein with yields ~14 times higher
than previously reported. ESMS studies showed two species with molecular masses of 10,182
Da and 9,816 Da, the latter being the dominant specie. Antibodies against both the trypsin
truncated and intact forms of cytochrome b5 were subsequently raised to study the
aggregation of the protein. Western blot analyses indicated the presence of mainly the
tetrameric aggregate in microsomes, raising the question whether the active form of the
protein in vivo might be the aggregate. A method for successfully preparing monomer and
aggregate specific antibodies from the whole serum is described, providing a marker for
future immunohistochemical studies into the localisation and aggregation state of cytochrome
b5 in vivo. The influence of purified cytochrome b5 on steroidogenesis in ovine adrenal
microsomes was subsequently investigated. The addition of truncated cytochrome b5 to a
microsomal assay system showed no difference from the control sample. Adding intact
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cytochrome b5, on the other hand, showed a ~100% increase in deoxycorticosterone
production with a concurrent decrease of ~60% in 17-OH progesterone levels during
progesterone metabolism. This indicated a possible stimulation of cytochrome P450c21
activity with an unchanged cytochrome P450c17 hydroxylase activity. Upon the addition of
full length cytochrome b5 during pregnenolone metabolism, deoxycortisol levels decrease and
an increase of ~30% is observed in the androstenedione formation. This lyase activity
stimulation reaches its maximum at added cytochrome b5:endogenous cytochrome b5 ratios of
7:1 to 10:1. This study raises the question whether the native form of ovine cytochrome b5 in
adrenal steroidogenesis is a tetramer, while at the same time cautioning against the use of
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ABSTRACT
Cytochrome b5 (cyt b5) is an ubiquitous hemoprotein also associated with
microsomal cytochromes P450. It has been reported that cyt b5 inﬂuences
cytochrome P450-dependent catalyses through electron transport as well as
direct protein–protein interactions. To investigate the inﬂuence of cyt b5 on
ovine adrenal steroidogenesis, we isolated and characterized cyt b5 from
ovine liver. The molecular mass of the puriﬁed protein was 15,260 as
determined by electrospray mass spectrometry. SDS-Polyacrylamide gel
electrophoresis, even after stringent detergent and mercaptoethanol pre-
treatment, indicated multimeric forms of the protein, the most prominent
being the tetramer (60 kDa) with minor bands corresponding to the
monomer (16 kDa) and dimer (30 kDa). Trypsin treatment of cyt b5
resulted in a truncated enzyme with a molecular mass of 10 kDa. The
aggregation of cytochrome b5 was abolished by the tryptic removal of
the membrane binding region. In Western blot analyses antibodies against the
truncated protein recognised only this low molecular mass form and not the
full length cyt b5, or any of the higher molecular complexes, showing
the involvement of the membrane binding domain of the protein, not only in
aggregation, but also in the quaternary structure which determines epitope
presentation for antibody production. Immunoblot analyses of sheep adrenal
microsomes with the anti-truncated cyt b5 antibody were also negative.
Immunoblot analyses and immunocytochemistry of adrenal tissue with
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antibodies against the full length cyt b5 indicated that the tetrameric form of
the protein was in all probability the dominant specie in vivo.
INTRODUCTION
Cytochrome b5 (cyt b5) is an electron transfer hemoprotein that catalyses a
wide range of reactions in mammalian tissue. The protein exists in two forms, an
amphipathic membrane-bound form and a water-soluble cytosolic form. The
membrane-bound form is found in the endoplasmic reticulum and mitochondria of
all cells and consists of a hydrophobic membrane-anchoring domain and a
hydrophilic catalytic domain.[1] During adrenal and gonadal steroidogenesis cyt b5
inﬂuences the action of the cytochromes P450-dependent steroid 17a-hydroxylase
and 21-hydroxylase (CYP17 and CYP21). These enzymes play a central role in
glucocorticoid, mineralocorticoid, and androgen biosynthesis and a number of
studies have shown the importance of cyt b5 in C19-steroid production by
CYP17.[2,3]
We have previously shown, in preliminary studies, that cyt b5 inﬂuences the
ratio of deoxycorticosterone to deoxycortisol production in ovine adrenal
microsomes.[4] During our previous investigations we encountered, what appeared
to be, higher molecular mass aggregates in our cyt b5 isolates. In this study the
apparent aggregation of ovine cyt b5 was investigated and the question arose
whether the protein exists as a monomer or an aggregate in vivo. Previous research
has shown that the aggregation of cyt b5 can be abolished by detergents
(deoxycholate) and it was concluded that the endoplasmic reticulum membrane
will have the same inﬂuence on the enzyme in vivo.[5] It was, however, also
demonstrated by Calabro et al. that low protein and salt concentrations favoured
smaller aggregates and that a pure monomeric form of cyt b5 could be isolated by
size-exclusion chromatography under these conditions.[6] These results indicated
that the aggregation of cyt b5 in vivo was inﬂuenced by a number of factors.
To prevent cyt b5 aggregation in aqueous solution the hydrophobic
membrane-anchoring domain can be removed by means of tryptic digestion. In
more recent work it was suggested that cyt b5 inﬂuences CYP17 activity, not
through direct electron transfer, but by steric interactions. These ﬁndings implicate
that cyt b5 would require its hydrophobic membrane binding domain to inﬂuence
steroidogenesis.[7] In this study we investigated the aggregation state of ovine
cyt b5 in solution, adrenal microsomes and in situ.
MATERIALS AND METHODS
Isolation of Full Length and Truncated Cytochrome b5
Ovine liver microsomes were prepared as described by Yang and
Cederbaum.[8] Cytochrome b5 was isolated from the ovine liver microsomes as
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described by Strittmatter et al.[9] Truncated cyt b5 was prepared as follows. Puriﬁed
cyt b5 solution (0.5mL) was dialysed against 10 volumes of a 10mM Tris-acetate
buffer (0.1mM EDTA, pH 8.1) and loaded onto a DEAE-cellulose column
(1 5 cm) equilibrated with the same buffer. After washing the column with
20mL of the equilibration buffer, a solution containing approximately 5000BAEE
units=mL trypsin in equilibration buffer was circulated through the column for
180min at 0.36mL=min. The column was washed extensively with 50mL of
equilibration buffer to remove all the trypsin and protein fragments. The tryptic
fragment was eluted with a 250mM NaSCN solution in 10mM Tris-acetate
(0.1mM EDTA, pH 8.1). The eluate was subsequently dialyzed against
equilibration buffer to remove excess salt.
Electrospray Massspectrometry of Puriﬁed Cytochrome b5
Samples for electrospray massspectrometry (ES-MS) analysis were prepared
by dialysing the puriﬁed cyt b5 solution (intact or fragment) overnight against
deionised water. The solution was subsequently diluted 1 : 20 in an 50%
acetonitrile solution to a ﬁnal amount of 0.35mmol. Solvent (acetonitrile : -
water—50 : 50 v=v) was delivered to the ES-MS using a Pharmacia=LKB2249
HPLC pump at 15mL=min. The sample (10mL) was injected via a Rheodyne
injection valve into the solvent stream and introduced through a conventional
electrospray probe with the capillary voltage set at 3.5 kV and the cone voltage at
70V. The source temperature was 80C and a coaxial ﬂow of nitrogen gas at
300Nl=h was applied. The instrument was operated and the data processed by the
MassLynx software supplied by the manufacturers. The multiple charged ions of
cyt b5 were observed by scanning the ﬁrst mass analyser of the instrument from
m=z¼ 400–1500 at a scanning speed of 100 amu=second (atomic mass units per
second).
Raising of Antibodies Against Full Length and
Truncated Cytochrome b5
Antibodies to full length and truncated cyt b5 were raised according to the
method of Bellstedt et al.[10]
SDS-PAGE and Western Blot Analyses
SDS-PAGE was carried out according to the method of Laemmli.[11] Western
blot analyses were carried out with the West DuraTM western blotting kit from
Pierce Chemical Co., Rockford, Ill, USA.
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High Performance Gel Permeation Chromatography
High performance gel permeation chromatography (HPGPC) was done using
a Waters HydrogelTM column connected to a Waters HPLC-system equipped with
a Waters 991 photo diode array detector at a ﬂowrate of 0.7mL=min with the
buffer systems and conditions as described by Calabro et al.[6]
Assays for Adrenal Microsomal Steroidogenic Activity
Adrenal microsomal assays were carried out as described by Swart et al.[4]
RESULTS AND DISCUSSION
The purity of the full length and truncated cyt b5 was assessed for by means of
SDS-PAGE. The full-length protein exhibited amajor protein band corresponding to
a molecular mass of 16 kDa which represented the monomeric form of cyt b5.
Several bands corresponding to multimeric forms of the protein was, however, also
observed. Electrospraymassspectrometry analyses of the cyt b5 solution loaded onto
the gel indicated a single protein (Mr 15260) (Fig. 1). This result conﬁrmed that
SDS-PAGE normally used for the resolution of protein complexes did not fully
dissociate the cyt b5 aggregates. The truncated cyt b5 showed no aggregation, only a
single band corresponding to a molecular mass of 10 kDa.
High performance gel permeation chromatography analyses of the puriﬁed
protein under conditions of low ionic strength (10mM Tris, 0.1mM EDTA, pH
8.15) yielded two peaks [Fig. 2(A)]. Both fractions exhibited a typical cyt b5
absorption spectrum. These two fractions were collected and immediately
rechromatographed under the same conditions. Each sample produced a single
peak (results not shown). When the same two fractions were incubated for 24
hours before they were rechromatographed, the higher molecular mass component
dissociated into two fractions while the lower molecular mass fraction remained a
single peak. High performance gel permeation chromatography in phosphate
buffered saline (PBS) yielded a single peak which correlated with the higher
molecular mass fraction [Fig. 2(B)]. High performance gel permeation
chromatography of truncated cyt b5 yielded a single peak at a lower molecular
weight than any of the other sample chromatographed. The retention time of this
peak remained the same irrespective of the salt or protein concentration [Fig. 2(C)].
These results showed that, like rabbit liver cyt b5, the aggregation of ovine cyt b5
was inﬂuenced by ionic strength. In addition the aggregated form of the enzyme
could be stabilized under appropriate conditions of ionic strength and pH.
The anti-serum against the intact puriﬁed cyt b5 recognised the monomeric,
trimeric, and tetrameric species (Fig. 3) of the enzyme. In the microsomal
preparations of ovine adrenal, liver and testes and bovine adrenal the tetrameric
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aggregate predominated. The same anti-serum recognised cyt b5 in the zona
fasciculate of the ovine adrenal cortex as well as the adrenal medulla (results not
shown). Antibodies raised against the truncated protein did not show
immunoprecipitation in any of the above-mentioned microsomal preparations.
The inﬂuence of cyt b5 on adrenal microsomal progesterone metabolism is
shown in Fig. 4. The truncated form of the protein did not have any inﬂuence on
the conversion of progesterone to deoxycortisol and deoxycorticosterone. Addition
of full-length cyt b5 increased the production of deoxycorticosterone with a
concomitant reduction in deoxycortisol production. These results are in
accordance with results previously published.[4]
At physiological ionic strength and pH ovine cyt b5 exists as a tetramer with a
Mr of 60 kDa. Immunoblot analyses of ovine and bovine steroidogenic
microsomes indicated the tetrameric form as the predominant specie. Although
the antibody could detect the monomeric form of the puriﬁed protein no
Figure 1. (A) Electrospray mass spectrum of puriﬁed ovine cyt b5. Each peak represents the same
protein with a different charge to mass ratio. (B) Deconvolution of the ESMS spectrum was carried
out by MaxEnt program1. The molecular mass indicated for cyt b5 was 15,263. No other
proteins could be detected in the sample.
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Figure 2. High performance gel permeation chromatogram of cyt b5 in a low ionic strength buffer
(10mM Tris, 0.1mM EDTA, pH 8.15) (A). Two forms of cyt b5 with different retention times was
observed. Both exhibited a typical cyt b5 absorption spectrum. When rechromatographed after a 24-
hour incubation period, the fraction correlating with the monomer still exhibited a single peak while
the fraction that correlated with the aggregate again exhibited two peaks. When the buffer was
changed to phosphate buffered saline, only a single peak, with the same retention time as the
aggregate, was observed (B). Irrespective of the salt or protein concentration, the truncated cyt b5
always exhibited a single peak (C).
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immunoprecipitation was detected at 16 kDa in Western blot analyses of adrenal or
liver microsomes. These results indicate that under conditions of physiological pH
and ionic strength the enzyme is in a tetrameric form in the endoplasmic membrane.
These ﬁndings are in contrast with previously published results of Doebler et al.[12]
Figure 3. Western blot analyses of: lane 1; ovine liver microsomes, lane 2; bovine adrenal
microsomes, lane 3; ovine adrenal microsomes, lane 4; ovine testicular microsomes, lane 5; puriﬁed
cyt b5. Into wells 1–4, 50mg of total protein was loaded, while 10 mg of puriﬁed cyt b5 was loaded
into well 5. Polyclonal rabbit anti-cyt b5 was used at a dilution of 1 : 2000.
Figure 4. Progesterone metabolism in ovine adrenal microsomes ([cytochrome P450]¼ 0.09 mM).
Progesterone, deoxycortisol (DOCL), and deoxycorticosterone (DOC) are indicated after a 14-min
incubation period. No cyt b5 was added to the control which had a [Cytochrome P450] : [cyt
b5]¼ 2.26. The addition of truncated cyt b5 had no effect on the progesterone metabolism. Addition
of full-length cyt b5 (1mM) increased the production of DOC and concomitantly reduced DOCL
production.
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which stated that neither cyt b5 nor its membrane-binding domain will self associate
in phosphatidylcholine vesicles. These experiments were, however, carried out in an
artiﬁcial system that contained no other proteins except cyt b5. In addition, a puriﬁed
recombinant mutant cyt b5 was used in these studies. Although the aggregation state
of intact cyt b5 in adrenal microsomes cannot be readily determined, the addition of
the aggregate to adrenal microsomes signiﬁcantly inﬂuenced the metabolism of
progesteronewhile the truncated form of cyt b5 had no effect. The aggregation of cyt
b5 in the endoplasmic membrane and the inﬂuence of the aggregation on the
biological activity of the enzyme will be further investigated.
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Abstract
The steroid 17-hydroxylase cytochrome P450 (CYP17) found in mammalian adrenal and gonadal tissues typically exhibits not only
steroid 17-hydroxylase activity but also C-17,20-lyase activity. These two reactions, catalyzed by CYP17, allow for the biosynthesis of
the glucocorticoids in the adrenal cortex, as a result of the 17-hydroxylase activity, and for the biosynthesis of androgenic C19 steroids
in the adrenal cortex and gonads as a result of the additional lyase activity. A major diﬀerence between species with regard to adrenal
steroidogenesis resides in the lyase activity of CYP17 toward the hydroxylated intermediates and in the fact that the secretion of C19
steroids takes place, in some species, exclusively in the gonads. Ovine CYP17 expressed in HEK 293 cells converts progesterone to
17-hydroxyprogesterone and pregnenolone to dehydroepiandrosterone via 17-hydroxypregnenolone. In ovine adrenal microsomes,
minimal if any lyase activity was observed toward either progesterone or pregnenolone. Others have demonstrated the involvement of
cytochrome b5 in the augmentation of CYP17 lyase activity. Although the presence of cytochrome b5 in ovine adrenocortical
microsomes was established, ovine adrenal microsomes did not convert pregnenolone or 17-hydroxypregnenolone to dehydroepi-
androsterone. Furthermore the addition of puriﬁed ovine cytochrome b5 to ovine adrenal microsomes did not promote lyase activity.
We conclude that, in the ovine adrenal cortex, factors other than cytochrome b5 inﬂuence the lyase activity of ovine CYP17.
 2002 Elsevier Science (USA). All rights reserved.
The abilities to accept more than one substrate and to
produce multiple products from single substrates place
the adrenal and gonadal steroidogenic enzymes in a rare
position in mammalian metabolism. The steroidogenic
enzymes most notable for multiple substrate and prod-
uct catalyses are steroid 17a-hydroxylase cytochrome
P450 (CYP17)1 and 3b-hydroxysteroid dehydrogenase/
D5!4-isomerase (3b-HSD). The latter has the ability to
convert the 3b-hydroxy-D5-steroid precursors pregnen-
olone (P5) and 17-hydroxypregnenolone (17-OHP5) and
dehydroepiandrosterone (DHEA) to the corresponding
D4 3-ketosteroids, while CYP17 can, depending on the
species and the tissue, convert P5 and progesterone (P4)
to the corresponding 17-hydroxy derivatives as well as
the two sex steroid precursors, DHEA and androstene-
dione (A4).
Because of the competition between CYP17 and 3b-
HSD for the same substrates, the ratio of one enzyme
activity to the other, as well as substrate speciﬁcities,
vitally determine the steroidogenic pathway and cata-
lytic eﬃciency with which steroid intermediates and end
products are formed. Furthermore, as only a single
CYP17 gene has been demonstrated in any species,
variations in the ratio of 17a-hydroxylase to 17,20-lyase
activity, seen in various adrenal and gonadal tissues,
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indicate that these two activities of CYP17 are modu-
lated on a posttranscriptional level [1,2]. Testicular
CYP17, for instance, has a relatively higher 17,20-lyase
activity compared to 17-hydroxylase than adrenal
CYP17 and much of the 17-hydroxy C21-steroid inter-
mediates are quantitatively converted to C19 steroids in
the testes. The 17a-hydroxylation of P5 or P4 takes
place wherever CYP17 is expressed but the subsequent
lyase activity for the hydroxylated intermediates diﬀers
markedly. Rat and porcine CYP17 metabolize both 17-
OHP5 and 17-hydroxyprogesterone (17-OHP4) to
DHEA and A4, respectively [3,4]. Human and bovine
CYP17 are unable to convert 17-OHP4 to A4 [5,6],
while guinea pig CYP17 cannot convert 17-OHP5 to
DHEA but does metabolize 17-OHP4 to A4 [7].
It is evident that the relative natures of 17a-hydrox-
ylase and 17,20-lyase activities are, by and large, species-
speciﬁc and are also inﬂuenced by a number of other
factors. The regulation of the relative ﬂow of steroids
through the glucocorticoid and adrenal androgen
pathways is unclear. It is established that the human
adrenal cortex acquires a marked capacity for adrenal
androgen biosynthesis at the time of adrenarche, prob-
ably developmentally regulated by changes in the func-
tion of the zona reticularis. Electron transfer proteins,
such as NADPH cytochrome P450 reductase, cyto-
chrome 21-hydroxylase (CYP21), and 3b-HSD [4,8,9],
as well as the liposomal membranous environment [10],
are factors which appear to inﬂuence the lyase activity
and therefore adrenal androgen production.
The production of C19 steroids in gonads and im-
portantly ovine placenta at the time of parturition re-
quires the manifestation of CYP17 lyase activity [11].
The purpose of this study was to compare the activity of
ovine CYP17 expressed in HEK 293T cells with the
activity of the enzyme in ovine adrenal microsomes. The
lyase activity of CYP17 in ovine adrenal microsomes
toward the D5 steroids, P5 and 17-OHP5, was also
evaluated.
Materials and methods
Preparation of ovine adrenal microsomes
The adrenals of sheep were immediately removed
after slaughter at local abattoirs and stored on ice. All
subsequent procedures were performed at 4 C. After
removal of the capsule and medulla, the adrenals were
homogenized in three parts of 10mM Tris–HCI buﬀer
(pH 7.4) containing 1.0mM EDTA and 0.25M sucrose
and centrifuged at 500g for 10min. The supernatant
fraction was subsequently centrifuged at 11,000g for
16min, and the postmitochondrial fraction was col-
lected. To prepare the microsomes a 50% (w/v) PEG
8000 solution was added slowly with stirring to the
postmitochondrial supernatant to a ﬁnal concentration
of 8.5% and the mixture was stirred for 10min at 4 C
and then centrifuged at 13,000g for 20min. The micro-
somal pellets were suspended in 10mM Tris–HCl buﬀer
(pH 7.4) containing 150mM KCl and 1.0mM EDTA.
PEG was again added to the suspension to a ﬁnal con-
centration of 8.5% and the mixture was stirred and
centrifuged at 13,000g for 20min. This procedure was
repeated twice until the supernatant was clear. The ﬁnal
microsomal pellet was suspended in 10mM Tris–HCl
buﬀer (pH 7.4) containing 0.25M sucrose and 1mM
EDTA and stored at )70 C until use.
Cytochrome P450 and cytochrome b5 assays
The cytochrome P450 and cytochrome b5 contents of
microsomal preparations were determined as previously
described [12,13].
Steroid-induced diﬀerence spectra
The microsomal preparation (1mg protein/ml,
0.45 nmol P450/mg protein) was divided into two opti-
cally matched cuvettes and a baseline was recorded be-
tween 385 and 500 nm using a Kontron Uviko 860
spectrophotometer. Steroid dissolved in ethanol was
subsequently added to the sample cuvette and an equal
volume of ethanol to the reference cuvette. The contents
of both cuvettes were mixed by gentle inversion and a
diﬀerence spectrum was recorded between 385 and
500 nm.
Cloning of ovine CYP17
Total RNA was extracted from ovine adrenal cortex
with guanidinium thiocyanate followed by centrifuga-
tion in a cesium chloride solution [14]. Polyadenylated
RNA was isolated using a mRNA Capture Kit (Boeh-
ringer–Mannheim Biochemicals).
Complementary cDNA was synthesized by reverse
transcription of mRNA using the Titan One Tube RT-
PCR system (Boehringer–Mannheim Biochemicals).
The reverse transcription reaction was performed at
50 C for 30min after which thermocycling was carried
out directly. Ovine-speciﬁc primers complementary to
the 50 (sense) and 30 (antisense) termini of ovine CYP17,
50-aagcttgacacaatgtgggtgctc-30 (includes a HindIII re-
striction site) and 50-tctcgagtcatgaggtgctaccctca-30 (in-
cludes a XhoI restriction site), respectively, were derived
from GenBank Accession No. L40335 for ovine CYP17.
The RT-PCR product was gel puriﬁed, digested with
HindIII and XhoI, and cloned into the mammalian ex-
pression vector pcDNA3.1 (InVitrogen, Paisley, UK).
Nucleotide sequences of both strands, puriﬁed RT-PCR
product and cloned cDNA, were determined using the
BigDye Version 2 terminator sequencing kit (Model
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373A ABI; Applied Biosystems, Foster City, CA, USA).
These were in accord with that sequence except that
amino acid residue 434 was Asn (caa) as noted in up-
dated GenBank Accession No. AF251388 (recorded in
L40355 erroneously as cta for Tyr).
Expression of sheep CYP17 in HEK 293T cells
HEK 293T cells were plated into six-well tissue culture
dishes at a density of 250,000 cells/well. The cells were
cultured for 24 h and transfection with the pcDNA3.1
vector was achieved using the GenePORTER II (Gene
Therapy Systems, San Diego, CA, USA) transfection
protocol.
Assay for microsomal steroid metabolism
Incubations were performed in a shaking water bath
at 37 C in a total volume of 1ml. The reaction was
carried out in a 50mM Tris buﬀer solution (pH 7.4) that
contained 1% bovine serum albumin and 50mM NaCl.
In addition, the reaction mixture contained microsomal
preparation (0.35 lM P450), NADPH (1mM), MgCl2
(10mM), isocitrate (2mg/ml), and isocitrate dehydro-
genase (0.2U/ml). After a 5-min preincubation period,
the reaction was initiated by the addition of the appro-
priate steroid substrate in ethanol. The steroids present
in the reaction mixtures were extracted from the incu-
bation mixture with methylene chloride (9:1 solvent to
incubation mixture). The water phase was removed and
the methylene chloride was evaporated under a stream
of air or nitrogen. The residues were subsequently dis-
solved in the appropriate solvent for TLC or HPLC
analyses. Steroid recovery was greater than 85%.
HPLC analyses of steroid mixtures
For radioactive and D4 steroids, methanol (100 ll)
was added to the dried steroid residue and the resultant
solution subjected to HPLC analysis on a Novapak C18
column (see legends to ﬁgures for solvents and detection
methods). Before HPLC analyses and UV-detection, D5
steroids were converted to D4 steroids by cholesterol
oxidase treatment. Cholesterol oxidase (2U/ml in 1%
sodium deoxycholate, pH 7.4) was added to the dried
steroid extracts. The conversion to the 4-ene-3-one de-
rivatives was performed at 37 C for 20min. Steroids
were subsequently extracted as described above and
analyzed by HPLC.
TLC analyses of steroid mixtures
Thin-layer chromatography was carried out on alu-
minum TLC plates coated with Silica gel 60 F254
(Merck, Darmstadt, Germany). The solvent system
used for development was chloroform:ethyl acetate 4:1
(vol/vol). Identiﬁcation and quantiﬁcation of steroids
was with a TLC radioimager (Bioscan 200 Imaging
Scanner; Bioscan Imaging Systems, Washington DC).
Isolation and puriﬁcation of ovine cytochrome b5
Sheep liver was obtained from the abattoir and kept
on ice until used. Liver microsomes were prepared and
fractionated as described by Yang and Cederbaum [15].
All procedures were carried out at 4 C. The supernatant
of the fractionation step was loaded on a DEAE-cellu-
lose column (3:2 20 cm) equilibrated with 80mM Tris
acetate, 1mM EDTA, 2% Triton X-100, pH 8.1. The
column was washed with 3 bed volumes of equilibration
buﬀer before cytochrome b5 reductase was eluted as a
yellow band with 0.1M Tris acetate, 1mM EDTA, 2%
Triton X-100, pH 8.1. After elution of the reductase, a
linear gradient from 0 to 50mM NaSCN was run over 3
bed volumes in 10mM Tris acetate, 1mM EDTA, 0.1%
deoxycholate, 0.2% Triton X-100, pH 8.1. The cyto-
chrome b5 was subsequently eluted with 90mM NaSCN
in the 10mM Tris acetate buﬀer. This fraction was di-
alyzed overnight against at least ten volumes of 10mM
Tris acetate buﬀer and applied to a DEAE-cellulose
column (2 20 cm) equilibrated with 10mM Tris ace-
tate, 1mM EDTA, 0.2% Triton X-100, 0.05% deoxy-
cholate, pH 8.1. After the column was washed with 3
bed volumes of equilibration buﬀer, a linear gradient of
NaSCN, in equilibration buﬀer, was run over 3 bed
volumes from 0 to 50mM NaSCN to remove trace im-
purities. The ﬁnal cytochrome b5 preparation was ob-
tained by running a linear NaSCN gradient from 50 to
90mM NaSCN over 5 bed volumes. The solution con-
taining puriﬁed cytochrome b5 was subsequently dia-
lyzed overnight against 10 volumes of elution buﬀer
(10mM Tris acetate, 0.1mM EDTA, pH 8.1) and the
resulting dialysate was applied to a 1 5-cm DEAE-
cellulose column equilibrated with elution buﬀer. The
column was washed with 2L of elution buﬀer to remove
the Triton X-100. The cytochrome b5 was eluted with
Tris buﬀer (10mM Tris acetate, 0.1mM EDTA, 0.25M
NaSCN, 0.25% sodium deoxycholate, pH 8.1) and the
eluate was dialyzed overnight against elution buﬀer. The
resulting cytochrome b5 preparation was stored at
)80 C.
Preparation of antibodies against cytochrome b5
Polyclonal antibodies against the puriﬁed cytochrome
b5 were raised in rabbits as previously described [16,17].
Western blot analyses
Puriﬁed cytochrome b5 and microsomal preparations
from ovine liver, testes, and adrenals and bovine liver
microsomes were subjected to SDS–PAGE according to
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the method of Laemmli using typical conditions for the
denaturing of membrane-bound proteins [18]. Western
blot analyses were carried out with rabbit anti-sheep
cytochrome b5 IgG at a 1:2000 dilution using the Su-
perSignal West Dura Western Blotting kit (Pierce-
Chemical, Rockford, IL, USA).
Electrospray mass spectrometry of puriﬁed cytochrome b5
Samples for ES-MS analysis were prepared by dia-
lyzing the puriﬁed cytochrome b5 solution (intact or
fragment) overnight against deionized water. The solu-
tion was then diluted 1:20 in a 50% acetonitrile solution
to a ﬁnal amount of 0.35 lmol. Solvent (acetoni-
trile:water—50:50 v/v) was delivered to the ES-MS using
a Pharmacia/LKB2249 HPLC pump at 20 ll/min. The
sample (10 ll) was injected via a Rheodyne injection
valve into the solvent stream and introduced through a
conventional electrospray probe with the capillary
voltage set at 3.5 kV and the cone voltage at 70V. The
source temperature was 80 C and a coaxial ﬂow of ni-
trogen gas at 100 psi was applied. The instrument was
operated and the data were processed by the MassLynx
software supplied by the manufacturers. The multiple
charged ions of cytochrome b5 were observed by scan-
ning the ﬁrst mass analyzer of the instrument from
m=z ¼ 400–1500 at a scanning speed of 100 amu/s.
Results
Cytochrome P450 and cytochrome b5 concentrations
A CO-induced diﬀerence spectrum of reduced versus
oxidized ovine adrenal microsomal cytochrome P450 is
shown in Fig. 1A and the NADH reduced versus oxi-
dized diﬀerence spectrum of cytochrome b5 in the same
preparation is shown in Fig. 1B. The cytochrome P450
concentration in sheep adrenal microsomes was
0.45 nmol/mg protein (actually computed from dithio-
nite-reduced plus CO versus dithionite-reduced diﬀer-
ence spectra) and the cytochrome b5 content was
0.2 nmol/mg protein.
Cytochrome P450 substrate-induced diﬀerence spectra
The ovine adrenal microsomal cytochrome P450
substrate-induced diﬀerence spectra are shown in Fig. 2.
All four steroids, P4, P5, and their respective 17-
hydroxysteroid derivatives, bound to the microsomal
cytochrome P450 inducing typical type I spectra with an
absorption maximum at 385 nm and an absorption
minimum at 420 nm.
Progesterone and pregnenolone metabolism by ovine
adrenal microsomes
The conversion of P4 to 17-OHP4 and subsequently
to deoxycortisol by sheep adrenal microsomes is shown
in Fig. 3. During the 12-min incubation period ap-
proximately 50% of the total P4 added was converted to
deoxycorticosterone and approximately 20% to deoxy-
cortisol. No formation of A4 was detected. [3H]Preg-
nenolone was converted to 17-OHP5, P4, deoxycortisol,
and deoxycorticosterone by sheep adrenal microsomes
(Fig. 4). After the 15-min incubation period no 17-
OHP4, androstenedione, or DHEA could be detected.
The inﬂuence of 3b-HSD on microsomal P5 metabolism
was subsequently minimized by the addition of the po-
tent 3b-HSD inhibitor, 17b-N,N-diethylcarbomyl-4-aza-
4-methyl-5-aandrostane-3-one (4MA). In the presence
of the inhibitor only P5 and 17-OHP5 could be identiﬁed
Fig. 1. (A) CO-induced reduced versus oxidized diﬀerence spectrum of
ovine adrenal microsomal cytochrome P450. (B) NADH reduced
versus oxidized diﬀerence spectrum of ovine adrenal microsomes.
Fig. 2. Type I induced diﬀerence spectra of ovine adrenal microsomal
cytochrome P450 produced with P4, P5, and their 17-hydroxy deriv-
atives.
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in the incubation mixture and no DHEA was formed
(Fig. 5A). When 17-OHP5 was provided as substrate, no
other steroids except the 17-OHP5 substrate could be
detected in the reaction mixture after a 30-min incuba-
tion period, indicating that this steroid was not readily
metabolized in sheep adrenal microsomes (Fig. 5B). A
time course of the metabolism of P5 to 17-OHP5 by
ovine adrenal microsomes in the presence of 4MA is
given in Fig. 6.
When an ovine adrenal microsomal assay (0.35 lM
P450) was supplemented with 0.5 lM puriﬁed ovine liver
cytochrome b5 (i.e., a fourfold increase in cytochrome b5
concentration) CYP17-related activities were not in-
creased compared to control activities as determined
over a 10-min assay period; in particular, no 17-OHP5
C-17,20-lyase activity was observed.
Metabolism of progesterone and pregnenolone in HEK
293T cells expressing ovine CYP17 cDNA
Sheep CYP17 expressed in HEK 293T cells converted
P4 to 17-OHP4 as the main metabolite. After an incu-
bation period of 8 h 90% of the added P4 was converted
to 17-OHP4 but no A4 was detected. After an incuba-
tion period of 12 h, approximately 14% of the radioac-
tivity was associated with A4 (Fig. 7A). In contrast to
P4, 70% of the P5 added was converted to the C19 ste-
roid, DHEA, via 17-OHP5 in 12 h (Fig. 7B).
Fig. 4. HPLC chromatogram of P5 metabolites produced by ovine
adrenal microsomes. No 17-OHP4 or C19 steroids were detected after a
15-min incubation period. Steroids were separated and quantiﬁed by
HPLC using a Novapak C18 column with mobile phases consisting of
solvent A (water/methanol 50/50) and solvent B (methanol). The col-
umn was eluted for 25min with solvent A followed by a linear gradient
from 100% A to 100% B in 5min and a further 10-min isocratic elution
with solvent B. Steroids were detected with a UV detector at 254 nm.
[P450] 0.35lM, [P5] 20lM, [3H]pregnenolone 100,000 cpm/ml. Peaks
1, P5; 2, P4; 3, 17-OHP5; 4, DHEA; 5, 17-OHP4; 6, deoxycorticos-
terone; 7, A4; 8, deoxycortisol.
Fig. 5. (A) HPLC chromatogram of P5 metabolites after incubation
with ovine adrenal microsomes in the presence of the 3b-HSD inhibitor
4MA (20lM). (B) HPLC chromatogram of 17-OHP5 metabolites after
incubation with ovine adrenal microsomes in the presence of the 3b-
HSD inhibitor 4MA (20lM). Note. The D5-3b-hydroxysteroids were
extracted and enzymatically converted to the corresponding D4 ste-
roids by cholesterol oxidase treatment (0.2mU/ml) before HPLC
separation. [P450] 0.35lM, [17-OHP5] and [P5] 30lM.
Fig. 3. Metabolism of P4 (20 lM) by ovine adrenal microsomes. Ste-
roids were separated and quantiﬁed by HPLC using a Novapak C18
column with mobile phases consisting of solvent A (water/methanol
40/60) and solvent B (methanol). The column was eluted for 15min
with solvent A followed by a linear gradient from 100% A to 100% B in
10min and a further 10-min isocratic elution with solvent B. Tritiated
steroids were detected with a Radiomatic A-100 ﬂow detector. [P450]
0.35lM, [3H]progesterone 100,000 cpm/ml.
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Isolation and puriﬁcation of ovine cytochrome b5
Table 1 presents the protein puriﬁcation data for
ovine cytochrome b5. A 37-fold puriﬁcation was ob-
tained with a cytochrome b5 yield of 44%. ES-MS
analyses of the puriﬁed cytochrome b5 preparation in-
dicated a single protein with a molecular mass of
15,260Da (Figs. 8A and B).
Fig. 6. Time course of P5 and 17-OHP5 metabolism by ovine adrenal
microsomes in the presence of the 3b-HSD inhibitor 4MA (20lM).
The dashed line denotes levels of 17-OHP4 derived from 17-OHP5
when the latter was added as the sole substrate. Note. The D5-3b-
hydroxysteroids were extracted and enzymatically converted to the
corresponding D4 steroids by cholesterol oxidase treatment (0.2mU/
ml) before HPLC separation. [P450] 0.35lM and [P5] 30lM.
Fig. 7. (A) Time course for the metabolism of P4 by HEK 293T cells
transfected with ovine CYP17. (B) Time course for themetabolism of P5
by HEK 293T cells transfected with ovine CYP17. Steroids were sepa-
rated and quantiﬁed by TLC as described underMaterials andmethods.
Table 1






















Microsomes 50 32.48 1624.00
Triton X-100 extract 430 3.42 1470.60 1.76 750 0.5 100
First DEAE eluate 170 2.52 428.74 3.89 660 1.5 3.00 87.6
Second DEAE eluate 30 0.58 17.46 10.94 330 18.8 36.61 43.5
Fig. 8. (A) Electrospray mass spectrum of puriﬁed ovine cytochrome
b5. The peaks at 803.70, 849.04, 898.85, 964.64, 1017.96, 1090.83,
1174.55, 1272.61, and 1387.86 represent the same protein with diﬀerent
charges. (B) Deconvoluted spectrum of the multiply charged ion
spectrum (A). Deconvolution was carried out using the MaxEnt pro-
gram which is an integral part of the instrument software. The resul-
tant molecular mass of the protein was 15,260Da.
Fig. 9. Immunoblot analyses of microsomes of ovine liver (1), bovine
adrenal (2), ovine adrenal (3), ovine testes (4), and puriﬁed ovine cy-
tochrome b5 (5). For each of the microsomal preparations, 50 lg of
protein was loaded per lane and for the puriﬁed cytochrome b5 prep-
aration, 10lg of protein. Rabbit anti-cytochrome b5 serum was used at
a 1:2000 dilution.
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Immunoblot analyses
The immunoblot analyses of microsomal prepara-
tions from ovine liver, adrenal, and testes and bovine
adrenal and of puriﬁed sheep cytochrome b5 are shown
in Fig. 9. The puriﬁed cytochrome b5 gave immuno-
precipitation bands at 60 and 15 kDa. The band at
60 kDa is a tetramer of the 15 kDa protein monomer
and not an impurity as the ESMS-analyses of this
preparation showed that only the 15 kDa species was
present (see Figs. 8A and B).
Discussion
Extragonadal C19 steroids are secreted in signiﬁcant
amounts only in man and higher primates exhibiting
adrenal CYP17 expression. In the adrenals of humans,
higher primates, and cattle the zona reticularis, like the
gonads, expresses CYP17 and 3b-HSD although the
latter may be quite low in the zona reticularis of non-
stressed humans [9]. Therefore, even though the adrenals
and gonads are functionally distinct they are both ca-
pable of synthesizing similar steroid intermediates.
However, P4 is not metabolized to A4 due to the rela-
tively ineﬃcient use of 17-OHP4 as a substrate for 17,
20-lyase activity. A4 in man and bovine is normally
biosynthesized via the D5 pathway. Porcine adrenal
CYP17 catalyzes the formation of A4 via the D5 and D4
pathways. In contrast in rats, mice, and rabbits, CYP17
expression is restricted to the gonads where A4 is pro-
duced by either of the two pathways.
Expression of ovine CYP17 in HEK 293T cells
showed that the enzyme has the ability to convert 17-
OHP5 to yield DHEA while C19 steroid production
from P4 was minimal. This is not surprising as steroid
metabolism in ovine testes and placentomes produces
the androgen precursors for testosterone and estrogen
production [11]. Ovine adrenal microsomes, however,
did not produce androgens through either the D5 or the
D4 pathway. No A4 was synthesized with P4 as sub-
strate, while P5 metabolism, in the absence of a 3b-HSD
inhibitor, also yielded the precursors for glucocorticoid
and mineralocorticoid production in ovine adrenal mi-
crosomes. When the actions of 3b-HSD were arrested by
the addition of 4MA, 17-OHP5 was produced as the sole
product. Substrate-induced diﬀerence spectra of ovine
adrenal microsomal cytochrome P450 showed that both
P4 and P5, as well as their 17-hydroxy derivatives, had
the ability to induce typical type I diﬀerence spectra. The
interaction of P5 and 17-OHP5, substrates for CYP17
alone, is signiﬁcant in this regard and indicates that the
microsomal enzyme has the ability to bind both sub-
strates and is therefore capable of potentially yielding
DHEA, yet this C19 steroid is not produced in adrenal
microsomes. It is also notable that ovine adrenocortical
cells, even after prolonged ACTH treatment, did not
produce C19 steroids [19]. Normal gonadal and placental
androgen production, steroid C-17,20-lyase activity to-
ward 17-OHP5 in HEK 293T cells expressing ovine
CYP17, the conversion of P5 as well as P4 to
glucocorticoids and mineralocorticoid precursors, and
substrate-induced diﬀerence spectra together conﬁrm
that ovine CYP17 is a fully functional enzyme capable
of converting P5 or 17-OHP5 to DHEA. The inability of
the adrenal enzyme to produce DHEA in ovine adrenals
therefore has to be attributed to one (or more) factor(s)
present in the adrenal cortex that speciﬁcally aﬀects the
formation of DHEA from its D5 precursors. A number
of previous studies have shown that cytochrome b5 has
the ability to amplify greatly the lyase activity of CYP17
not only in humans [6,20] but also in other species
[1,2,21]. As shown in Figs. 1A and B, cytochrome b5 is
present in ovine adrenal microsomes at a concentration
of 0.2 nmol/mg protein. The ratio of cytochrome
P450:cytochrome b5 in adrenal microsomes is about
2.5:1 and, making a reasonable assumption that both
CYP17 and CYP21 contribute similarly to total adrenal
microsomal P450, the relative level of cytochrome b5 to
CYP17 compares well with ﬁgures previously reported
for ovine gonadal tissue in which adequate D5-lyase
activity is demonstrable [22]. The immunoblot analysis
of ovine adrenal microsomes after SDS–PAGE shows
that cytochrome b5 is present in an amount comparable
to those in microsomes of ovine testes and liver and
bovine adrenal tissues. The maintenance of a tetrameric
state after the reasonably standard denaturing condi-
tions [18] employed suggests signiﬁcant secondary
structural interactions in this cytochrome structure. In
addition the signal for cytochrome b5 in the ovine tissue
is on the same order of intensity and character as that
for bovine adrenal microsomal cytochrome b5. The
typical quaternary structure of cytochrome b5 does not
appear to have been addressed in the literature with any
detail although multimeric species of human cyto-
chrome b5 have been noted [8]. It remains a possibility
that only monomeric cytochrome b5 can eﬀectively
promote ovine adrenal CYP17-dependent lyase activity;
however, it must be noted that monomeric cytochrome
b5 is a very minor species not only in other ovine tissues
but also in bovine adrenal where C-17,20-lyase activity
is well established. The quaternary structural status of
cytochrome b5, or even that of cytochrome P450, under
reconstituted activity conditions has not been addressed
in the numerous studies examining the eﬀect of cyto-
chrome b5 on cytochrome P450-dependent activities and
therefore is an avenue for future studies.
From the results presented in this paper it is evident
that ovine adrenal microsomes do not convert P5 or P4
to C19-androgen precursors. The absence in the ovine
adrenal cortex of CYP17 lyase activity toward D5 ste-
roids is not because of a lack of cytochrome b5 in ovine
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adrenal endoplasmic reticulum. It is therefore be de-
duced that the inability of ovine adrenal CYP17 to lyze
17-OHP5 is due to the presence or absence of a modu-
lating substance other than cytochrome b5.
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